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A study was made of some aspects of the pathogenic and antigenic
relationships between 2 reference strains of cytopathic (CP) pestivirus, namely
bovine virus diarrhoea (NADL strain) (BVDV-NADL) and border disease virus
(Moredun strain) (BDV-M).
Initial _in^ vitro studies showed that only cultured cells of bovine and
ovine origin allowed virus growth with the production of cytopathic effect.
BVDV-NADL gave comparable levels of virus in various foetal tissues from both
species, whereas ovine foetal tissues were superior for the growth and assay of
BDV-M. Ovine foetuses had the added advantage that only 2 of 105 (1.9%)
abattoir foetuses were contaminated with noncytopathic (NCP) pestiviruses as
against 15 of 113 (13.3%) bovine foetuses.
A severe acute disease resembling bovine mucosal disease was produced in 7
of 8 recovered hairy shaker (RHS) sheep which were persistently infected with
BDV and subsequently superinfected with high tissue culture passage BDV-M
derived from the infectious brain pool used to infect their dams at 54 days'
gestation. No disease occurred in RHS from the same origin superinfected with
BVDV-NADL or left unchallenged.
Superinfection with low passage BDV-M of RHS from field outbreaks of BD
produced serious acute or chronic disease in 4 of 10 cases but in none of 5
normal controls receiving the same inoculum. All surviving RHS lambs
seroconverted to BDV-M but NCP pestiviraemia was sustained and the animals
remained infectious to other lambs.
Low tissue culture passage BDV-M was used to infect 15 pregnant ewes at 54
days's gestation. Five produced 9 viable lambs, all of which had clinical BD
and an NCP pestiviraemia at birth. At 9 weeks of age a set of twins was killed
after exhibiting a mucosal disease-like syndrome, and CP BD virus was isolated
from many organs. The twins were the only live progeny of one of the 2 tups
used as sires. No such disease occurred in the other RHS in the same pen.
The pathogenicity for the placenta and foetuses of ewes infected with
plaque purifed stocks of the 2 reference strains or of 3 field isolates of CP
BVDV was very mild. Failure to recover virus easily was attributed to poor
replication of these stocks in vivo.
Antisera to the plaque purified viruses were produced in gnotobiotic lambs.
By cross-immunofluorescence the 5 viruses were indistinguishable whereas cross-
neutralisation segregated BDV-M as a distinct serotype from the 4 BVD viruses.
Western blotting demonstrated 2 virus-induced proteins (78K and 35K) in cells
infected with BVDV but only the 78K protein in cells infected with BDV-M.





Bovine virus diarrhoea (BVD) virus was first isolated
in North America from an outbreak of enteric disease in
cattle (Baker et al.,1954). Border disease (BD), a
congenital disease of sheep first described in the border
region of England and Wales, was later shown to be caused
by a virus serologically related to BVD virus (Acland et
al.,1972; Hamilton and Timoney, 1972).
An earlier important finding was that viruses from
cases of BVD (synonym: mucosal disease) were serologically
related to viruses isolated from cases of hog cholera
(synonym: swine fever), a fatal systemic disease of pigs
(Darbyshire,1960; 1962). These three viruses have been
grouped in the genus Pestivirus in the family Togaviridae
(Porterfield et al., 1978). Pestiviruses have a world-wide
distribution and are a significant cause of disease among
susceptible domestic livestock. In Britain, HC has been
eradicated by a slaughter policy, but no means of control
of cattle and sheep diseases caused by pestiviruses has yet
been introduced. Effective control measures rely on a
knowledge of the pathogenesis of infections with these
viruses and possible variations in the antigenicity of BVD
and BD virus isolates. Studies in this thesis are on the
pathogenic and antigenic relationships between the two
viruses. In the following review of the extensive
literature on BVD and BD viruses emphasis has been placed
on work relevant to these areas. Other aspects of
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infections with the two viruses have been included in other
works (Pritchard,1963; Saurat et al..l972; Horzinek,1981;
Barlow and Patterson,1982). This review is of reports
published before 1983; relevant papers published since then
will be included in the discussion of chapters to which
they relate.
FIRST DESCRIPTIONS AND NOMENCLATURE.
Virus diarrhoea, 'X' disease and mucosal disease were
the names given to apparently new transmissible enteric
diseases of cattle first described in different regions of
North America (Olafson et al.,1946; Childs,1946: Ramsey and
Chivers,1953). The terms virus diarrhoea or BVD and mucosal
disease(MD) were sustained in early reports from 18 other
countries around the world (Mills et al.,1965). The main
clinical symptoms were diarrhoea and erosions and
ulceration of the oral mucosa. Pyrexia, anorexia,
salivation and nasal discharge usually also occurred, while
some cases had skin lesions and were lame due to
interdigital ulceration and inflammation of the coronary
bands. The main pathological features were erosions,
ulcerations, hyperaemia, haemorrhage and oedema of the
mucosae of the alimentary tract with atrophic changes in
lymphatic tissues. For some time, at least two separate
diseases were thought to exist, but clinical and
pathological similarities between the two syndromes were
recognised and in an early review the name BVD-MD complex
was introduced (Pritchard,1963) . Viruses were isolated
from animals suffering from BVD (Baker et al.,1954;
3
Gillespie et al.,1960) and MD (Underdahl et al.,1957) and
serological tests showed that these and other isolates were
antigenically related (Gillespie et al.,1961). Viruses
from BVD and MD cases in U.S.A., West Germany, Scotland and
England were also shown to be related (Kniazeff et al.,
1961). For reasons of historical precedent the reference
virus for the two syndromes was termed BVD virus (BVDV).
The name 'B' or 'Border disease' was proposed by
Hughes et al.(1959) for a disease affecting young lambs of
the Clun Forest and Kerry Hill breeds in counties on both
sides of the England/Wales border. The syndrome was
characterised by an increased amount of long, wavy, often
abnormally pigmented, hair in the birth-coat of lambs a
proportion of which showed nervous symptoms varying from a
slightly defective gait to a violent tremor. Affected
lambs were smaller, grew less well than normal and few
survived beyond weaning. The major pathological finding
was a deficiency of myelin throughout the central nervous
system (CNS) of lambs with nervous symptoms. This finding
led to the use of an alternative name, 'hypomyelinogenesis
congenita', in a description of the neurological
manifestations of the disease in lambs of mixed breeds
(Markson et al.,1959).
In New Zealand a congenital chorea in lambs with
hairy fleeces and reduced amounts of myelin in the CNS was
first described in Romney crosses (Hartley and Kater,1962),
and later in a wider variety of breeds (Manktelow et
al.,1969). Affected lambs were described as
'hairy-shakers'.
4
The world-wide distribution of Border disease is
shown by reports from North America (Osburn et al., 1972;
Physick-Sheard et al., 1980), Ireland (Hamilton and
Donnelly, 1970), Scotland (Dickinson and Barlow, 1967),
Greece (Spais et al., 1975) and Australia (Acland et al.,
1972) .
The transmissible nature of BD was first shown by the
inoculation of pregnant ewes with tissue homogenates of
affected lambs and foetuses (Dickinson and Barlow,1967;
Shaw et al.,1967),and evidence for a viral aetiology came
from transmission experiments using cell-free filtrates of
tissue homogenates (Gardiner and Barlow,1972).
CLINICAL DISEASES CAUSED BY OR ASSOCIATED WITH BVDV AND BDV
Diseases in cattle and sheep
Since the original descriptions of the two syndromes
no other diseases have been attributed to border disease
virus which is, therefore, regarded solely as a cause of
congenital disease with its most obvious clinical
manifestations occurring at lambing time.
In contrast, BVDV has been associated with a number
of other diseases. Serological surveys have shown that
BVDV is widespread in cattle throughout the world (see
Saurat et al.,1972). Ubiquity of the virus, often without
related disease implies that many infections must be
subclinical. However, as well as causing enteric disease,
BVDV is an important cause of foetal disease when
infections of susceptible pregnant cattle occur
(Kahrs,1973) . Characteristically, both syndromes are
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manifested by a wide range of symptoms from extremely
severe to clinically inapparent.
The evidence for the role of BVDV in causing other
diseases is not so conclusive, principally because of
difficulties in reproducing the syndromes experimentally.
Respiratory disease consisting of nasal discharges,
persistent coughs and hyperaemia of the respiratory mucosae
has been observed in some animals during field outbreaks of
BVDV (Olafson et al.,1946; Dow et al.,1956). In a
comprehensive investigation of viral causes of respiratory
disease in young housed calves seroconversion to BVDV was
associated significantly with outbreaks of disease, but no
cytopathic BVDV isolates were made (Stott et al.,1980).
Other workers have suggested that post-natal infection with
BVDV predisposes animals to infection with other
microorganisms and it is in this way that BVDV contributes
to outbreaks of respiratory disease (Reggiardo and
Kaeberle,1980; Roth and Kaeberle, 1982).
BVDV has been associated with infertility and early
embryonic death in cattle (Archbald et al.,1979). In view
of its ability to cause reproductive failure later in
gestation this property would not be unexpected but
experimental evidence is lacking. Indeed, seronegative cows
infected by natural routes at the time of breeding had
pregnancy rates comparable to uninfected controls (Whitmore
et al.,1981). BVDV has been associated with an immune
mediated ovaritis in infertile heifers but the significance
of this finding must await further studies (Ssentongo et
al. ,1980) .
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It is, therefore, largely as causes of congenital
infections in cattle and sheep that BVDV and BDV share
common properties.
Cross-infections between cattle and sheep
The first cytopathic virus isolated from tissues of
cattle with MD was shown to stimulate the formation of
neutralising antibodies in sheep (Underdahl et al.,1957).
This virus was not fully characterised but the first
cytopathic reference strain, Oregon C24V, was successfully
propagated by inoculating lamb foetuses in-utero (Taylor et
al.,1963). The significance of these reports appears to
have passed unnoticed. Neutralising antibody to BVDV was
detected in ovine sera in U.S.A. and Australia (Seibold
and Dougherty,1967; St.George,1971), but it was not until
1972 that sheep from flocks with BD were shown to produce
neutralising antibody to BVDV (Acland et al.,1972; Hamilton
and Timoney,1972).
In the meantime, two strains of BVDV were shown to
cause abortion and congenital defects when injected into
pregnant sheep (Ward,1971). The pathogenicity of BVDV
isolates for the sheep foetus has since been demonstrated
by other workers (Snowdon et al.,1975; Parsonson et
al.,1979; Terlecki et al.,1980). The reverse is also true;
material from BD lambs injected intramuscularly into
pregnant heifers caused foetal death in 9 of 10 animals
with all the dams developing antibodies to BVDV (Gibbons et
al.,1974).
Diseases of other species
Pigs. Serological cross-reactions between HCV and
BVDV continue to hamper HC control programmes in countries
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where that disease is endemic. Results from Australia and
Ireland where virulent HC has never occurred have shown
that antibodies to BVDV are readily detectable in some pig
herds with no recognised disease problems (French and
Snowdon,1977; Lenihan and Collery,1977). No natural
outbreaks of disease in pigs due to pestiviruses more
closely related to BVDV or BDV have been described but
experimental infections have shown that infection can occur
in a low percentage of piglets born to sows infected with
BDV and BVDV in early gestation (Wrathall et al.,1978;
Stewart et al.,1980).
Goats. Experimental infection of pregnant goats with
BDV resulted in a high incidence of abortions and the birth
of kids with tremor, hypomyelinogenesis and hypergliosis of
the CNS (Barlow et al.,1975). A natural outbreak of border
disease has been described in Norway (Loken et al.,1982),
and in Australia a pestivirus was isolated from the
pneumonic lung of a kid, but its role in the aetiology of
the disease was unknown (Fraser et al.,1981).
Wildlife species. Outbreaks of MD and BVD-like
diseases have been seen in wild deer in U.S.A. and wild
ruminants in the Hanover zoo, but conclusive virological
studies were not done (Karstad,1981). Viruses related to
reference strains of BVDV have been isolated from the
spleens of roe deer and red deer but were probably not
wholly responsible for the death of the animals (Romvary,
1965; Nettleton et al.,1980).
FIGURE 1.1 Species of British domestic animals
susceptible to BVD and BD viruses.
Serological surveys have shown infection to
be most prevalent among cattle.
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PROPERTIES OF THE VIRUSES
Early studies showed BVDV to be a lipid-containing
virus,approximately 40 nm in diameter containing infectious
RNA (Hermodsson and Dihter,1962; Diderholm and
Dinter,1966). Other BVDV isolates were susceptible to
ether, chloroform,trypsin and heat and virions were shown
to contain single-stranded RNA (Gillespie et al.,1963;
Tanaka et al.,1968; Hafez and Liess,1972). The presence of
an envelope was confirmed by electron-microscope studies on
partly purified virus preparations which also revealed a
considerable size range of viral particles from 30 to more
than lOOnm (Ritchie and Fernelius,1969). Other workers
have described more homogeneous virus preparations with an
average diameter 50-80 nm. Virions were pleomorphic,
roughly spherical and covered with a compact membrane
(Stott et al.,1974; Della-Porta,1976). In some particles a
d.i stinctive 28nm core can be seen and beaded envelope
structures have also been described (Horzinek,1981).
Thin sections of BVDV-infected cell cultures have
n
also detected viral particles 45-55 nm in diameter within
characteristic vesicular structures (Chasey and
Roeder,1981). In a detailed study of viral morphogenesis it
was concluded that a budding process was not involved in
the development of BVDV (Ohmann and Bloch,1982).
Low virus titres, fragility of the virus and
contamination of purified preparations with cellular
contaminants have all hampered detailed physico-chemical
analysis of the virus. Three publications on the structure
of viral RNA from the NADL strain of BVDV (BVDV-NADL) have
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produced conflicting data. The major RNA component
extracted from isopycnically banded ( H) uridine
labelled virus had a sedimentation coefficient of 38s but
two minor components of 31s and 21s were also present. All
three RNA species were susceptible to digestion with RNAase
(Pritchett et al.,1975). In a second study one RNA species
with a sedimentation coefficient of 40s was extracted from
purified virus. This was also shown to be single stranded
by its susceptibility to digestion with RNAase. In the
same study two species of RNA were present in infected
cells. One appeared identical to the viral RNA and the
second RNA, which sedimented at 20s in sucrose gradients,
was resistant to RNAase and was considered to be the
replicative form of the virus RNA (Felmingham and
Brown,1977). While further elucidation of the form,
sedimentation characteristics and presence of heterogeneous
RNA species in BVD virus populations is clearly required
the studies have provided evidence that the molecular
weight of viral RNA is between 3.2 x 10^ and 3.6 x
10^, corresponding to 9.0 to 10.2 kilobases.
Conflicting results have also been reported on the
structural components of BVDV-NADL. Early studies
identified four virus-specific proteins having molecular
weights of 110K, 93K, 70K and 23K (Pritchett and Zee,1975).
Other workers have reported two major polypeptides, 144K
and 138K, and two minor ones, 117K and 100K (Felmingham and
Brown,1977), while in another study three structural
proteins with molecular weights of 57K, 44K and 34K were
described with the two larger proteins being glycosylated
(Matthaeus,1979).
FIGURE 1.2 Thin sections of cells infected with BVD
virus (Above) and BD virus (Below) reveal




FIGURE 1.3 At higher magnification virus particles,
40-50 nm in diameter are visible closely
associated with endoplasmic reticulum
(Above), and in vesicles near the surface of




FIGURE 1.4 Pestiviruses have a very indistinct structure
even in sharply focused prints. Although
virus particles are not believed to 'bud'
through cell membranes they may be seen





There is much less controversy over the structure of
BD viruses simply because no detailed studies have yet been
done. Virus in infective nervous tissue was shown to be
small, around 27nm, with an ether-soluble envelope. It was
inactivated by heating to 60°C for 90 minutes (Gardiner et
al., 1972). Studies on the cytopathic Moredun strain
BDV-M) and the non-cytopathic BD-2 strain have provided
further evidence that infectious virus is small,sensitive
to ether, chloroform, trypsin and heat (56°C for 30
minutes), and has RNA as its nucleic acid (Vantsis et al.,
1976; Harkness and Vantsis,1982). Comparative
centrifugation analysis of BD-2 virus with BVBD-NADL showed
that both had buoyant densities of 1.105 g./ml. in
Urografin gradients (Harkness and Vantsis,1982). Other
values for BVDV-NADL in caesium chloride gradients have
been reported as 1.14 g./ml. and 1.15 g./ml. (Hafez and
Liess,1972; Della-Porta,1976). In sucrose gradients BDV-M
had a buoyant density of 1.115 g./ml. (Vantsis et
al.,1976). This value is also similar to those of 1.092
g./ml. and 1.11 g./ml. obtained for BVDV-NADL under
comparable conditions. (Parks et al.,1972; Stott et
al. ,1974 ) .
BVDV and BDV, therefore, both have physico-chemical
properties consistent with their classification in the
family Togaviridae. In sucrose density gradients the
sedimentation coefficients and buoyant density of nine BVDV
strains, two BDV strains and six HCV strains were very
similar and these viruses were distinguishable from other
representative members of the togavirus family. It was
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concluded that BVDV, BDV and HCV form a structurally
homogeneous group within the Toqaviridae {Laude,1979).
ANTIGENIC RELATIONSHIPS
Within the Toqaviridae. The majority of togaviruses depend
on biological transmission by arthropods for their
survival. This is true of all alphaviruses and most
flaviviruses, the two major antigenically distinguishable
genera within the family. Antigenically distinct from these
two groups are those togaviruses which do not have an
arthropod vector, the so-called "non-arthropod-borne" or
nonarbo togaviruses (Horzinek,1973). Within the nonarbo
togaviruses two genera have been distinguished; Rubivirus
with its sole representative member rubella virus, and
Pestivirus within which BVDV, BDV and HCV are grouped. The
pestiviruses are serologically related but unrelated to
rubella virus (Porterfield et al.,1978). Between the
pestiviruses the basis for the formation of the pestivirus
genus came from the discovery of a serological relationship
between viral antigens present in tissues of animals
suffering from swine fever(HC) and mucosal disease(BVD)
using an agar gel diffusion test (Darbyshire,1960;
Darbyshire,1962). This relationship has been studied
intensively using a variety of serological methods, largely
to explore the feasibility of exploiting BVDV vaccines to
protect pigs against HC. Further work on the common
precipitation lines in immunodiffusion tests (IDT) using
infectious tissue culture fluids have shown that the
precipitating antigens are "soluble" antigens (SA)
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separable from infectious viral particles by
ultracentrifugation and ultrafiltration (Gutekunst and
Malmquist,1963). Immunoelectrophoresis (IEP) has confirmed
a reaction of identity between "soluble" HCV and BVDV
antigens (Matthaeus and Van Aert, 1971; Dalsgaard,1976).
The common pestivirus antigen is a glycoprotein (Dalsgaard
and Overby,1977) but its relationship to virus structure
remains unknown. Both IDT and IEP have shown that the
common SA of HCV and BVDV are not viral structural proteins
(Matthaeus,1977; 1980). The immunological relationship
between BDV, BVDV and HCV has been confirmed by ID tests
with no analysis of the precipitating proteins (Plant et
al.,1973) .
An antigenic relationship between HCV and BVDV has
been established by complement fixation (CF) tests
(Eskildsen and Overby,1976) and CF tests have been used to
measure the formation of "soluble" BVDV antigen in infected
cells. The SA was detectable intracellularly prior to the
appearance of infectious virus and was released from cells
at the same time as the virus (Gutekunst and
Malmquist,1965). When sheep and goats were inoculated with
tissues from cases of BD, CF antibodies to BVD antigens
were found in the sera (Huck et al.,1975).
Immunofluorescence (IF) tests have also been used to
demonstrate the relationship between HCV, BVDV and BDV.
For example HCV antisera have been used to detect BDV
(Harkness et al.,1977; Terpstra,1978). Some sera, notably
those raised against BVDV which lack neutralising antibody
against HCV still react strongly with HCV in IF tests
13
(Horzinek,1981). This shows that the determinants of
antigen detected by IF are different from those functioning
in virus neutralisation. Further evidence to support this
has come from studies on the time of appearance of
fluorescence in both HCV and BVDV infected cells.
Intranuclear fluorescence has been detected in a few BVDV
infected cells but diffuse intracytoplasmic fluorescence
originating close to the nuclear membrane is usually first
seen in BVDV and HCV infected cells as early as 4-6 hours
post-infection. After reaching maximum intensity and
extent between 20 and 60 hours fluorescence gradually fades
(Mengeling and Drake,1969; Fernelius,1969 ) . Both these
reports provide evidence that the appearance of specific
fluorescence coincides with the appearance of SA before the
production of infectious virus.
The antigenic relationship between the three
pestiviruses as detected by ID, IEP, CF and IF tests,
therefore appears to be largely dependent on a common SA.
This is a virus-induced non-structural glycoprotein, which
from its early appearance in infected cells is probably a
precursor of a viral component. SA prepared from BVDV
injected into calves and pigs had some protective function
apparently by priming the immune system. Calves showed a
rapid development of neutralising antibody following
challenge (Gutekunst and Malmquist,1964). Pigs were
protected against challenge with virulent HC and showed an
accelerated rate of HCV antibody production following
exposure (Volenec et al.,1972).
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The relationship between pestiviruses has also been
established by the detection of cross-neutralising
antibodies. It has become clear, though, that the degree of
cross-neutralisation between pestiviruses is very variable,
and depends on the strains used. The relationship between
HCV and BVDV is weak with only some hyperimmune sera
against HCV neutralising BVDV (Dinter,1963; Corthier,1976).
In pigs, some strains of BVDV produce antibodies but the
level of cross-neutralisation against HCV depends on the
strain used for immunisation (Snowdon and French,1968;
Stewart et al.,1971). In one study one strain of BVDV was
capable of protecting some pigs challenged with HCV whereas
those strains less closely related in serum neutralisation
(SN) tests failed to protect. In the same study calves
injected with HCV were resistant to challenge with BVDV
regardless of the challenge virus used. It was also noted
that homologous antibody production occurred earlier,
following inoculation of HC virus, in pigs previously
injected with BVDV than in the control pigs. The same
findings with regard to the antibody to BVDV were obtained
in calves previously inoculated with HCV (Castrucci et
al. ,1970).
Cross-neutralisation has also been demonstrated
between BDV, BVDV and HCV (Osburn et al.,1973). Again
strain differences appear to be important. In pigs, higher
homologous SN titres were produced by the Moredun strain of
BDV than by the BD-2 strain. Pigs receiving Moredun virus
survived HCV challenge while those injected with BD-2 virus
succumbed (Laude and Gelfi,1979). Cross-neutralisation
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between BDV-M and BVDV-NADL has been demonstrated. In
sheep injected with BDV, SN antibodies developed earlier
and to higher titres to the homologous virus than to
BVDV-NADL (Vantsis et al.,1980).
Within BVDV strains. Considerable serological variation has
been detected in cross-neutralisation tests between BVDV
strains (Castrucci et al.,1968; Hafez and Liess, 1972).
Demonstrable strain differences led to a classification
into 3 serotypes represented by the NADL strain, the Oregon
C24V strain and three non-cytopathic strains. These
serotypes were also related to the type of Cytopathic
effect (CPE) produced in bovine embryonic kidney (BEK)
cells. Changed viruses, i.e. "biotypes" produced by
passage in cells or rabbits, were concomitantly converted
to the serotypes of the virus they biotypically resembled
(Fernelius et al.,1971). The use of anti-NADL and
anti-Oregon C24V sera against 17 BVDV isolates failed to
produce any evidence for the existence of different
serotypes, but some significant serological differences
between the virus strains indicated a wide antigenic
heterogeneity (Corthier and Aynaud, 1973). A study of
three serologically heterologous strains of BVDV in
reciprocal cross-immunity tests in calves showed good
protection. Each of the 3 strains provoked the production
of antibody to the heterologous as well as to the
homologous strain (Castrucci et al.,1975).
Within BDV strains. Border disease virus isolates have been
differentiated on the basis of their serological
relationship to BVD-NADL (Vantsis et al.,1979). The
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Moredun strain of BD virus is different serologically from
BVDV-NADL. In a natural outbreak of BD, ewes developed
higher SN titres to BVDV-NADL than to BDV-M. During their
next pregnancy ewes were susceptible to challenge with
BDV-M but not to the homologous BD virus (Vantsis et
al.,1980).
VIRUS CULTIVATION
Host range in laboratory animals and chick embryos.
Attempts to propagate BVDV in embryonated hens' eggs, mice,
unweaned mice, rat foetuses, guinea-pigs, hamsters, ferrets
and pigeons were all unsuccessful (Olafson and
Rickard,1947; Baker et al.,1954; Huck,1957 ; Taylor et
al.,1963). Of all laboratory animals only rabbits have
been used for successful passage of the virus (Baker et
al.,1954; Fernelius et al.,1969b).
Host range in tissue culture. Virtually all researchers
into BVDV have used virus propagated in cells cultured from
trypsinised tissues. Primary cells and some cell lines of
cattle, sheep and pig tissues have been shown to be
susceptible to both BVD and BD viruses. The cytopathic
NADL and C24V strains of BVDV have been adapted to
established cell lines of hamster kidney (HAK) and human
cells resembling the HELA line (ERK-IO), but both became
non-cytopathic and were detectable only by
immunofluorescence (IF) tests (Fernelius et al.,1969).
Truitt and Shechmeister (1973) reported adaptation of
BVDV-NADL to cells of a canine kidney (CK) line in which a
CPE was produced 96 hours after infection. In the absence
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of confirmation of this result it would appear possible
that the CK line may have been a calf kidney cell line. In
the same report it was shown that BVDV replicated in bovine
macrophage and lymphocytes cultivated in-vitro.
For studying BVDV, primary or low pass bovine cells
particularly kidney cells have been most widely used
(Underdahl et al.,1957; Gillespie et al.,1963; Mills
et &1" ,1965). Other workers have preferred bovine testis
cells (Van Bekkum and Straver,1964) or bovine embryonic
spleen cultures (Malmquist,1968). In a study of plaque
formation by BVDV-NADL similar sized plaques were formed in
kidney, lung and testis cultures derived from bovine
foetuses while smaller plaques were formed in lamb testis
cultures (Singh, 1969a). In contrast to this, one isolate of
BDV has been shown to replicate well in foetal lamb kidney
(FLK) cells but poorly in BEK cells (Vantsis et al.,1976).
Other BDV strains have been grown in sheep choroid plexus
cells (Niemi et al.,1982; Potts et al.,1982), but bovine
testis cells were used for the replication of an Australian
isolate (Plant et al.,1976).
The use of bovine cultures has been plagued by the
adventitious contamination of cells with non-cytopathic
BVDV. The virus has been shown to originate from the cells
themselves and from the foetal calf serum used to
supplement the cell growth medium. Cells shown to be
contaminated have been BEK (13 of 133 foetuses tested),
calf testis (1 of 14 tested), calf kidney (10 of 63
tested), and bovine foetal lung (1 of 37 tested) (Smithies
and Modderman,1975; Nuttall et al.,1977; Rossi et
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al.,1980). BVDV contamination rates of commercially
available foetal calf serum (FCS) have been variously
reported as 17% (1 of 6 batches), 75% (14 of 19 batches),
100% (5 of 5 batches) and 62 % (13 of 21 batches) (King and
Harkness,1975; Smithies and Modderman,1975; Nuttall et
al.,1977; Rossi et al.,1980). Heat inactivation at 56°C
for 30 minutes, and irradiation of FCS have both been shown
to reduce greatly but not totally eliminate BVDV
contamination arising from this source (Nuttall et
al.,1977; Rossi et al.,1980). Given this apparent
widespread contamination of bovine tissue culture systems
with non-cytopathic BVDV it is possible that many
experiments conducted before this problem was recognised
were compromised to some extent.
One way round the contamination problem would be to
use cell lines shown to be free of BVDV grown in medium
supplemented with virus — free serum. There are, however,
few reports of successful virus growth using such a system,
the majority of workers apparently preferring to use cells
with a low passage history. The reasons for this are not
immediately apparent from the literature, although passage
of BVDV virus in a PK-15 cell line resulted in a change in
the CPE when the virus was later grown in primary BEK cells
(Fernelius et al. , 1969a). The most consistent use of a cell
line has been by workers at the National Animal Diseases
Laboratory, Ames, Iowa, U.S.A. who have used a bovine
turbinate (BT) line for growing BVDV (McClurkin et
al.,1974). A foetal lamb muscle cell line has been shown
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to be useful for the propagation and assay of both BVDV and
BDV (Laude and Gelfi,1979). As well as being used for the
growth of BVDV, the PK-15 line has been used for culturing
a non-cytopathic isolate of BDV (Potts et al.,1982).
Cytopathogenicity. Both cytopathic (CP) and non-cytopathic
(NCP) strains of BVDV and BDV have been described. In a
comprehensive list of thirty strains of BVDV isolated
between 1954 and 1969, nineteen were CP and 11 NCP (Saurat
et al.,1972). Expression of cytopathogenicity depends on
inherent properties of the virus strain, but can also be
influenced by the conditions in which it is cultured. The
first reference strain of BVDV isolated was designated VD
New York 1 (NY-1) (Baker et al.,1954). This was later
shown to replicate well in bovine skin, muscle and
embryonic kidney cells without producing a CPE (Lee and
Gillespie,1957) . No CPE was produced when the virus was
cultured in a range of primary bovine cells as well as in
cell lines of bovine, ovine, porcine and caprine kidney,
and human cervix (HeLa), liver (Chang) and intestine
(Henle) (Pri t c ha rd , 1963 ) . The two other major reference
strains of BVDV, Oregon C24V (Gillespie et al.,1960) and
BVDV-NADL (Gutekunst and Malmquist,1963) are both
cytopathic in BEK cells but the type of CPE produced is
different. CPE is slow to develop in C24V infected
cultures, multiple intracytoplasmic vacuolation occurs,
nuclei become pyknotic and a low percentage of cells round
up and detach from the glass. A much more rapid and
complete CPE is caused by the NADL-MD strain. Cells
develop pyknotic nuclei and round up and detach from the
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glass before intracytoplasmic vacuolation develops
(Fernelius and Ritchie,1966).
The CPE in BEK cells of BVDV-C24V and BVDV-NADL has
been shown to change following passage in different cell
systems. After passage in a PK-15 cell line BVDV-C24V was
NCP, while BVDV-NADL retained its cytopathogenicity. After
adaptation to rabbits, though, the cytopathogenicity of
NADL resembled that of C24V. Change in the type of CPE was
termed "biotypic conversion" (Fernelius et.al.,1969a;
1969b). In the discussion of the second of these papers
there are reports of a non-cytopathic strain which is CP
for certain batches of BEK cells. This and two other named
strains with the same capability were described as being of
intermediate virulence. The belief was expressed that
there are BVDV strains having high, intermediate and low
cytopathogenicity. This was confirmed by French and
Snowdon (1964) who isolated virus of all three types from
their clinical cases.
Further evidence that the cytopathogenicity of
pestiviruses can vary according to the culture conditions
has come from studies with BDV. The majority of BDV
isolates have been non-cytopathic in vitro, and have been
detected by interference tests (Hadjisavvas et al., 1975)
or immunofluorescent tests (Harkness et al.,1977;
Terpstra,1978). There are three reports of the isolation
of cytopathic agents. In an Australian study of ovine
perinatal mortality, 4 viruses were isolated which were
serologically related to the C24V strain of BVDV and which
were cytopathic for bovine testis cells (Hore et al.,1973).
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One of these viruses, strain HE 18, caused abortion and was
shown to infect foetuses when injected intravenously into
pregnant ewes (French et al.,1974). Vantsis et al., (1976)
isolated a cytopathic virus (BDV-M) from homogenised brains
of experimentally produced BD lambs by inoculating FLK
cultures. Cytopathic isolates have also been recovered in
sheep choroid plexus cells from nasal and vaginal swabs
from post-partum ewes (Niemi et al.,1982). Interestingly,
cytopathic isolates from these last two laboratories
produced little or no CPE in calf kidney or primary BEK
cells. Similarly BDV isolated and passed in calf testis
cells was NCP in these cells but was cytopathic in a foetal
lamb muscle cell line (Laude and Gelfi,1979).
While the cytopathogenicity of some BVDV and BDV
isolates can vary depending on the cell system used other
isolates are genuinely non-cytopathic. Comparative studies
of the growth of CP and NCP strains of BVDV showed no
difference in the kinetics of replication but the CP virus
produced 58 times more infectious virus per cell
(Nuttall,1980). A single study on the mechanism of
persistence by NCP virus concluded that persistence was not
the result of the induction of defective interfering
particles or the selection of temperature sensitive mutants
but was the result of a stable phenotypic property of the
virus (Coria and McClurkin,1981).
PATHOGENESIS OF DISEASES IN CATTLE AND SHEEP
Experimental infections to study the pathogenesis of
disease have, naturally, attempted to reproduce the
syndromes seen in field outbreaks. Studies on enteric
disease have yielded much information on the response of
young cattle to BVDV while the equivalent response of sheep
to BDV is virtually unknown, since investigations have
focused on pregnant animals. Except where stated,
experimental infection of sheep refers to infection with
BDV, and that of cattle with BVDV.
Foetal disease following the exposure of susceptible
dams is, almost certainly, the most serious consequence of
pestivirus infections in cattle as well as sheep.
Congenital infection plays a central role in the
pathogenesis and epidemiology of disease in both species
and will be considered first.
CONGENITAL INFECTION
Experimental infections of pregnant cattle and sheep
have shown that pestiviruses can cause a wide range of
foetal disease varying from foetal death and abortion to
the birth of live apparently normal offspring, some of
which may be persistently infected with virus and yet
remain healthy for years.
The maternal infection is usually subclinical or
mild. In sheep, mild fever six to eleven days after
inoculation and transient neutropaenias detected ten days
after infection have been recorded (Shaw et al.,1967;
Vantsis et al.,1979). In cattle, pyrexia and leucopaenia
are common usually without malaise. Occasional animals
show anorexia, diarrhoea and nasal, lachrymal and vaginal
discharges (Kendrick,1971; Brown et al.,1979).
The most important route of foetal infection is
transplacental. Exposure of susceptible pregnant dams
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results in viraemia with spread of virus to the placenta
(French et al.,1974; Snowdon et al.,1975). Transmission to
the foetus has been achieved by infected semen in sheep,
but under natural conditions this is unlikely to be a major
route of infection (Gardiner and Barlow,1981).
Replication of the virus in the placenta has been
studied more in sheep than in cattle. Since both animals
have similar forms of placentation, epitheliochorial in
which 6 tissue layers separate maternal and foetal blood,
it is likely that similar mechanisms occur in both species.
A placentitis has been detected as early as 10 days after
infection in pregnant ewes. Lesions developed in the
endothelium of the maternal capillaries resulting in
occlusion of the vessels and focal or diffuse necrosis of
the caruncular septa. The lesion spread so that,
ultimately, necrotic septal tissue dissected the
foeto-maternal union. Bleeding from maternal capillaries
accentuated the separation of the union between foetus and
mother, with blood and necrotic debris being ingested by
the trophoblast. The placentitis may be severe enough to
contribute to the early foetal death and abortion which
occur in some cases, but if the pregnancy is sustained the
placentitis heals in about 25 days (Barlow,1972).
In another study BDV grew to high titres in the
placentome of sheep without producing lesions, and yet
still crossed to the foetus and caused abortion (French et
al.,1974). There is some evidence from both sheep and
cattle that virus does not cross to the foetus in the first
month of pregnancy (Manktelow et al.,1969; Whitmore et
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al.,1981). A possible explanation for this could be that
implantation and the development of close contact between
maternal villi and the trophoblast is essential for virus
to infect the foetus.
Once the placenta has been penetrated the virus is
protected from the maternal immune response which has
occurred following infection (Gardiner,1982). The foetus
and virus are on their own. The ultimate outcome of this
particular relationship depends on several factors, the
major one of which is the stage of foetal development at
which infection occurs. The most serious consequences
occur following exposure during early pregnancy. Other
factors include the strain and dose of the virus, the breed
of the foetus and its ability to repair damage.
A critical factor in determining the distribution and
persistence of virus, which, in turn, influences the extent
of foetal damage is the age at which the foetus gains
immunological competence. The ovine foetus can first
respond to an antigenic stimulus between 64 and 82 days of
its approximately 150 day gestation period (Fahey and
Morris, 1978). In cattle, which have a gestation period of
approximately 280 days, a specific immune response to BVDV
has been detected in foetuses inoculated at 135-150 days
gestation (Ohmann et al.,1982). Development of foetal
immune competence, therefore, starts around mid-gestation
in both species.
Knowledge of the foetal response to pestivirus
infection has been derived predominantly from experiments
in which the foetus has been infected via the dam. The
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speed with which the virus crosses the placenta is unknown
so that the actual timing of foetal infections may be only
approximate. Nevertheless, some clear findings have
emerged.
There is considerable evidence that foetal infection
in cattle after 6 months gestation rarely causes disease
and provokes a specific immune response similar to that in
post-natal life so that calves are born with neutralising
antibody (Ward et al.,1969; Braun et al.,1973; Brown et
al.,1979). In sheep, infection of the foetus after 80 days
results in the birth of clinically normal lambs. These
lambs have a characteristic nodular periarteritis, which
was suggestive of a cell-mediated allergic reaction
(Zakarian et al.,1976). Neutralising antibody to BD was
detected in precolostral sera from 20 of 39 lambs whose
dams had been infected at 90 days (Gardiner et al.,1980).
There is, thus, good evidence in both species that
foetal infection in the last third of pregnancy results in
the birth of normal offspring possessing specific
neutralising antibody to their infecting agent. Viral
antigen has been detected in association with the lesions
of periarteritis for up to 6 months after birth but it is
not known if such lambs excrete virus (Gardiner et
al.,1980). This would seem unlikely. Calves
experimentally infected as foetuses late in pregnancy and
born with specific neutralising antibody failed to infect
susceptible calves with which they were kept for the first
4 months of life (Ward,1969).
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The outcome of foetal exposure to virus at other
stages of gestation is less predictable. Understandably,
more information is available from sheep experiments than
from cattle infections. The production of clinically
affected "hairy-shaker" lambs has been achieved most
consistently by infecting ewes between 50 and 63 days
gestation, that is, before the onset of immune competence.
In such lambs viral antigen is widespread (Terpstra,1978).
There are, however, few histopathological changes in the
viscera, although reduced thymus weight and poorly
developed lymphatic nodules and a scarcity of lymphocytes
in the spleen have been noted (Richardson,1982). Typically
there is no evidence of any inflammatory reaction. The
principal pathological finding, myelin deficiency in the
CNS, is thought to result from direct viral action on
oligodendrocyte precursors, leaving a deficit of mature
myelin-forming cells at critical stages of CNS development
(Barlow,1982). Precolostral sera from "hairy-shaker" lambs
do not contain specific neutralising antibodies against
pestiviruses. (Vantsis et al.,1979). Such lambs are
tolerant to the virus and have a persistent infection
usually for life (Plant et al.,1977).
Following some experimental BD infections at 50-55
days gestation, inflammatory lesions heavily infiltrated
with macrophages and mononuclear cells, and liquefactive
necrosis have been seen in the granuloprival layers of the
CNS. These lesions were seen within 21 days of infection
in sacrificed foetuses and were considered to be the cause
of severe brain malformations seen in lambs surviving to
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term. The malformations included hydranencephaly,
porencephaly and cerebellar hypoplasia, and some lambs also
had arthrogryposis. Affected lambs had none of the clinical
or pathological stigmata of classical BD (Clarke and
Osburn,1978; Barlow,1980). The reasons for the development
of this "alternative pathology" (AP) have not been fully
elucidated. A review of the conditions under which it had
occurred showed that the nature of the agent, and the breed
and immune status of the ewe were important factors
(Barlow,1980). There is also an altered immune
responsiveness of the foetus since the majority of lambs
with AP are born with specific neutralising antibody to BDV
(Gardiner,1982) . This precocious immune response by the
foetus would certainly explain the inflammatory and
necrotic lesions of AP.
Analogous findings have been reported in cattle.
Bovine foetuses exposed to some strains of BVDV between 3
and 6 months gestation have shown CNS and ocular lesions at
birth. The CNS lesions were principally cerebellar
degeneration and hypoplasia (Ward,1969; Brown et al.,1973).
The ocular lesions have included retinal atrophy, optic
neuritis, cataract and microphthalmia with retinal
dysplasia (Bistner et al.,1970). The cerebellar lesions
were considered too severe to have been caused by direct
cell destruction due to the virus. They were interpreted to
be a consequence of vasculitis which caused folial oedema
with subsequent severe cerebellar destruction and it has
been proposed that the vasculitis may have an immune
component (Brown et al.,1974). Indirect evidence to
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support this comes from the regular finding that virus
cannot be detected from such animals and they have
neutralising antibodies to BVDV at birth. Occasionally both
virus and antibody have been detected in the same animal
but, in general, the presence of SN antibody was associated
with a failure to recover virus from foetal tissues (Badman
et al.,1981).
The outcome of early foetal infection clearly
depends on a dynamic interplay between viral and host
properties. The unpredictability of the outcome was
demonstrated in one experiment in which a wide range of
possible sequelae occurred. Fifteen susceptible pregnant
heifers received the same inoculum of a mixture of field
isolates of BVDV at 100 days gestation. This resulted in 5
foetal deaths and the birth of 10 live calves. All calves
showed evidence of intra-uterine growth retardation and 3
were affected with clinical nervous disease. Two of these
3 had brain malformations. They were born with specific SN
antibody to the virus and were virus free. Virus was
recovered from the remaining 8 calves which were antibody
free. These 8 calves were considered to be immunotolerant
to BVDV (Done et al.,1980).
In both cattle and sheep, therefore, there is
evidence of a very complex interaction between the
infecting pestivirus, the dam and the foetus. Virus
strains vary in their antigenicity and pathogenic
potential. The dam can prevent or modify the virus attack
on the foetus. The foetus, depending on its stage of
development, can react immunologically and rid itself of
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the virus, but sometimes at the cost of causing severe
malformations. Early foetal infection without an immune
response can cause foetal death and abortion but the low
pathogenicity of some viral strains ensure the survival of
offspring which are persistently infected with, and
apparently immunotolerant to their infecting virus. These
animals are of immense importance in the epizootiology of
BVD and BD.
PERSISTENT INFECTION IN POST-NATAL LIFE
Persistent infections often continue into post-natal
life, and are characterised by a generalised infection in
the host, which constantly sheds virus into the
environment. The existence of cattle persistently infected
with BVDV has been recognised for many years but
persistence was generally associated with unthriftiness
(Malmquist,1968). More recently it has been shown that
persistent infections with BVDV can occur in apparently
healthy animals (Coria and McClurkin,1978b). Similarly,
both "hairy-shaker" and apparently normal lambs have been
shown to be persistent excretors of BDV (Terpstra,1981).
Persistent infections have been established
experimentally by both cytopathic and non-cytopathic
strains of virus grown in tissue culture. Cattle given
BVDV which was cytopathic in-vitro produced persistently
infected calves from which only non-cytopathic virus could
be recovered (Done et al,1980). When the same inoculum was
used in pregnant ewes virus recovered from infected lambs
was again found to be non-cytopathic (Terlecki et
al.,1980). This suggests some alteration to the virus
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within the host and could explain why Kendrick (1971), who
only looked for cytopathic virus, did not detect virus in
calves born to dams infected in early gestation.
Non-cytopathic BDV has also been shown to establish
persistent infections in lambs (Terpstra,1981).
Persistently infected cattle and sheep are viraemic
and have no, or low, levels of anti-pestivirus neutralising
antibodies. They readily yield non-cytopathic virus from
blood and bodily secretions and appear to be immunotolerant
to the virus infecting them. Normal levels of serum
protein and immunoglobulins and the ability of the animals
to produce antibodies to other agents confirm that
persistently infected animals can have a normal humoral
responsiveness in spite of their specific immune tolerance
(Coria and McClurkin,1978b; Terpstra,1981). Development of
antipestivirus antibodies by some persistently infected
sheep in later life also shows that the immune tolerance
may not be absolute (Terpstra,1978; Westbury et al.,1979).
Persistently infected animals often have reduced
fertility. In one report cows had reduced conception
rates, aborted or gave birth to persistently infected
calves. A bull had poor quality sperm which contained
virus but, when seropositive cows were bred normal
virus-free calves were born. When seronegative heifers were
bred, successful conception and pregnancy resulting in
normal calves occurred only following seroconversion
(McClurkin et al.,1979). Virus-containing semen from a
persistently infected ram produced infected offspring
(Gardiner and Barlow,1981), and persistently infected ewes
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have produced infected lambs in successive pregnancies
(Westbury et al.,1979; Barlow et al.,1980). Vertical virus
transmission by persistently infected animals, particularly
females, is also an important method by which the level of
chronic virus excretors is maintained.
There is no evidence that pestiviruses can establish
persistent infections in animals exposed to virus at times
other than early pregnancy. BVDV could be detected for up
to 103 days in susceptible calves infected at birth, and
although 2 calves did not produce detectable levels of
virus neutralising antibodies for 42 and 73 days the
majority had seroconverted by 21-28 days and all calves
were immune to challenge (Lambert and Fernelius,1968).
The mechanisms involved in the establishment and
maintenance of persistent virus infections are complex, but
low or no cytopathology and the ability to infect
lymphocytes and macrophages are important properties
(Mims,1974). The lack of cytopathogenicity has been
confirmed for BVDV and BDV. BVDV has been shown to
replicate in both cell types (Truitt and Shechmeister,1973)
and a strong association of viral antigen with cells of the
mononuclear phagocyte system has been demonstrated in
et al.
inoculated foetuses (Ohmann£l982). Some control of viral
replication must be exerted since some persistently
infected immunotolerant animals can survive for years as
clinically normal animals. An unstable equilibrium appears
to be established between the virus and host.
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ENTERIC DISEASE OF CATTLE
BVD and MP
Two syndromes were described originally. BVD was
very contagious with moderate clinical disease and
pathological changes and had a high morbidity and low
mortality (Olafson et al.,1946). This syndrome most
probably resulted from the introduction of a virulent
strain of virus into a naive herd. Such an epidemic form of
infection is now rarely encountered. More commonly seen is
the sporadic form of infection. This was originally named
MD and had a low morbidity, was not highly contagious but
affected animals had severe clinical signs and pathological
lesions and the mortality rate was high (Ramsey and
Chivers,1953). These two names have been sustained because
for some outbreaks they remain clinically and
pathologically valid. Not all outbreaks conform to the high
morbidity/low mortality or high mortality/low morbidity
patterns. The two syndromes represent overlapping extremes
at either end of a range of disease.
Experimental transmission studies, using filtered
inocula from clinical cases, confirmed that following
infection by several routes virtually all susceptible
calves suffered only a mild disease. Pyrexia and
leucopaenia were the only constant features. Oral
hyperaemia with or without erosions, anorexia, depression,
dyspnoea, serous nasal discharge and transient diarrhoea
were other regular findings. The same disease was
reproduced whether the inocula were from cases designated
BVD or from animals dying of severe MD (Baker et al.,1954;
FIGURE 1.5 A confirmed case of clinical mucosal disease.
Principal symptoms were depression and
diarrhoea (Top), and crusting over muzzle and




Huck,1957; Jarrett,1958; Pritchard,1963; Thomson and
Savan,1963; Taylor et al.,1963; Tyler and Ramsey,1965).
Occasional animals suffered severe ulceration lasting
several weeks (Jarrett,1958), and 5-10% developed chronic
lesions following acute infections (Pritchard,1963). In
all the early transmission studies there were only 2
reports of deaths occurring. Baker et al. (1954)
inoculated 100 calves of which 85 were susceptible to the
virus. Only two animals died 11 and 14 days after
inoculation and interestingly these both had
hyperkeratosis, a possible indication of chronic persistent
BVDV infection, at the time of inoculation. At post-mortem
examination they showed ulcers in the mouth and extensive
pneumonia, features that were not common in 19 other calves
killed 4-16 days after inoculation. Pritchard (1963)
recorded deaths in two calves 3 and 42 days after
inoculation without providing details.
Inability to reproduce fatal mucosal disease has been
for many years an enigmatic feature of BVDV infections. In
addressing this problem Malmquist (1968) reported the
detection of 4 unthrifty calves that had persistent
viraemia and failed to produce neutralising antibodies. He
attributed this failure to respond to the virus to
immunological tolerance which could be acquired by
intrauterine infections. It has been well established that
animals succumbing to both acute and chronic MD are
viraemic and have no, or very low, levels of neutralising
antibodies to BVDV (Borgen,1963; Thomson and Savan,1963;
Schaal et al.,1972). These features are common to
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persistently infected calves. Fatal cases of MD amongst
congenitally infected calves have been attributed to
immunopathological mechanisms (Liess et al.,1974). In
another important study, it was shown that animals dying of
MD could be immunologically tolerant to one particular
strain of BVDV but immunocompetent to another strain (Steck
et al.,1980). The pathogenesis of MD remains largely
unresolved.
Neonatal Enteric Disease
Both in-utero and post-natal infection with BVDV can
result in enteric disease in the neonatal period. Severe
in-utero infection caused 30 stillbirths and the death of
27 calves in one herd of 286 cows. Oral and lip lesions
were seen at birth in both stillborn and live calves.
Affected calves developed diarrhoea soon after birth and
died between 2 and 13 days old (Romvary, 1965a).
Post-natal infection with BVDV has been studied in
specific-pathogen free calves. Eighteen calves were
exposed orally or intranasally on the day of birth or at 3
days old. All developed mild to severe diarrhoea which
persisted for 7 to 10 days and 4 of 13 colostrum-deprived
calves died (Lambert et al, ,1974).
RESPIRATORY DISEASE IN CATTLE
In spite of the apparent association of BVDV with
respiratory disease in field outbreaks, experimental
infections have resulted in only mild lesions. Exposure of
calves to BVDV aerosols produced only mild interstitial
pneumonitis in two separate studies (Mills,1966;
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Phillip,1973). In a third study no lung lesions were
produced nor was there impaired clearance of Pasteurella
haemolytica (Lopez et al.,1982).
DIAGNOSIS
Laboratory confirmation is required for the
unequivocal diagnosis of the diseases caused by BVDV and
BDV. As has been noted, congenital infection can result in
the delivery of young infected with virus or with serum
neutralising antibody. Tests for both must, therefore, be
undertaken to establish whether or not in-utero infection
has occurred.
Virus can be readily isolated from leukocytes of
persistently infected cattle using bovine tissue culture
systems (Malmquist,1968). Tests for NCP viruses are
essential, and two methods have been used to detect BVDV
and BDV in tissue culture. Interference tests (Gillespie et
al.,1962; Hadjisavvas et al.,1975), and immunofluorescent
tests (Fernelius and Lambert,1969; Harkness et al.,1977).
Immunofluorescence and immunoperoxidase methods have also
been used to demonstrate antigen in cryostat sections of
organs from persistently infected animals (Terpstra,1978;
Gardiner,1980; Ohmann et al, 1981). Comparative studies of
direct detection of BVDV in organ sections and virus
isolation in tissue culture with additional
immunofluorescence staining for NCP virus showed that the
latter method was three times more sensitive than the
former for confirming BVDV infection in dead cattle
(Bechmann et al.,1977).
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The transitory nature of many postnatal infections
makes virus isolation difficult, so that retrospective
serology on acute and convalescent sera from several
animals may be the only way of confirming recent infection.
CONTROL
The control of BVDV infections in some countries has
been based on the use of modified live virus vaccines. The
use of such vaccines has been associated with the
production of disease. In a thorough investigation
involving 9,891 cattle in 17 herds, Peter et al. (1967)
reported that the disease which occurred was similar to the
field form of MD. The average morbidity rate was 5.2% and
the mortality rate among affected animals was estimated at
75%. Dying calves failed to seroconvert to BVDV but
seroconversion occurred in calves recovering after having
signs of MD and in those with no evidence of disease. The
authors concluded that the condition was primarily caused
by failure of the immune mechanisms in a few animals.
Other studies have also shown that the use of live vaccines
can be detrimental to some animals (Steck et al.,1980).
Loss of confidence with live vaccines has led to the
development of inactivated ones but these have not been
widely evaluated in the field (Fernelius et al.,1972;
McClurkin$ Cor i a ,1978).
The use of live and inactivated vaccines containing
BDV has been investigated experimentally. Double
vaccination of ewes with certain inactivated virus
preparations produced good antibody titres which protected
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more than 50% of foetuses after the ewes had been
challenged (Vantsis et al.,1980)
EPIDEMIOLOGY
The natural host range of Pestiviruses is restricted
to ruminants and pigs. Among domestic animals experimental
cross-infection has been demonstrated between cattle,
sheep,pigs and goats (Ward,1971; Phillip and Darbyshire,
1972; French et al.,1974; Gibbons et al.,1974; Taylor et
al.,1977). Interspecies infection, by some pestivirus
strains at least, is therefore a possibility. There is
serological evidence of widespread infections in a variety
of wild ruminants, which should also be considered
potential reservoir hosts. Positive results from African
species with no known contact with domestic livestock
suggest a longstanding natural infection (Hamblin and
Hedger,1979; Karstad,1981) .
British farming methods are not conducive to the
exchange of pestiviruses from pigs to other susceptible
species. Cattle and sheep, however, are often farmed
together and shared grazing systems are encouraged for
parasite control. Experimental cross infectivity is well
documented but only circumstantial evidence of natural
infection from cattle to sheep has been described
(Physick-Sheard et al.,1980). Serological studies of
cattle and sheep populations in several countries have
confirmed that cattle are the principal hosts of
pestiviruses. Thirty to 80% of adult cattle have antibody
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to BVDV, the equivalent figure for sheep being 5 to 11%
(Harkness and Vantsis,1982). This difference in frequency
of infection between cattle and sheep could be explained by
variable opportunities for spread of infection among and
between species arising from different types of management.
Alternatively, cattle may be more susceptible to infection
with pestiviruses or some strains may only be able to
replicate in cattle.
AIMS OF THIS THESIS
The work reported in this thesis had two aims, both
relevant to future pestivirus control policies.
The first was to investigate the response of normal
lambs and those persistently infected with BD virus to
further infection with pestiviruses. It was hoped that
this would provide some insight into the outcome of the use
of modified live virus vaccines in these two classes of
animals.
The second aim was to study the degree of antigenic
relatedness between reference and field strains of BVDV and
BDV.
Initially, however, investigations were undertaken to
establish a common tissue culture system for the
propagation and assay of these viruses.
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CHAPTER 2
GENERAL MATERIALS AND METHODS
INTRODUCTION
The contents of this chapter describe the basic
technical work. More specialised procedures are included
in the appropriate sections.
TISSUE CULTURE TECHNIQUES
Medium. The growth medium used for nearly all cell
cultures was Eagle's minimal essential medium (MEM)
(Eagle,1959) supplemented with lactalbumin hydrolysate
(LAH) (0.5%), glucose (0.2%) and 10% heat inactivated calf
serum (56°C for 45 minutes), and containing 100 units per
ml penicillin, 100 pg per ml streptomycin and 2 pg per ml
amphotericin B deoxycholate. In some experiments Medium
'199' (Morgan et al.,1950) replaced the MEM.
The maintenance medium for all cells was '199' medium
supplemented with 0.5% bovine serum albumin (BSA), 0.1%
lactalbumin hydrolysate (LAH) and 0.1% yeast extract, and
containing the same antibiotics as in the growth medium.
The heat-inactivated serum supplement for virus isolations
was foetal calf serum (2%) and for virus growth it was 3%
horse serum.
Cell culture procedures. Bovine and ovine foetuses
contained within unopened uteri were collected from local
abattoirs and transported to the laboratory. Primary and
secondary cultures of foetal tissues were prepared using
the trypsin disaggregation method described by Paul (1970a)
for monkey kidney cell cultures, except that the growth
medium for the pooled cell suspensions was supplemented
Eagle's MEM as described above.
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Semi-continuous and established cell lines were
cultured using standard techniques (Paul,1970b).
VIROLOGICAL TECHNIQUES.
Viruses. Two cytopathic reference strains of virus were
used throughout this work. The BVD virus was originally
isolated from the spleen of a naturally occurring fatal
case of BVD in the closed herd at National Animal Disease
Laboratory, Iowa, U.S.A., and is referred to as BVDV-NADL
(Gutekunst and Malmquist,1963). The BD virus was isolated
at Moredun from a pool of brains from newborn lambs
clinically affected with BD, and is referred to as BDV-M
(Vantsis et al.,1976).
All other viruses, details of which are shown in
Table 2.1, were isolated from clinical cases of BVD or BD
in Scotland at the virus diagnostic laboratory, Moredun
Research Institute.
Preparation of virus stocks.
Reference strains. Stocks of BVDV-NADL at an unknown
passage level, and BDV-M at the 28th passage level were
kindly supplied by Dr. D.R. Snodgrass, Microbiology
Department, Moredun Research Institute.
BVDV-NADL, derived from the American type culture
collection (ATCC VR-534), which had been passaged 7 times
in bovine cells was kindly supplied by Dr. P. Roeder,
Central Veterinary Laboratory, Weybridge; this virus was
amplified by two further passages in bovine cells at low
multiplicity of infection (m.o.i.) and stored as a master
stock in small aliquots at -70°C.
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A similar master stock of BDV-M was established at
the 3rd FLK passage level by culturing a homogenate of the
BD IIB brain pool (Barlow,1972) kindly supplied by Mr.
A.C. Gardiner, Moredun Research Institute.
For all pathogenicity studies virus inocula were
prepared from the lowest passage level available. For
antigenic studies the viruses were passaged further
including three plaque purifications in cultures of foetal
lamb brain (FLB) cells. To minimise the production of
defective interfering particles a low m.o.i. was used to
produce new virus stocks.
Other isolates. Small stocks of all the other isolates
were available at the second passage level in BEK (bovine
isolates) or FLK cells (ovine isolates). All the viruses
were purified by three plaque purifications (CP isolates)
or three passes at terminal dilution (NCP isolates) in FLB
cells. Master stocks of the viruses were prepared as for
the reference strains and working stocks grown from these
as required.
Titration of virus infectivity. Serial ten-fold dilutions
of the virus suspension were made in maintenance medium in
bijou bottles.
Initially, titrations were done in test tube cell
cultures. Unless stated otherwise bovine isolates were
titrated in secondary BEK cultures and ovine isolates in
secondary FLK cultures. Cells were grown on the wall of 15
cm x 1.5 cm glass test tubes or on 6 x 22 mm coverslips
inside tubes. Cultures at the point of confluence were
washed three times with Hanks' basic salt solution (BSS).
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An aliquot of each virus dilution was inoculated on to at
least two tube cultures, and allowed to adsorb for 2 hours
at 37°C. After this time 1 ml of maintenance medium was
added to each tube, and cultures were reincubated at 37°C
for up to 7 days. Those with characteristic cytopathic
effect (CPE) 7 days after inoculation were scored as
positive. When assaying for the presence of NCP virus
coverslips were removed after 5 days' incubation and
examined for virus using an indirect immunofluorescence
test (IIFT).
Titrations of viruses in FLB cells were carried out
using small volumes of reagents. Cytopathic viruses were
titrated in 96 well plastic microplates, using 4 wells per
dilution. Fifty yl of virus were added to each well
followed by 100 yl of 199 medium supplemented with 10%
horse serum containing 104 cells. The plates were
sealed, and incubated at 37°C for up to 7 days after which
wells were examined for the presence of CPE. The titration
of NCP viruses was carried out in Lab-Tek chamber/slides
(Miles Scientific Ltd.). Fifty yl volumes were added to
each of 4 wells per dilution followed by 4 x 104 cells
in 400 yl of medium as used in microplates. After 5 days,
cells were stained by an IIFT to detect virus.
Virus titres were expressed as the l0<?io tissue
culture infective dose 50 (TCID^^) as calculated by the
Karber method (Lennette and Schmidt,1979).
Indirect immunofluorescence test to detect virus. All
samples were coded to obscure their origin. After the
removal of medium, coverslips or chamber/slides were washed
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three times with prewarmed phosphate buffered saline (PBS),
before being air-dried. The cells were then fixed in cold
acetone for 10 minutes and re-dried. Predetermined optimal
working dilutions of two anti-pestivirus sera were used in
the first stage of the test. A hyperimmune serum against
BVDV-NADL prepared in a gnotobiotic calf (Nuttall et
al.,1977), kindly supplied by Dr. E.J. Stott, Institute
for Research on Animal Diseases, Compton, Berkshire, was
used for bovine isolates. A convalescent sheep serum
against BDV-M (Gardiner,1980) was used on ovine isolates.
These sera were applied to the cells and incubated at 37°C
for 30 minutes. Cells were washed in 3 changes of PBS for
20 minutes. An optimal dilution of rabbit anti-sheep
immunoglobulin conjugated to fluorescein isothiocyanate
(Wellcome Reagents Ltd., Beckenham, England) was applied to
all cells as the second stage serum. After incubation at
37°C for 30 minutes cells were washed as before, air-dried,
and mounted under phosphate buffered glycerol (pH 8.2).
Known infected and uninfected cells were included in every
test.
For the examination of cells for specific
fluorescence a Leitz Ortholux 2 microscope was used. This
was fitted with a pleomopak 2 vertical illuminator
employing an incident light source from a 50 Watt
ultra-high pressure mercury lamp.
Virus isolation. Swabs were collected into separate bottles
of 4 ml Hanks' BSS containing 1% BSA, 300 iu/ml penicillin,
300 ug/ml streptomycin and 50 iu/ml polymixin B (virus
transport medium (VTM)). Tissues were collected
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aseptically into the same volume of VTM to give an
approximate 1 to 10 ratio of tissue to fluid. Swabs were
sonicated for 30 seconds in an ultrasonic waterbath
(Engisonic Ltd., model B32), and the medium passed through
0.45 nm filters. Tissues were homogenised, clarified by
centrifugation at 2,000 x g for 10 minutes and the
supernatant fluid passed through 0.45 pm filters.Duplicate
tubes of washed confluent monolayers of secondary FLK cells
were each inoculated with 0.2 ml of test fluid. After two
hours' adsorption at 37°C, 1 ml of maintenance medium was
added to each tube.
To isolate virus from blood, samples were collected
into 7 ml evacuated tubes (Vacutainers: Becton-Dickinson
Ltd.), which contained 70 units of preservative-free
heparin sodium BP (Evans Medical Ltd.). Tubes were
centrifuged at 2,000 xg for 15 minutes at room temperature,
the plasma was collected and the buffy coat was aspirated
into 1 ml of maintenance medium. Cells were separated by
vigorous pipetting before 0.2 ml of suspension was
inoculated into each of 2 tubes of washed confluent
monolayers of secondary FLK cells. After 2 hours'
co-cultivation 2 washes with maintenance medium were used
to remove the inoculum, and 1 ml of maintenance medium was
added to each tube.
Inoculated tubes were incubated at 37°C and examined
regularly for virus CPE . After 7 days, cultures were
frozen and thawed once and passaged onto further FLK
monolayers. All specimens received a minimum of 2 such
passages after which time frozen and thawed cultures were
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passaged onto FLK cells grown on coverslips. Seventy-two
hours later cells were examined for the presence of
pestivirus antigen by IIFT. Further passages onto cells in
tubes were used to determine the cytopathogenicity of
isolates.
Virus purity checks. Throughout this work the following
tests were used to test the purity of virus stocks and
isolates recovered from infected animals:-
Cytopathology of virus-infected cell cultures. At
intervals after inoculation coverslip cultures were removed
from tubes, washed in PBS, fixed in Bouin's solution,
cleared in alcohol and stained with May-Grunwald stain
followed by 10% Giemsa. Coverlips were differentiated in
distilled water, blotted dry, rinsed in xylene and mounted
in DPX.
Haemadsorption. At intervals after inoculation cells were
washed three times in PBS and 0.2 ml of a 0.5 % suspension
of guinea-pig erythrocytes was added to each tube. After 30
minutes incubation at 37 C, cells were washed thoroughly
with PBS and then examined for the presence of
haemadsorption. Uninoculated cells and cells infected with
parainfluenza type 3 virus (Strain G2) (Hore,1966) were
used as controls.
Electron microscopy. Cells from cultures with evidence of
virus-induced CPE were scraped from the glass and pelletted
at 2000 x g for 10 minutes in conical-bottomed plastic
universal bottles. Medium was drained off and the cells
resuspended in a small volume of distilled water. The cell
lysates were applied to a formvar/carbon coated grid and
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negatively stained with 1% potassium phosphotungstic acid,
pH 7.0 (Brenner and Horn,1959).
Thin sections of infected and uninfected cells were
also examined. Cells were fixed in freshly prepared 3%
glutaraldehyde in phosphate buffer (pH 7.4), and post-fixed
in 1% osmium tetroxide in phosphate buffer (pH 7.4). After
dehydration in graded alcohols, cells were embedded in
Araldite. Sections were cut on a Reichart 0MU4
ultramicrotome and stained with uranyl acetate followed by
lead citrate.
E.W. Gray and J.D. Menzies of the Electron
Microscopy Section, Moredun Research Institute, carried out
the electron microscope studies.
SEROLOGICAL TECHNIQUES
Serum-virus neutralisation tests.
All serum and plasma samples were heat-inactivated at
56°C for 30 minutes soon after collection and stored at
-20°C until they were tested. To minimise the effect of
test-to-test variations, samples collected at the one time
from all animals in an experiment were included in the same
test. The medium used for all dilutions and for cell
growth was '199' supplemented with BSA (0.5%), yeast
extract (0.1%) and 10% heat-inactivated horse serum.
Antibiotics were included as detailed under tissue culture
medium (see above).
Constant virus-varying serum. A microneutralisation test
was used, based on the method of Rossi and Kiesel (1971).
Tests were carried out in 96-well microtitre plates.
Serial two-fold dilution series (25 ul per well) of test
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serum were prepared in duplicate, and an equal volume of
virus containing approximately 100 TCID5Q was added to each
well. Duplicate wells containing the lowest dilution of
test serum without antigen were included as controls to
detect cytotoxic sera. After incubation at 37°C for one
hour, 100 pi of a suspension of FLB cells containing
104 cells were added to each well. Plates were sealed
with non-toxic clear adhesive tape and incubated at 37°C.
Cultures were examined for the presence of CPE after 5-7
days and the result expressed as the reciprocal of the
serum dilution corresponding to the 50 per cent end-point
of neutralisation as calculated by the Karber method
(Lennette and Schmidt,1979). The actual titre of virus
used in the test was always determined and if this was
outside the range of 32-320 TCID5Q Df virus per well
the test was repeated. Known negative and positive sera
were included in every test.
Constant serum-varying virus. Serial ten-fold dilutions of
virus were prepared in bijoux bottles. A 0.2 ml aliquot
of each dilution of virus was added to an equal volume of a
1 in 20 dilution of test or control antiserum. After
incubation at 37°C in a water bath for 1 hour residual
infectious virus was titrated in FLB cells as described
above. The serum neutralisation index was calculated by
subtracting the log^Q titre of virus incubated with the
test serum from the titre of virus incubated with
the control serum.
Immunofluorescence test for titrating antibodies in sera.
Virus was diluted so as to contain sufficient infectious
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particles to infect approximately 50% of cells in confluent
FLB cells grown on coverslips in tubes. Seventy-two hours
after infection coverslips were washed, fixed in cold
acetone and either used immediately or stored at -20°C in
boxes containing silica gel.
Serial two-fold serum dilutions in PBS were made in
microplates and duplicate coverslips were each overlaid
with 25 pi of dilutions of test sera. After incubation at
37°C for 30 minutes cells were washed in three changes of
PBS for 20 minutes. An optimal working dilution of rabbit
anti-sheep immunoglobulin conjugated to fluorescein
isothiocyanate (Wellcome reagents Ltd, Beckenham, England)
was used as the second stage serum as previously described.
Cells were mounted under phosphate buffered glycerol (pH
8.2) and examined for evidence of characteristic
immunofluorescence. Low dilutions of sera were also tested
on uninfected cells. Before reading, the origin of each
coverslip was obscured. Coverslips were recorded as being
positive or negative for immunofluorescence and the result
expressed as the reciprocal of the serum dilution
corresponding to the 50% end-point of detectable
fluorescence as calculated by the Karber method (Lennette
and Schmidt,1979).
HAEMATOLOGY
All blood samples were collected into evacuated glass
tubes containing 10 units of preservative-free heparin
sodium BP per ml of collected blood.
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Haematological examinations from experimental animals
were carried out according to the methods described in
Schalm et al. (1975). Blood cell counts were made using
an electronic particle counter (Coulter Counter; model
ZB1). Haemoglobin was measured in a haemoglobinometer
(Coulter Electronics Ltd., Harpenden, Herts.), and Packed
cell volume (PCV) was determined using a micro-haematocrit
(MSE Ltd., Crawley, West Sussex).
Blood smears for differential leukocyte counts were
fixed in methanol and stained with 10% Giemsa stain for 30
minutes. Smears were differentiated in distilled water and
air-dried. Two hundred leukocytes were identified and the
results expressed as percentage of total count and as
absolute numbers per yl of blood.
PATHOLOGY
Animals either died or were exsanguinated under deep
sodium pentobarbitone anaesthesia. At necropsy, the entire
central nervous system (CNS) and representative samples of
other organs and tissues were fixed by immersion in Baker's
calcium formol; blocks were taken,processed to
paraffin,sectioned and examined by light microscopy.
Stains used included haematoxylin and eosin (HE), luxol
fast blue, alcian blue-periodic acid schiff, methyl green
pyronin and Feulgen.
Dr. R.M. Barlow of the Pathology Department,




Cell cultures, virus stocks and animal tissues were
tested for the presence of bacteria by inoculating broth
cultures and by streaking out on 7% sheep blood agar
plates. Following incubation at 37°C for 24 or 48 hours
bacteria were identified on the basis of their colony
morphology on blood agar and by Gram stain. Broth cultures
were sub-cultured on to blood agar if direct cultures onto
blood agar yielded few or no colonies.
Mr. J. Fraser of the Bacteriology Section, Moredun
Research Institute, carried out the bacteriological
examinations.
MYCOPLASMOLOGY
Cell cultures, virus stocks and animal tissues were
tested for mycoplasma contamination by inoculating 0.2 ml
of a 1 in 10 suspension of sample into 2 ml each of OB, UB
and AB mycoplasma broth medium and by streaking out a
loopful of suspension on OA agar (Jones,1978). Isolates
were identified by growth inhibition tests or indirect
immunofluorescence tests.
Mr. A.G. Rae of the Mycoplasma Section of the
Microbiology Department, Moredun Institute, carried out the
examinations for mycoplasma.
TABLE 2.1
Details of field isolates of BVD and BD viruses
Designation Date and place Animal Disease
of origin
CP









































































MD - Mucosal disease CP - Cytopathic isolate
NCP - Non-cytopathic isolate
BVDV - Bovine virus diarrhoea virus
BDV - Border disease virus
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CHAPTER 3
CELL CULTURE STUDIES WITH BVD AND BP VIRUSES
INTRODUCTION
Reliable cell culture methods were required for the
propagation and assay of BVD and BD viruses. The
susceptibility of a range of cell cultures to BVDV has been
documented and the virus has been shown to replicate in a
number of bovine cell lines as well as in low passage
bovine cells (Saurat et al.,1972). Studies with BDV,
however, have usually used low passage ovine or bovine
cells for virus growth.
Continuous cell lines have two outstanding advantages
that make them attractive for this kind of study. Their
ready availability allows large stocks to be produced so
that all experiments can be conducted using few passages
from the starting material. Stocks can be thoroughly
screened for the presence of 'wild' viruses: this is
particularly useful since BVDV is a major contaminant of
bovine foetal cells (Kniazeff, 1973). One cell line,
derived from foetal lamb muscle, has been used for the
growth and assay of BVDV and BDV (Laude and Gelfi,1979).
Unfortunately, this cell line is no longer available
(Laude, personal communication).
In this laboratory previous studies have utilised
secondary BEK cells for the assay of BVDV-NADL, and
secondary ELK cells for the assay of BDV-M. Comparative
serum neutralisation tests using these systems have
consistently detected differences in the humoral antibody
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response of sheep to infection with various BVD and BD
viruses (Vantsis et al.,1976; Vantsis et al.,1900 ; Vantsis
et al.,1980 ). It has, been recognised, however, that the
use of the two assay systems has meant that comparison of
the titres to each virus ought to be made with caution
(Vantsis et al.,1979). A single cell system for the assay
of the two viruses would be advantageous since the amount
of neutralisation in serum-virus interactions is influenced
considerably by the host cell system in which residual
virus infectivity is assayed (Della-Porta and
Westaway,1977).
This chapter is concerned with several aspects of the
in-vitro cultivation of BVDV and BDV which were
investigated in attempts to establish a single reliable
cell culture system for the growth and assay of both
viruses.
SECTION 1. THE SUSCEPTIBILITY OF DIFFERENT CELL CULTURES
TO BVD AND BD VIRUSES.
Established cell lines, low-passage (semi-continuous)
cell lines established from foetal organs, and secondary
cells were tested for their susceptibility to BVD and BD
viruses.
MATERIALS AND METHODS
Viruses. BVDV-NADL had been passaged an unknown number of
times in bovine kidney cells. BDV-M had been passaged 28
times in FLK cells. Working stocks of these viruses were
stored as 1 ml aliquots at -70°C and used as required.
Cell cultures and infectivity assays. The cell cultures
tested and their passage histories are shown in the Tables
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in the Results section. Cells were grown to confluence on
coverslips in glass test tubes, and infected with serial
ten-fold dilutions of virus as described in Chapter 2.
The cells were examined for evidence of virus-induced
CPE at 5, 8 and 10 days. If no CPE was detected in cells
infected with BD virus, coverslips were removed from tubes
receiving low dilutions of virus , and the cells were
stained by IFT to detect any evidence of replicating virus.
Uninfected control cells were also examined for the
presence of virus by IFT.
Statistical Analysis. The infectivity titres of the two
viruses in secondary BEK and FLK cultures were compared
using 2x2 factorial analysis of variance. The level of
significance of differences for comparisons with
significant F-ratios was established using an honestly
significant (HSD) test (Runyon and Haber,1980).
RESULTS
Titration of stock viruses in secondary BEK and FLK
cultures. The results of five replicate tests, read 10 days
after inoculation, are shown in Table 3.1. The mean
infectivity titre of BVDV-NADL was higher in BEK than in
FLK cells, but the difference was not significant. The
mean infectivity titre of BDV-M, however, was significantly
higher (p<0.01) in FLK cells than in BEK cells.
Established cell lines. The results are summarised in
Table 3.2 from which it can be seen that both viruses
failed to cause CPE in any of the lines tested. The IFT
failed to show any evidence of BD virus replication in cell
TABLE 3.1
Titration of stock viruses in secondary BEK and FLK cells
BEK CELLS FLK CELLS
Batch No. BVDV-NADL BDV-M Batch No. BVDV-NADL BDV-M
272 5.0 * 2.0 273 4.5 4.5
278 5.5 3.5 277 4.5 4.0
297 4.5 2.5 306 5.5 4.5
308 5.5 2.5 313 4.5 4.5
312 4.0 3.5 315 3.5 3.5
Mean 4.9 2.8 4.5 4.2
* Logic TCID50 per 0.2 ml virus
TABLE 3.2
Titration of stock viruses in established cell lines
Cell Line Passage BVDV-NADL BDV-M
Number CPE after CPE after IFT






















? = Not Known = No CPE at a virus
dilution of 10~
- = No fluorescence at a + = Fluorescence detected at
virus dilution .a virus dilution of
10"1 10"1
+C+ = Fluorescence detected in uninfected control cells
as well as infected cells
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lines derived from mouse, monkey or hamster tissues. Of
the two rabbit cell lines tested, specific fluorescence was
seen in both. With 1/10 dilutions of virus, fluorescence
was restricted to two small areas of SIRC cells on one of
the coverslips; no fluorescence was seen in cells infected
with higher dilutions of virus or in uninfected SIRC cells.
In RK-13 cells fluorescence was apparent in many cells
infected with low dilutions of virus; uninfected RK-13
cells showed a similar pattern of widespread fluorescence.
Similarly, the PK-Pirbright and MDBK cell lines showed
virtually all cells to be fluorescing whether they were
infected or not. No fluorescence was detected when the
first stage serum was replaced with a calf serum without
detectable neutralising antibody to BVDV-NADL or BDV-M, and
it was concluded that the RK-13, PK-Pirbright and MDBK cell
lines were persistently infected with a BD-related virus.
Semi-continuous cell lines and secondary cells. The
results are summarised in Table 3.3. Several clear results
emerged from these titrations. Cells of ovine origin were,
with only one exception, susceptible to both viruses.
Their sensitivity for the assay of BD-M was shown by the
fact that the final titre was apparent by the fifth day.
In contrast to this, slower development of the CPE in cells
infected with BVDV-NADL meant that the final titre was not
reached until the eighth day. Comparable titres of BDV-M
were obtained in all the cells tested with the exception of
the foetal lamb (FL) lung cells. Sheep thyroid, FL skin
and FL brain cells were the most sensitive for the assay of
BVDV-NADL and it was encouraging that even after 38
passages the FL brain cells were sensitive to both viruses.
TABLE 3.3
Titration of stock BVD and BP viruses in semi-continuous
cell lines and secondary cells of ovine, bovine and
porcine origin
Cell Type Passage BVDV-NADL BDV-M
Number 5# 8 10 5 8 10
OVINE
Sheep Thyroid 3 3.2* 4.5 4.5 4.2 4.2 4.2
Foetal Lamb (FL)
Muscle
2 3.0 3.5 3.5 4.0 4.0 4.0
FL Spleen 13 1.5 2.5 2.5 4.5 4.5 4.5
FL Skin 15 3.0 4.5 4.5 4.5 5.0 5.0
FL Brain 8 4.0 4.0 4.5 3.5 3.5 4.0
FL Lung 12 3.0 3.0 3.0 <1.0 <1.0 <1.0
BOVINE
Bovine embryonic
(BE) Trachea 2 3.5 3.5 3.5 <1.0 <1.0 <1.0
BE Turbinate 0 4.5 4.5 4.5 1.5 2.5 2.5
BE Skin 2 5.0 5.0 5.0 <1.0 <1.0 <1.0
BE Testis 3 5.0 5.0 5.0 2.5 3.5 4.0
PORCINE
Pig Kidney 2 <1.0 <1.0 <1.0 <1.0 <1.0 <1. 0
Pig Testis 3 A • o <1.0 <1.0 <1.0 <1.0 <1.0
# Days post-inoculation when titres calculated
* Results expressed as Log1Q TCID^q per 0.2 ml virus
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All the bovine cells were susceptible to BVD-NADL and
only 5 days were required for the CPE to develop at
terminal dilutions to give the final titres. The trachea
cells at passage 32 were the least sensitive to BVD-NADL,
but turbinate and testis cells at 20 and 13 passages
respectively recorded high titres. These last two cell
types showed some CPE when infected with BDV-M but this was
slow to develop and only the testis cells gave a final
titre comparable to those recorded in ovine cells.
No CPE developed in the two porcine cell types
tested. Pig testis cells infected with both viruses stained
by immunofluorescence were positive at titres of 2.5 and
3.5 for BVD-NADL and BD-M respectively.
CONCLUSIONS
None of the established cell lines tested were of
value for this work. Whilst a range of cells of both
bovine and ovine origin was susceptible to BVDV-NADL a more
rapid CPE developed in the bovine cells. The BD virus was
more fastidious in its cell requirement for growth. A
rapid CPE at terminal dilution was seen only in ovine cells
infected with BDV-M; replication with CPE did, however,
occur slowly at low dilutions in some bovine cells. Both
viruses showed evidence of replication in porcine cells but
without the production of CPE.
SECTION 2. THE GROWTH OF BVD AND BD VIRUSES IN SELECTED
CELL CULTURES FROM OVINE AND BOVINE FOETUSES
The results from Section 1 showed that cells derived
from several foetal lamb organs were susceptible to both
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viruses. The highest titres of the two viruses were
recorded in foetal lamb kidney, skin and brain cells. Of
the bovine embryonic tissues tested only testis cells
showed good evidence of BD virus replication. In this
section the ability of skin, testis and brain cultures made
from ovine and bovine foetuses to produce infectious virus
has been studied.
MATERIALS AND METHODS
Viruses. The high passage stocks of BVDV-NADL and BDV-M
described in the previous section were used.
Cells. Primary skin, testis and brain cell cultures were
established by trypsin disaggregation from each of three
ovine foetuses of approximately the same age, and three
bovine foetuses of approximately the same age. Cells were
passaged as necessary, being used between the second and
eighth pass.
Experimental Procedure. The method was based on that
described by McFerran et al.(1972), in which test viruses
were titrated over two passages in different cell culture
systems followed by titration in kidney cells derived from
the same species of animal as that from which the virus was
originally isolated.
Newly confluent cell monolayers consisting of
approximately 2 x 10' cells grown in Sani/Glass (S/G)
bottles were washed thoroughly with Hanks' BSS and infected
with 1 ml of stock virus. Fifty ml of maintenance medium
were added to each bottle and the cells incubated at 37°C
for 5 days. After this time the state of the cell monolayer
was recorded and the supernatant fluid collected. After
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clarification at 2000xg for 15 minutes aliquots of the
fluid were stored at -70°C. For the second passage onto
cells in S/G bottles 10 ml of first harvest supernatant
were used as inoculum, and removed before maintenance
medium was added. Cells were incubated for 5 days,
examined and virus recovered and stored as before. Virus
yields from both passes were titrated in tube cultures of
homologous cells , and yields from the second passage were
also titrated in FLK and BEK cells. All titrations were
read 5 days after inoculation.
Statistical analysis of results. Virus infectivity titres
in different cells at the two passage levels were compared
using 2 x 6 or 3 x 6 factorial analysis of variance. The
level of significance of differences for comparisons with
significant F - ratios was established using an HSD test.
RESULTS
Cell Growth. All cells were grown successfully with one
exception. The brain culture from the first lamb stopped
growing after 5 passages before the second virus passage
had been undertaken. No cause was established. A brain
culture from a fourth lamb was used for the second virus
passage and virus titrations.
Development of CPE in cells grown in S/G bottles. In
comparison to uninfected control cells a clear CPE was seen
in all cell types infected with BVDV-NADL at both passages.
More than 50% of cells in the monolayers were showing
evidence of degeneration and many had become detached from
the glass. Some evidence of CPE was apparent in all the
ovine cell types infected with BDV-M but this was generally
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far less advanced than that seen in BVD virus-infected
cells. Apart from the degree, there was no discernible
difference between the effects produced by the two viruses.
In bovine cells, BDV-M-induced CPE was not extensive but
was apparent in all but the skin culture of one calf at the
first pass, and the skin culture of the other two calves at
the second pass. One brain culture at the first pass was
also free of detectable CPE.
Virus yields from different cell types. The results of the
virus titrations in homologous cells after passage are
shown in Table 3.4. All titres were lower than those
previously obtained with the stock viruses in these cell
types. After 1 passage, there were no significant
differences among the virus yields from the three ovine
cell types. Combined virus yields from BE skin and BE
brain cells, but not BE testis cells, were significantly
lower (p<0.01) than yields from the ovine cells. Since
there was no significant difference between yields of
BVD-NADL from any of the cell types from either species,
disparity between combined virus yields from ovine and
bovine cells was due to the reduced growth of BDV-M in
bovine cells. Comparison of the yields of BDV-M from cells
of the two species showed that the reduced growth was
significant in all cell types, brain(p<0.001), skin(p<0.01)
and testis(p<0.05).
After 2 passages, the reduction in growth of BDV-M in
bovine cells was even more marked, brain (p<0.001), skin
(p<0.001) and testis (p<0.01). One other significant
finding was the lower yield of BVDV-NADL from BES cells
compared to FLS cells (p<0.05).
TABLE 3.4
Virus yields from cell cultures derived from ovine
and bovine foetuses
Pass 1 Pass 2
Cell type BVDV-NADL BDV-M BVDV-NADL BDV-M







FL Testis 3.3 + 0.6 3.6 + 1.0 3.6 + 1.0 3.3 + 0.3
FL Brain 2.5 + 0.0 3.8 + 0.8 3.2 + 0.8 3.3 + 0.3
BE Skin 2.5 + 1.5 0.8 + 0.8 2.0 + 0.9 0.8 + 0.8
BE Testis 3.2 + 0.3 2.0 + 0.5 3.2 + 0.6 1.5 + 1.0
BE Brain 2.3 + 0.8 0.8 + 0.8 3.2 + 0.6 0.8 + 0.3
* Mean ± SD from 3 foetuses expressed as Log^^
TCID^q per 0.2ml of virus.
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When the virus yields from the second passages in
different cell types were assayed in secondary BEK and FLK
cells some clear differences emerged (Table 3.5). The
differences all involved the assay of BDV-M. Titration of
BVDV-NADL in BEK cells gave slightly higher values than in
the homologous cells. Overall, however, there were no
significant variations in BVDV-NADL virus yields from any
of the 6 cell types whether they were assayed in homologous
cells, BEK cells or FLK cells.
The most striking of the results was that BDV-M had
been produced to a high titre in the three bovine cell
types but this had not been detected by assay in these
cells. Only when FLK cells were used for titration was the
relatively high concentration of virus detected. Analysis
of BDV-M titres in FLK cells from the six cell types showed
that virus yields from FLT and FLS cells were significantly
lower (p<0.05) than yields from at least one of the bovine
cell types; virus yields from FLB cells, however, were not
significantly lower than yields from any of the bovine
cells.
Comparison of BDV-M titres in homologous cells, BEK
cells and FLK cells showed that FLK cells were
significantly (p<0.001) the most sensitive for virus assay.
Low virus titres in secondary BEK cells re-emphasised the
unsuitability of bovine cells for the assay of BDV-M.
Comparison of BDV-M virus titres in homologous and FLK
cells showed that variation depended on the cells used for
virus growth. Thus, virus grown in ovine cells gave
TABLE 3.5
Titration of stock viruses in secondary BEK and FLK cells
after two passages in stated cell types compared with the
titres obtained in those homologous cells
Titre in Titre in Titre in
Cell Homologous cells BEK Cells FLK Cells
Type
BVDV-NADL BDV-M BVDV-NADL BDV-M BVDV-NADL BDV-;
FL Skin 3.5* 4.0 2.7 1.3 3.7 3.8
±1.0 ±1.3 ±0.3 ±1.9 ±0.3 ±1.2
FL Testis 3.6 3.3 3.2 0.5 3.0 3.0
±1.0 ±0.3 ±0.8 ±0.5 ±1.0 ±0.5
FL Brain 3.2 3.3 3.3 1.3 3.3 4.2
±0.8 ±0.3 ±1.0 ±1.5 ±1.0 ±1.5
BE Skin 2.0 0.8 3.8 1.0 3.5 4.7
±0.9 ±0.8 ±1.3 ±1.0 ±0.5 ±1.3
BE Testis 3.2 1.5 4.3 1.5 3.0 5.7
±0.6 ±1.5 ±1.6 ±1.0 ±0.5 ±1.0
BE Brain 3.2 0.8 4.5 2.7 3.0 4.5
±0.6 ±0.3 ±0.5 ±1.4 ±0.9 ±0.5
Mean ±SD from 3 foetuses expressed as Log-^Q
TCIDj-q per 0.2ml of virus.
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comparable titres in homologous and FLK cells, whereas
virus grown in bovine cells gave significantly higher
titres (p<0.001) when assayed in FLK cells.
CONCLUSIONS
There were no significant differences between the
yields of BVDV-NADL from any of the six cell types used.
After two passages in these cell types virus yields were
comparable whether assayed in homologous cells, BEK cells
or FLK cells.
The apparent yields of BDV-M from the six cell types
varied according to which cells were used to assay the
virus. The most sensitive cells for assaying BDV-M were
FLK cells. When these were used for virus assay, it was
apparent that the highest virus yield had been produced in
bovine testis cells. This yield was not significantly
different from the yields from the other bovine cell types
and the FL brain cells.
The best growth system for the two viruses appeared
to be BE testis cells but bovine cells were consistently
unsuitable for the assay of BD-M virus. All three ovine
cell types, however, were sensitive indicators of the CPE
produced by both viruses, but only FL brain cells had
supported growth of BD-M to a level comparable with that
obtained in the bovine cells. For this reason FL brain
cells were used subsequently for comparative in-vitro
studies on the antigenicity of BVD and BD viruses.
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SECTION 3. INVESTIGATIONS INTO POSSIBLE SOURCES OF
PESTIVIRUS CONTAMINATION OF SUSCEPTIBLE
OVINE AND BOVINE CELLS
Having established the suitability of ovine cells of
foetal origin for the cultivation and assay of both
BVDV-NADL and BDV-M it was of interest to determine if
latent pestivirus contamination of such cells was likely to
pose a problem. Ovine cells have been used in studies on
BVD viruses (Siebold and Dougherty, 1967 ; Singh, 1969a), but
no reports of latent contamination of such cells are known.
Pestivirus contamination of bovine cells, however, has been
well documented and recognised as a serious disadvantage of
using bovine tissue cultures. Contamination can be present
in the cells themselves or can arise from the bovine serum
supplement used in the growth medium (Nuttall et al.,1977).
In some instances it was not possible to ascertain which of
these two sources was the cause of the contamination (Rossi
et al.,1980 ) .
In this section pestivirus contamination rates of the
sera most commonly used for supplementation of tissue
culture medium, and bovine and ovine foetal cell cultures
were studied.
SECTION 3.1. PESTIVIRUS CONTAMINATION OF BOVINE SERA.
MATERIALS AND METHODS.
Virus isolation. Six batches each of commercially
available foetal bovine serum (FBS) and newborn calf serum
(NBCS) were tested for the presence of pestiviruses. All
the sera had been 'virus screened' by the suppliers.
Thirty-five ml of each serum, not heat-inactivated, were
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used as a 10% supplement of '199' medium for the growth of
a semi-continuous cell line derived from foetal lamb brain
known to be susceptible to BVD and BD virus. In each test,
a batch of FBS and a batch of NBCS were used in parallel on
the same cells. Fifty ml of test medium containing 1 x
510 cells were added to a Sani-glass(SG) bottle. Cells
were grown to confluence in 3-5 days, washed, trypsinised,
resuspended in 150 ml of fresh growth medium, and seeded
into 3 SG bottles. When confluent, cells from the 3
bottles were trypsinised, pooled, and resuspended in a
further 150 ml of growth medium at a count of 1 x 105
cells/ml. Confluent cells were trypsinised, pooled,
resuspended as before and seeded into 6 test tubes
containing coverslips. After four days, the coverslips
were removed and the cells stained in an IIFT as described
in Chapter 2. Three coverslips were tested with
hyperimmune calf serum aganst BVD virus, and three with
sheep anti-BD virus serum.
Measurement of neutralising antibody to BVD and BD viruses
in commercial bovine sera. Heat-inactivated FBS and NBCS
were tested for neutralising antibody to BVD and BD viruses
in micro-neutralisation tests as described in Chapter 2.
RESULTS.
Pestivirus contamination of bovine sera. No virus was
detected in FL brain cells grown in NBCS. Of the six
batches of FBS tested, four were contaminated with
non-cytopathic BVD virus. Specific fluorescence was
widespread in cells on all coverslips stained with either
of the two first stage sera.
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Neutralising antibody to BVD and BP viruses in commercial
bovine sera. The results are summarised in Table 3.6. All
batches of NBCS had high levels of neutralising antibody to
BVDV-NADL virus. The corresponding titres against BDV-M
virus were always lower.
Of the 23 batches of FBS tested, fifteen had antibody
to BVDV-NADL. This was generally detected at low serum
dilutions only, but one batch had a reciprocal neutralising
titre of 32. No neutralising antibody to BDV-M was present
in any of the batches of FBS.
SECTION 3.2. LATENT PESTIVIRUS CONTAMINATION OF BOVINE AND
OVINE FOETUSES COLLECTED FROM ABATTOIRS.
In this section the results are presented of a three
and a half year study on the latent pestivirus
contamination rates of kidney cells grown from ovine and
bovine foetuses collected from local abattoirs.
MATERIALS AND METHODS.
Source and culture of foetal material. Within five
hours of slaughter, pregnant uteri were collected from
local abattoirs and tranported to the laboratory. Kidneys
from both species were treated in the same way, being
removed aseptically, chopped finely and disaggregated with
0.25% trypsin. The method was that described by Paul
(1970a) for monkey kidney cells except that the growth
medium for the pooled cell supensions was Eagle's MEM
supplemented with 10% bovine serum and containing 100
1.u/ml penicillin, 100 pg/ml streptomycin, 50 iu/ml
polymixin-B and 2 y/ml amphotericin B deoxycholate.
Cells were seeded into Thompson bottles and the
TABLE 3.6
Neutralising antibody to BVDV-NADL and BDV-M viruses in
batches of bovine sera
FBS NBCS
BVDV-NADL BDV-M BVDV-NADL BDV-M
No. of batches tested 23 23 12 12
No. of batches positive 15 0 12 12
Range of antibody titres 2-32 0 256-1024 6-128
Geometric mean titre 4 0 483 21
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growth medium was changed to remove dead cells the
following day. Confluent monolayers were produced within
3-5 days with foetal lamb kidney (FLK) cells showing faster
growth than the bovine embryo kidney (BEK) cells.
Confluent cells were trypsinised and 105 cells in 1 ml
volumes were seeded into test tubes some of which contained
coverslips. When monolayers became confluent they were
washed three times with Hanks' BSS and then maintained with
'199' medium supplemented with 0.5% BSA, 0.1% LAH, 0.1%
yeast extract and 2% heat-inactivated foetal bovine serum
free of anti-pestivirus antibodies; antibiotics were
included in the same concentrations as used in the growth
medium. Three days after the addition of maintenance
medium duplicate coverslip cultures were examined for the
presence of pestiviruses using an IIFT. Cells showing
specific fluorescence were considered contaminated and all
stocks of these cells were discarded.
Test tube cultures of IFT doubtful or negative cells
were maintained for 1 week after which time cells were
frozen and thawed once and 0.2 ml volumes of lysate were
inoculated into further tubes of washed confluent
homologous kidney cells free of pestivirus contamination.
After 2 hours' adsorption maintenance medium was added and
the cells incubated for a further week. During these blind
passages cells were examined regularly for evidence of CPE.
At the end of the second blind pass cells were frozen and
thawed and 0.2 m aliquots were added as before to at least
6 coverslip cultures of pestivirus-free BEK or FLK cells.
Three days later the coverslip cultures were tested for the
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presence of pestiviruses using an IFT. If there was no
evidence of specific fluorescence the cells were considered
to be free of contaminating pestiviruses.
Virus detection by IFT. This test was performed as
described in Chapter 2. Two first stage sera were used. A
hyperimmune serum against BVDV-NADL prepared in a
gnotobiotic calf (Nuttall et al.,1977) was used on BEK
cells and a convalescent sheep serum against BDV-M
(Gardiner et al.,1980) was used on FLK cells. To test the
ability of these two sera to detect noncytopathic
pestiviruses from both cattle and sheep 12 BVD virus field
isolates and 6 BD virus field isolates from disease
outbreaks in Britain were used. These viruses had all been
isolated at Moredun and stored at -70°C as second pass
stocks in BEK or FLK cells for up to 14 months. Volumes
(0.2 ml) of bovine isolates were inoculated on to each of 4
washed monlayers of pestivirus-free BEK cells grown on
coverslips.. After three days cells were stained in an
indirect IFT, two coverslips receiving calf anti-BVD serum
and two sheep anti-BD serum as the first stage sera. Sheep
isolates inoculated onto pestivirus-free FLK cells were
tested in the same way.
Results
The 12 non-cytopathic BVD and 6 non-cytopathic BD
virus isolates all showed clearly detectable specific
immunofluorescence with both first stage sera.
The number of cell batches tested and the pestivirus
contamination rates are summarised in Table 3.7. Of the
113 batches of BEK cells tested 15 were contaminated with
TABLE 3.7
Pestivirus contamination of foetal bovine (BEK) and
foetal ovine (FLK) kidney cells
BEK FLK
Number cultured 113 105
Number contaminated 15 2
Percentage contamination 13.3 1.9
TABLE 3.8



















































Totals 4/37 7/43 4/25 0/8
* Number contaminated/Number tested
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latent pestivirus infection. In twelve of these batches
the contamination was detected in the first test on the
secondary cells. Three other batches were detected as
positive after further passage. The detection rate in FLK
cells was significantly lower. Only two batches were
contaminated and these were detected only after cell
passage.
The monthly totals of the contamination rates of BEK
cells are shown in Table 3.8. Although latent pestivirus
infections were detected throughout the year, there was a
tendency for this to be recognised in foetuses collected in
the first four months of the year. Ten of 44 foetuses were
positive during this time compared with 5 of 69 foetuses
collected during the other 8 months. This difference was
significant (X^-4-3; p<0.05).
The two contaminated batches of FLK cells were
detected in foetuses collected in January 1981 and March
1982.
CONCLUSION.
Pestivirus contamination of FLK cells was detected,
but the contamination rate was significantly lower than
that of BEK cells.
DISCUSSION.
Titration of the cytopathic reference strains of BVD
and BD viruses showed that the production of CPE was
restricted to primary or semicontinuous cultures of ovine
and bovine cells. Established cell lines of mouse, hamster
and monkey tissue origin were refractory to both viruses;
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no fluorescence was detected in cells infected with BDV-M
or in uninfected cells. This finding compares with a
previous report that BVDV-NADL and BVDV-C24V produced
abortive infections, detectable only by immunofluorescence
in hamster kidney and primate cells resembling the HeLa
cell line (Fernelius et al.,1969b).
Of the two rabbit cell lines tested neither showed
CPE but both had evidence of pestivirus replication as
detected by immunofluorescence. In SIRC cells the small
amount of fluorescence at a high virus concentration was
due specifically to BDV-M but widespread fluorescence in
both infected and uninfected RK-13 cells confirmed that
this cell line was persistently infected with a virus
related to BD-M. The susceptibility to pestiviruses of
rabbit cells in-vitro has been reported previously
(Hassan, 1979), and rabbits have been used for the serial
passage of the non-cytopathic NY-I BVD virus and the NADL
and C24V strains (Baker et al.,1954; Fernelius et
al.,1969a). The bovine kidney and porcine kidney cell lines
were also contaminated with a BDV-M related virus as judged
by immunofluorescence, and were unsuitable for further
study.
A wide range of tissues from ovine foetuses showed
CPE with both viruses. Previous studies of BVD virus have
utilised lamb testis cells (Siebold and Dougherty,1967;
Singh, 1969a). The second of these reports noted that the
NADL strain caused a more slowly developing and less
widespread CPE in the lamb cells than it did in BEK, BE
lung and BE testis cells. It was also true of the findings
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in this chapter that BVDV-NADL caused a more rapid CPE in
the 4 bovine cell types studied. Nevertheless virus
titrations showed that FLK, FL skin, FL brain and sheep
thyroid cells were all equally susceptible to the two
viruses.
Bovine foetal cells were not, in general, susceptible
to BDV-M virus, as judged by the development of CPE. Only
BE testis cells were likely to be of value even though the
development of CPE was slow in these cells. Bovine testis
cells have been used for studying cytopathic BD viruses
(French et al.,1974) and non-cytopathic isolates ( Harkness
et al.,1977; Terpstra,1981). One of the non-cytopathic
isolates , Weybridge BD-2, was later shown to be cytopathic
in a foetal lamb muscle cell line (Laude and Gelfi,1979).
The assay of the two viruses in porcine cells further
demonstrated that the development of CPE was not always a
reliable indicator of virus replication.
Immunofluorescence tests were positive for both viruses and
comparative titrations of them in pig testis cells
suggested that this system was more sensitive to BDV-M than
to BVDV-NADL.
Having established that both viruses were able to
produce CPE in several ovine and bovine cell types, the
ability of the three most promising cell types from the 2
species to produce infectious virus was tested. Previous
work had shown that the ability of cells to detect a virus
is correlated with their ability to produce infectious
virus (McFerran et al.,1972). In these studies this was
true of BVD-NADL virus in all 6 cell types, while for BDV-M
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it was only true when the virus was grown and assayed in
ovine cells. Growth of BDV-M in bovine cells produced a
paradoxical result. When assayed in bovine cells virus
growth appeared to be significantly less than that achieved
in ovine cell types. Assay of the virus in FLK cells,
however, showed that high levels of infectious virus had
been produced by the bovine cells, particularly BE testis
cells. This discrepancy was almost certainly exacerbated
by the short period (5 days) allowed for CPE to develop,
but it emphasised the unsuitability of bovine cells for the
assay of BDV-M. In the wide range of viruses studied by
McFerran and co-workers (1972) one other ovine virus, an
adenovirus, gave a similar result.
Latent BVD virus contamination of foetal bovine serum
and foetal bovine tissues has been widely recognised
(Kniazeff, 1973; King and Harkness, 1975; Smithies and
Modderman,1975; Nuttall et al.,1977; Rossi et al.,1980).
In this laboratory the two major serum supplements of
tissue culture growth medium are commercially supplied
foetal bovine serum (FBS) and newborn calf serum (NBCS).
Both sera are sold 'virus screened', which includes testing
for BVD virus by a fluorescence test as well as checking
for the presence of cytopathic agents. The suppliers'
testing procedure would appear to be inadequate since NOP
BVD virus was detected in 4 of the 6 batches of FBS tested.
None of the 6 batches of NBCS contained BVD virus, and this
was almost certainly due to the high levels of
anti-pestivirus neutralising antibodies, which were found
in all batches tested. It has been shown previously with
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other bovine viruses that infectious virus could not be
isolated from serum containing specific neutralising
antibody even though electron microscopy revealed the
presence of the viruses (Swack et al.,1975). Of the 23
batches of FBS tested, fifteen had neutralising activity
against BVD-NADL, precluding their use in medium employed
to maintain cells during virus growth.
Heat (56°C for 30 minutes) has been advocated for the
inactivation of BVD virus in FBS. This has not always been
effective, however (Nuttall et al.,1977; Rossi et
al.,1980). There is also evidence that some isolates are
more resistant to heat than others (Done et al.,1980).
Susceptible cells grown in the presence of contaminated FBS
may have to be subcultured several times before showing
et at
evidence of BVD virus infection (Nuttall,1977) . Since it
was envisaged that semi-continuous cell lines of ovine
cells would be used for comparative studies of BVD and BD
viruses it was felt to be essential that they were not
exposed to potentially contaminated FBS.
Latent pestivirus contamination of foetal tissues
results from transplacental infection. Isolation of virus
from a variety of organs following experimental infection
provides strong evidence of a viraemia in the foetus (
French et al.,1974; Snowdon et al.,1975). The detection of
latent BVD virus contamination in several bovine cell types
would tend to support this view. In order to compare
likely pestivirus contamination rates of locally available
bovine and ovine foetuses, kidney cells were cultured from
both species.
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Pestivirus contamination was detected in 15 of 113
(13.3%) BEK cultures. Twelve of the cultures were positive
at the second passage level, having been grown in medium
supplemented with NBCS. Growth of cells latently infected
with BVD virus in the presence of high levels of
neutralising antibody has been reported previously and
indicates that persistence is maintained by passage of the
viral genome to each daughter cell during cell division
(Coria and McClurkin,1981). The BVD virus contamination
rate found from this series of bovine embryos was
comparable to the 20% detected in Belgium (Wellemans and
Leunen,1974), the 10% detected in U.S.A. (Smithies and
Modderman, 1975) and the 16% detected in an English survey
(Nuttall et al.,1977). In each of these studies virus was
detected by immunofluorescence. In a fourth study, a
contamination rate of 40% was reported; of the 25 kidneys
cultured, 7 were immunofluorescence positive, and 3 other
kidneys were detected as positive by an interference test
(Hassan, 1979). The interference test is not a sensitive
test and variable results are obtained with different virus
strains (Nuttall, 1977; Shirai et al.,1984). If the 3
kidneys detected as positive by the interference test alone
are excluded the detection rate was 28%. One possible
explanation for this high contamination rate could be that
the foetuses were collected early in the year, since
results reported in this Chapter showed that a significant
number of positive foetuses was collected in the first four
months of the year. Spread of virus among susceptible cows
shortly after housing in the autumn might be one
explanation of this finding.
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Only two of 105 ovine kidney cultures had a latent
pestivirus infection. This was another compelling reason
for using ovine cells for studying BVD and BD viruses, but
it demonstrated that regular screening of all cells would
be needed. The prevalence of BD virus among Scottish sheep
is low (Vantsis et al., 1979). In other areas of Britain,
notably the English Midlands and Wales, serological surveys
have demonstrated a higher prevalence (Sands and
Harkness,1978). The risk of pestivirus contamination of
ovine foetuses collected in such areas could, therefore, be
expected to be higher.
The work in this chapter was undertaken in an attempt
to find a common cell system for the growth and assay of
BVD and BD viruses. Low passage ovine foetal cells,
particularly FL brain cells, were found to be suitable for
the growth and assay of the two reference strains. The use
of these cells for studying the antigenic relationships
between field isolates and the two reference strains is
described in Chapters 7 and 8.
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CHAPTER 4
THE EXPERIMENTAL PRODUCTION OF A MUCOSAL
DISEASE-LIKE SYNDROME IN SHEEP
INTRODUCTION
Lambs born with clinical symptoms of BD resulting
from intrauterine exposure excrete virus for long periods
of their lives (Gard et al.,1976; Plant et al.,1977). Such
persistently infected lambs have been identified following
experimental infection of ewes with tissue homogenates from
BD lambs (Plant, Gard and Acland,1976), and BD and BVD
viruses grown in cell cultures (Plant, Acland and
Gard,1976; Sweasey et al.,1979; Terlecki et al.,1980;
Terpstra,1981) .
Persistent infections have also been detected in
animals without clinical symptoms; some of these have shown
symptoms as lambs and recovered, while others have been
born apparently normal (Barlow et al.,1979; Westbury et
al.,1979; Terpstra,1981) .
Persistently infected sheep readily transmit
infection to susceptible sheep, cattle and pigs (Barlow et
al.,1980b; Terpstra, 1981). In addition, persistently
infected lambs which survive and breed, frequently produce
persistently infected offspring (Westbury et al.,1979;
Barlow et al.,1980b; Gardiner and Barlow,1981). Such
animals are, therefore, very potent sources of virus and
their existence has a dominating influence on disease
control stategies.
Virus persistence is possible only if the host's
immune system fails to mount an effective attack on the
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virus , or if the virus and virus-infected cells elude the
attack. The mechanisms involved in the persistence of
pestiviruses await elucidation. The usual finding that
sheep persistently infected with pestiviruses have no
anti-pestivirus neutralising antibodies has been
interpreted as immunological tolerance (Gard et al.,1976).
Persistently infected lambs can mount humoral antibody
responses to other infectious agents, and occasional lambs
produce anti-pestivirus neutralising antibody (Westbury et
al.,1979; Terpstra,1981). These findings imply that if
virus persists because of immunological tolerance, the
tolerance is specific but may not be absolute.
In this chapter, two experiments are described in
which normal lambs and lambs persistently infected with BD
virus were challenged with BDV-M and BVDV-NADL viruses.
The experiments were designed to test the stability and
specificity of the putative immunological tolerance.
MATERIALS AND METHODS
The preparation of cell cultures, virus stocks and
the serological tests and virus isolation procedures used
were as described in Chapter 2. High passage BDV-M and
BVDV-NADL viruses were used for animal inoculation and
serum neutralisation tests. The details of the actual
inocula are given in the design of each experiment.
EXPERIMENT 1
DESIGN OF EXPERIMENT.
Seven sheep without neutralising antibody to BDV-M or
BVDV-NADL were used. Five were animals which had recovered
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from clinical BD (recovered hairy shakers (RHS)), and 2
were from a flock in which there had never been any
evidence of border disease. All the RHS had been born to
ewes inoculated at 54 days gestation with the Moredun IIB
brain pool (Barlow,1972).
The seven sheep were each injected subcutaneously
over the left shoulder with 2 ml of a clarified suspension
of BDV-M grown in FLK cells from the 28th passage virus as
described by Vantsis et al.,(1980). The inoculum contained
5.7 TCID5o Per infectious virus when assayed in
tube cultures.
The humoral response of all animals was to be
assessed by measurement of neutralising antibodies to BDV-M
and BVDV-NADL at 3 weeks post-infection and at regular
intervals thereafter.
RESULTS
Clinical Observations. No clinical symptoms were seen in
the two control sheep but, surprisingly, all 5 RHS became
depressed 2 to 3 weeks after inoculation. Other symptoms
also developed and are summarised in Table 4.1, together
with the fate of the RHS. Sheep number 102A was the least
affected of the group and recovered. It remained
clinically normal until killed 273 days after inoculation.
Serology. Three weeks after injection the two control sheep
both had SN titres of >320 to BDV-M, while only 3 of the
RHS showed any evidence of seroconversion with titres of 5
or 10. The final titres at time of death are shown in
Table 4.1. Animal number 102A was seronegative at 3 weeks
TABLE 4.1
Experiment 1 - Clinical and serological response of RHS
to infection with BDV-M virus
Animal Sex/ Age Clinical Fate SN Antibody
Breed (Mths) Disease (Days p.i.) to BDV-M at
death
Z999 M/DHxCh* 9 Diarrhoea Died(22) 7
Z 9 9 4 F/SxCh 10 Diarrhoea Died(28) <5
X730 F/BF 18 Respiratory Killed(28) 12
V519 F/DH 21 Diarrhoea Killed(35) 12
102A F/SxCh 18 None Killed(273) 73
* M, Male; F, Female; DH, Dorset Horn; Ch, Cheviot
S, Suffolk; BF, Blackface
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but subsequently seroconverted specifically, having anti-BD
titres of 47, 110 and 73 at two, four and eight months
after inoculation, respectively, whilst anti-BVD antibodies
were undetectable at these times.
Pathology. At necropsy, the 3 lambs that had scoured all
had lesions involving the caecum and proximal colon. These
lesions varied in intensity from slight thickening to gross
oedematous swelling of the bowel wall. The mucous membrane
showed diffuse and polypoid hyperplasia, hyperaemia,
ulceration and haemorrhage. The lamb with respiratory
difficulty had severe encrustation and clogging of the
nares. Exudate was present only at the nares, but the
nasal mucosa and turbinates were very hyperaemic. This
lamb also had thickening of the wall of the caecum and
proximal colon.
The distribution of microscopic lesions is given in
Table 4.2. In all the affected organs the lesions were
essentially lymphoid and proliferative.
The intestinal lesions were most marked in the 3
diarrhoeic sheep. The epithelium was hypertrophied and
grossly elongated glands not infrequently breached the
muscularis mucosae. The lamina propria was diffusely
infiltrated with lymphoid cells and villi were distended.
Focal mucosal sloughing with haemorrhage and ulceration was
also seen. The submucosa and subserosa were usually
oedematous and infiltrated with lymphocytes. Muscle coats
were often hypertrophied and oedematous.
In the CNS there were lymphoid infiltrations
containing variable proportions of plasma cells and
TABLE 4.2
Experiment 1 - Results of histopathological and virus
isolation studies from the 4 RHS with clinical disease
SHEEP NUMBER
Organ Z999 Z994 X730 V519
Brain +/+ * +/+ +/+ +/+
Large intestine +/+ +/+ +/+ +/+
Mesenteric Lymph node +/+ +/+ +/+ +/+
Spleen +/+ +/+ +/+ +/+
Lung +/ND +/+ +/+ +/ND
Testis/ovary -/ND "/+ -/+ "/+
Liver -/ND -/ND +/+ "/+
Kidney -/ND +/ND +/ND +/+
Heart +/ND -/ND +/ND +/ND
Thyroid NE/ND NE/+ +/ND "/+
Submaxillary L.N. NE/ND NE/+ NE/+ NE/ND
Blood Clot NE/ND NE/+ NE/- NE/+
* Histopathology result/ virus isolation result
e.g. +/+ Lesions present, virus isolated
NE Organ not examined histologically
ND Virus isolation not done
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macrophages. These were prominent in the choroid plexuses.
The choroidal epithelial cells were often rounded and
vacuolated. Some had sloughed to form aggregates with
lymphocytes in the ventricular system. There was a
periventricular encephalitis with perivenous lymphoid cuffs
and focal and diffuse glial proliferation. The lamb that
recovered had evidence of a residual meningitis when it was
killed 273 days after inoculation.
Other organs in which lesions were most often
detected were kidney, heart and lung.
Virus isolation. The organs from which virus was isolated
are summarised in Table 4.2. Virus was widespread in all
animals, being isolated from all samples except the blood
clot of X730. All isolates were cytopathic after 3 passages
in secondary FLK cells. All were positively identified as
BD virus by IFT and selected isolates from each animal were
neutralised by specific antisera against BDV-M.
CONCLUSION
Dramatic and unexpected consequences followed the
infection of RHS with a high tissue culture pass of
cytopathic BDV-M virus derived from the brain pool with
which their dams had been inoculated at 54 days gestation.
Profound lymphoid disturbances and widespread virus
replication resulted in enteric or upper respiratory tract
disease in 4 of the 5 RHS. The development of SN antibodies
to the virus by the RHS was feeble in those animals dying
or killed in extremis. The surviving animal also
seroconverted poorly compared to the controls.
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EXPERIMENT 2
The purpose of this experiment was to repeat the
infection of persistently infected lambs with BDV-M and to
extend the investigation by infecting similar lambs with
BVDV-NADL.
DESIGN OF EXPERIMENT
Nine persistently infected RHS and four normal sheep,
were used. All were free of neutralising antibody to BDV-M
and BVDV-NADL viruses, and non-cytopathic BD virus had been
isolated from blood clots from all the RHS. The RHS had
been born to ewes inoculated at 54 days' gestation with the
Moredun IIB brain pool (Barlow,1972). Three age-matched
groups of 3 RHS were housed separately as were 2 groups of
2 normal sheep.
One group (Group 1) of RHS and 1 pair of normal sheep
were each injected subcutaneously with 2 ml of a clarified
suspension of BDV-M virus grown in FLK cells from the 28th
passage virus as described by Vantsis et al.,(1980). The
suspension, although derived from the same stock and
prepared in the same way, was not the same as that used in
the first experiment. It contained 5.2 TCID50
infectious virus per ml when assayed in tube cultures.
The second group (Group 2) of RHS and pair of normal
sheep were each injected subcutaneously with 2 ml of a
clarified suspension of BVDV-NADL virus of unknown passage
level grown in BEK cells. The inoculum contained 5.5 log^O
TCID50 when assayed in BEK tube cultures.
The third group (Group 3) of RHS was left
unchallenged.
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Animals were observed clinically, bled for serology 3
weeks after infection and killed for virological
examination 4 to 5 weeks after infection.
RESULTS
Clinical Observations. Clinical symptoms were seen only in
2 RHS in group 1. Animal No. 100A became depressed 16 days
after infection and had an intractable scour from 3 weeks
onwards. Animal V520 also scoured, but the onset was later
and the animal was not so debilitated. The illness in both
lambs was severe enough to necessitate killing them on
humanitarian grounds. Animals from other groups were killed
at the same times for comparative studies.
Serology. Neutralising antibodies to BDV-M and BVDV-NADL
at three weeks and time of death are summarised in Table
4.3. Normal susceptible sheep seroconverted to the virus
with which they were infected and 3 of 4 of them also
produced low levels of antibody to the other pestivirus.
All 3 RHS injected with BVDV-NADL but only one of the 3 RHS
injected with BDV-M showed evidence of antibody to the
viruses they received. None of the RHS produced antibody
cross-reacting with the other pestivirus.
Pathology. Gross pathological lesions were seen only in
the RHS in group 1. The two animals with scour had lesions
in the caecum, proximal colon and terminal ileum similar to
those observed in the large intestine of animals in
experiment 1. In the third animal (365B) there were focal
areas of typhlitis and 1 patch of colitis was seen. In
addition, this animal and animal V520 had grey hepatization
TABLE 4.3
Experiment 2 - Serological responses of sheep to
BDV-M and BVDV-NADL
Group No. Animal Sex/ Age Day p.i. SN antibody





RHS 10 OA M/DHxCh 18 27 <5 <5
RHS V520 F/DH 30 35 <5 <5
RHS 365B F/SxCh 8 35 16 <5
Normal 27x84 M/Ch 18 36 335 7




RHS 101A F/SxCh 18 28 <5 5
RHS V521 M/DH 30 35 <5 15
RHS 366B M/SxCh 8 35 <5 25
Normal 27x88 M/Ch 18 ND 9* 35*
Normal Z197 18 ND <5* 24*
Group 3
Unchallenged
RHS Z991 M/DHxCh 18 28 <5 <5
RHS X7 31 F/BF 30 35 <5 <5
RHS 364B F/SxCh 8 35 <5 <5
RHS, Recovered Hairy Shaker; M, Male; F, Female
DH, Dorset Horn; Ch, Cheviot; S, Suffolk; BF, Blackface
* SN antibody levels 35 days post-infection.
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in the apical and cardiac lobes of the lungs. The number
of tissues showing lesions is summarised in Table 4.4.
Lymphoproliferative lesions in the gut, similar to those
described in experiment 1, were most severe and widespread
in the 2 RHS in group 1 that had scoured, and the other
animal in that group. Slight mucosal hypertrophy and focal
submucosal and subserosal lymphoid infiltrations were seen
in 2 RHS in group 2, and one RHS in group 3.
Lymphoproliferative lesions in other organs were also
most severe and were seen most frequently in the RHS in
group 1. Mild lesions were present, however, in occasional
organs in 1 of the 2 normal animals in group 1, in 2 of the
3 RHS in group 2 and in 2 of the 3 unchallenged sheep in
group 3.
Virus isolation. No virus was isolated from any organ from
the 2 normal sheep injected with BDV-M. The number of
tissues examined and the virus isolation results are
summarised in Table 4.4. Of 21 organs tested from
unchallenged RHS, 12 contained virus and all were
non-cytopathic after 3 weekly passages in FLK cells.
Isolates from 2 of the sheep injected with BVDV-NADL were
non-cytopathic, but the third animal in this group yielded
both non-cytopathic and cytopathic viruses from different
organs. Interestingly, this sheep had shown more lesions
than the other 2 in the group. In Group 1 RHS, virus was
isolated from nearly all the tissues examined. From the 2
animals with clinical symptoms all but one of the isolates
were cytopathic. The animal that had not developed disease
yielded cytopathic virus from 4 organs but virus from three
other organs was not cytopathic.
TABLE 4.4
Experiment 2 - Results of histopathological and virus
isolation studies
Group No. Animal Histopathology Virus Isolations
Treatment Number No. of No. with No. of
& status tissues lesions tissues




RHS 10 OA 7 7 10 1 7
RHS V520 6 5 7 1 5
RHS 365B 7 3 8 3 4
Normal 27x84 7 2 6 0 0




RHS 101A 7 1 7 4 0
RHS V521 7 3 7 2 3
RHS 366B 7 0 7 7 0
Group 3
Unchallenged
RHS Z991 7 2 7 5 0
RHS X7 31 7 0 7 3 0
RHS 364B 7 2 7 4 0
NCP, Non-cytopathic virus; CP, Cytopathic virus
RHS, Recovered hairy shaker
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DISCUSSION
In two experiments, cytopathic virus derived from the
28th passage of BDV-M produced disease in a total of 7 of 8
RHS. Six of these animals died or were killed on
humanitarian grounds. These animals, and one of the
remaining two which was killed 35 days post-infection had
widespread and severe lymphoid proliferations in several
organs. No disease was seen in any of the other sheep, but
minor lesions of the same type were present in occasional
organs of one of two normal susceptible sheep receiving the
same inoculum, as well as in 2 of 3 RHS receiving BVDV-NADL
and in 2 of 3 uninoculated RHS. There was, thus, strong
evidence that the high passage BDV-M inoculum was
pathogenic for RHS, although the possibility that the RHS
were uniquely susceptible to some other unknown infection
cannot be totally discounted.
Disseminated lymphoid proliferations of the type seen
here occur in some neoplastic disorders and in conditions
such as bovine malignant catarrhal fever (MCF) . Major
features of MCF lesions, namely focal necrosis of lymph
nodes and fibrinoid necrosis of the media of arteries,
appeared to be absent in these sheep, however.
The CNS lesions were similar to those described
following maedi/visna virus infection of sheep
(Palsson,1976). Serological examination of the sheep in the
present experiments showed that they were all free of
precipitating antibody to this virus (Dawson, personal
communication). The lung changes seen were similar to
those occurring in maedi, but they have also been
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demonstrated in cases of chronic atypical ovine pneumonia
(Gilmour, Jones and Rae, 1979). Since the latter is a
common disease of sheep the possibility that the pulmonary
changes represented intercurrent infection cannot be
excluded.
The enteric lesions were more specific, being
histologically distinguishable from most other forms of
ovine enteritis. Some of the changes, namely the
hyperplastic epithelium and the glandular penetration of
the submucosa with extension into lymphatics, were
tumour-like and closely resembled those seen in porcine
adenomatosis (Rowland, lawson and Maxwell,1973). Others ,
such as the ulcerated, haemorrhagic, heavily infiltrated
hyperplastic mucosa with crypt abscesses, strongly
resembled lesions seen in calves with mucosal disease.
Furthermore, the distribution of the enteric lesions
present in affected sheep was similar to that of the most
marked pathomorphological changes seen in cattle with
mucosal disease (Ohmann,1983).
The purpose of these experiments was to see if RHS,
persistently infected with non-cytopathic BD virus, were
immunocompetent when challenged with cytopathic
homologous(BDV-M) or heterologous (BVDV-NADL) pestiviruses.
The widespread and severe lymphoproliferative lesions in
the RHS injected with homologous BDV-M suggested an
immunological response. Cytopathic virus was not
eliminated, however, and the animals failed to produce
convincing levels of specific neutralising antibody when
compared to the normal susceptible sheep receiving the same
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inoculum. Their immune system, therefore, appeared
compromised when faced with this virus, possibly due to
tolerance resulting from exposure to the same virus during
early foetal life. If this was the case, the tolerance was
not absolute since in the one surviving animal specific SN
antibodies were produced,albeit slowly and to a relatively
low titre. Even though it survived for 10 months this
animal did not develop cross-neutralising antibody against
BVDV-NADL.
The BVDV-NADL inoculum was weakly immunogenic as
judged by the low levels of neutralising antibody in the 2
normal susceptible sheep. Nevertheless, all 3 RHS injected
with this virus seroconverted to it and remained healthy,
cytopathic virus having been largely eliminated. Although
lack of disease may have been due to low pathogenicity of
the virus resulting from prolonged passage in tissue
culture, these findings suggest a competent immune response
to the virus.
If immune tolerance is responsible for virus
persistence, these results suggest that the tolerance is
highly specific. Analogous findings have been reported in
cattle. Steck et al.(1980) immunised 209 seronegative
animals with an attenuated live virus vaccine, prepared
from the BVDV-C24V strain. Two hundred and seven
seroconverted. The two seronegative animals became
clinically ill 8 and 16 days post-vaccination, and MD was
diagnosed in the first of these. Four other animals died
from a disease indistinguishable from MD, even though,
after vaccination, they developed high titre SN antibody
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which was directed specifically against C24V strain virus
and which did not react with the virus involved in the
persistent viraemia. This latter virus was neutralised by
sera from other healthy animals in the herd, but not by
sera from the dying animals. A very specific immune
dysfunction is implied by these results.
The results of the experiments reported in this
Chapter revealed a new aspect of BDV infection of sheep.
The enteric lesions resembled changes seen in calves with
mucosal disease, thus establishing a further link between
BDV and BVDV infections in the two species. The mucosal
disease-like syndrome in sheep was restricted to RHS
receiving the BD-M inoculum, suggesting that the antigenic
relationship between the persistently infecting and the
'superinfecting' virus was an important factor in the
pathogenesis of the disease. One other unknown factor,
however, was the relative pathogenicities of the two high
passage viruses. It, thus, seemed important to
characterise virus stocks of known passage history, and
this work is described in the next Chapter.
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CHAPTER 5
PATHOGENICITY STUDIES WITH LOW PASSAGE PESTIVIRUSES
INTRODUCTION
The pathogenicity of pestiviruses has been shown to
change after passage in-vivo and in-vitro. During early
transmission experiments with BVD virus it had been noted
that clinical signs in calves were more intense after
inoculation with a recently isolated BVD virus than with
the same virus after it had been passaged in calves 4 to 6
times (Pritchard,1963). Similarly, the passage of BVD
virus strains in tissue culture cells has been shown to
decrease their pathogenicity for calves (Coggins et
al.,1961; Castrucci, cited in Roeder et al.,1983).
The use of BVD viruses passaged more than 20 times in
bovine tissue cultures has made it difficult to interpret
the results of some experimental infections of calves.
Both attenuation of virulence of the viruses, and their
possible contamination with non-cytopathic pestiviruses
derived from cell cultures or serum supplements have had to
be considered (Nuttall et al.,1980; Lopez et al., 1982).
The same considerations need to be applied to studies
with high passage BD viruses. The mechanisms involved in
the new and interesting lymphoproliferative disease
reported in the last Chapter require elucidation. This
will be achieved with a high degree of certainty only if
low passage virus free of adventitious contamination with
non-cytopathic pestiviruses is used.
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In this Chapter, experimental infections of sheep and
cattle with low passage BVDV-NADL and BDV-M are described.
They were undertaken to study the pathogenicity of the
strains and to prepare reference antisera.
SECTION 1. REFERENCE ANTISERUM PRODUCTION AND
PATHOGENICITY STUDIES WITH LOW PASSAGE
BVDV-NADL VIRUS.
Antisera prepared against BVD viruses have been shown
to react with components of uninfected cells in CF, ID and
IF tests. The problem has been most frequently associated
with hyperimmune sera prepared in rabbits but sera from
sheep and cattle have also suffered from this disadvantage
(Fernelius and Packer, 1969; Hassan and Scott,1980). In an
attempt to abrogate this difficulty antisera to BVDV-NADL
were prepared in calves using autologous tissue cultures
and serum supplements.
MATERIALS AND METHODS
Animals. Two Jersey bull calves were used. At two months
of age they were bled and shown to be free of serum
neutralising antibody to BVDV-NADL and BDV-M viruses. One
month later, approximately 200 ml. of serum was derived
aseptically from each calf. Three days later the calves
were castrated under general anaesthesia. They recovered
well from the operation.
Cell culture and virus growth. Primary testis cultures
were prepared by trypsin disaggregation. Cultures from
each calf were handled separately and grown at 37°C in
Eagle's MEM supplemented with 10% of the calves' own sera.
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When confluent, cell monolayers were washed three times
with Hanks' BSS and inoculated with low passage BVDV-NADL
at a m.o.i. of one. After 2 hours' adsorption at 37°C,
the inocula were removed and maintenance medium of Eagle's
MEM supplemented with 2% of the calves' own sera added.
Three days later cultures showed extensive CPE.
Supernatant fluid was harvested, clarified at 2000 xg for
15 minutes at 4°C and divided into 4 ml. aliquots, which
were stored at -70°C. The titre of virus from each calf
was 7.2 Log^QTCID^Q per ml. when they were assayed
in tube cultures of autologous cells.
Animal inoculation. Twelve days after castration each calf
was injected intravenously with 1 ml. of virus grown in
its own cells. Two weeks, three weeks and four weeks later
each calf was injected intravenously with 4 ml., 5 ml. and
10 ml. of the same virus harvests. Two weeks after the
last injection calves were bled out, and separated serum
was stored at -20°C in 5 ml. amounts.
Pathogenicity studies. Clinical examination of the calves,
including temperature recording, was carried out daily for
3 weeks after injection. Calves were bled, daily for 3
weeks and at weekly intervals thereafter, into heparinised
vacutainer tubes for haematological studies and into
vacutainer tubes for serological studies.
Haematology. This was performed as described in Chapter 2.
Serology. Sera were heat inactivated, and titrated for the
measurement of neutralising antibodies to BVDV-NADL and
BDV-M as described in Chapter 2. Dilutions of sera were
used in the first stage of an IIFT against uninfected and
BVDV-NADL infected BEK cells.
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RESULTS
Clinical observations. Both animals showed mild clinical
symptoms of diarrhoea and serous nasal discharge, 5 to 8
days after inoculation with virus. Calf 368 was anorexic
on days 6 and 7. Both calves had pyrexia and leucopaenia,
although the degree and timing of these events were
different (Fig. 5.1). Calf 368 showed a biphasic
temperature response with the first peak being detectable
on days 6 and 7, and the second peak on day 10. Calf 385,
however showed evidence of pyrexia from day 2 onwards with
values > 40°C on days 4, 5, 8 and 11.
The leucopaenia was most pronounced in calf 368 with
cell counts being depressed between day 2 and day 12 by >
25% of the level at the time of infection. Calf 385 had
leucopaenia from day 4 to day 6 and leucocytosis on day 8.
Differential leucocyte counts showed the leucopaenia to be
due to a decrease in both lymphocytes and neutrophils,
although the neutropaenia was particularly marked in both
calves between 4 and 6 days after infection (Table 5.1).
Serology. Serum neutralising antibodies to BVDV-NADL virus
were first detected at a low level 11 days after infection.
Thereafter, antibody levels rose quickly until day 17, but
continued to rise until the final bleeding on day 45 when
sera from both calves had SN titres of 2560 (Figure 5.2).
Neutralising antibody titres to BDV-M at the final bleeding
were 80 and 40 respectively for calves 385 and 368. No
cytotoxicity was observed in the SN tests at reciprocal
serum dilutions of 4.
FIGURE 5.1 The clinical and haematological responses of
2 Jersey calves to the intravenous injection





Differential leucocyte counts for 2 calves




Infection Calf 368 Calf 385 Calf 368 Calf 385
0 6043 (72.5)* 7961 (81.0) 2292 (27.5) 1867 (19.0)
1 5622 (86.0) 4670 (83.0) 915 (14.0) 957 (17.0)
2 4393 (85.0) 5927 (74.5) 775 (15.0) 2029 (25.5)
3 4866 (89.0) 5446 (86.5) 601 (11.0) 800 (13.5)
4 4181 (97.0) 5997 (96.5) 129 ( 3.0) 217 ( 3.5)
5 4040 (94.5) 5394 (86.5) 235 ( 5.5) 842 (13.5)
6 4667 (97.0) 5919 (93.5) 144 ( 3.0) 411 ( 6.5)
7 5091 (82.0) 7872 (87.0) 1117 (18.0) 1176 (13.0)
8 5021 (90.0) 11655 (90.0) 558 (10.0) 1295 (10.0 )
9 4203 (91.5) 6632 (78.0) 390 ( 8.5) 1870 (22.0)
10 5748 (93.0) 7520 (80.0) 433 ( 7.0) 1880 (20.0)
11 4541 (92.0) 6292 (76.0) 395 ( 8.0) 1982 (24.0)
12 4583 (91.5) 6450 (82.0) 426 ( 8.5) 1416 (18.0)
13 5485 (81.5) 6439 (75.5) 1245 (18.5) 2090 (24.5)
14 6757 (85.5) 6454 (77.5) 1146 (14.5) 1874 (22.5)
Q
* Results are expressed as absolute counts xlO /I and
the percentage of the total leucocyte count is
shown in brackets.
FIGURE 5.2 The development of serum neutralising
antibodies to BVDV-NADL by two Jersey calves.
The calves were injected intravenously on day
0, day 14, day 21 and day 28 with 1ml, 4ml,
5ml and 10ml respectively, of low passage
BVDV-NADL, containing 7.2 TCID^q per
ml.














In the IIFT, no specific fluorescence was detected in
uninfected cells exposed to the calf sera diluted 1:10.
Infected cells, however, fluoresced brightly up to serum
dilutions of 1:40, and weak fluorescence was discernible up
to dilutions of 1:160.
CONCLUSIONS
Low passage BVDV-NADL was pathogenic for both calves
producing diarrhoea, pyrexia and leucopaenia, principally
neutropaenia. These findings were consistent with
previously reported experimental infections
(Pritchard,1963). High titre specific neutralising
antibodies were produced which cross-reacted with BDV-M
virus, but which were free of antibody to uninfected bovine
cells.
SECTION 2. Reference antiserum production and
pathogenicity studies with low passage
BDV-M, following the infection of ewes in
late gestation.
Lambs infected with BD virus in-utero during late
gestation are born with specific SN antibodies to the virus
(Gardiner,1982). This section describes the exploitation of
this ability of BD virus to produce antisera free of
non-specific reactions.
MATERIALS AND METHODS
Experimental procedure. Four seronegative Blackface ewes
were injected intravenously at 115 days' gestation with 2
ml. of low passage BDV-M containing 6.4 Log1Q TCID^q. Lambs
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were to be delivered into sterile isolators and reinfected
intranasally with the same dose of virus two days after
birth. Lambs put into isolators were exsanguinated under
general anaesthesia at three weeks of age, and brain and
spinal cord collected into 10% formal saline for
pathological examination.
Four seronegative, castrated male Blackface lambs
were injected subcutaneously with 2 ml of tissue culture
fluid derived from uninfected cells passaged in parallel
with those used to grow BDV-M virus since its derivation
from the IIB brain pool.
Serology. Sera were heat inactivated, and titrated for the
measurement of SN antibodies to BVDV-NADL and BDV-M as
described in Chapter 2. Dilutions of sera were used in the
first stage of an IIFT against uninfected and BDV-M
infected FLK cells.
Results
Outcome of infecting ewes. Twenty eight days after
infection 2 ewes produced apparently normal single lambs.
The lambings were unattended, both lambs drank colostrum
and were not used further. One ewe lambed naturally 31
days after infection; the lambing was attended and the lamb
transferred to an isolator. Twin lambs from the fourth ewe
were delivered by caesarian section 33 days after infection
and reared together in one isolator. The lambs in the
isolators were never strong and the single lamb had
superior prognathism from birth. No specific symptoms
developed following intranasal infection with BDV-M.
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Serology. All four ewes had produced high antibody titres
to BDV-M (>360) when bled 21 days after infection. The
control lambs given tissue culture fluid had no detectable
SN antibody to BDV-M or BVDV-NADL viruses one month after
injection.
Lambs born to infected ewes all had low SN antibody
titres to BDV-M at birth namely 3, 22 and 180 respectively;
and these were raised to 1440, 256 and 720 at death. Serum
neutralising antibody titres against BVDV-NADL at the final
bleedings were 8, 16 and 8 respectively. No cytotoxicity
was observed in the SN tests at dilutions of 1:4. Sera
from the final bleedings showed no specific fluorescence at
dilutions of 1:10 when tested against uninfected FLK cells
in an IIFT. Against infected cells, however, these sera
gave bright, specific intracytoplasmic fluorescence up to
dilutions of 1:40, with less obvious fluorescence at
dilutions of 1:80 to 1:160.
Pathology. Lesions of periarteritis were detected in the
CNS of the three lambs.
CONCLUSIONS
Specific antisera to BDV-M had been raised. This had
low neutralising activity against BVDV-NADL and did not
react with uninfected FLK cells. The CNS lesions were
similar to those seen in lambs born to ewes infected late
in gestation with the Moredun IIB brain pool (Zakarian et
al. ,1975).
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SECTION 3. Protection test between BVDV-NADL and BDV-M
in ewes.
Results in the previous two sections had demonstrated
a low degree of relatedness between BDW-NADL and BDV-M in
reciprocal neutralisation tests. The experiment described
in this section was designed to see if exposure of ewes
before pregnancy with BVDV-NADL would protect, or change
the pathogenesis of disease in their . progeny following
challenge of the ewes at 50 days gestation with BDV-M
virus. An earlier study, in which 6 ewes previously
exposed to BVDV-NADL were challenged with Moredun IIB pool,
had resulted in a range of foetal abnormalities; one ewe
aborted, one produced a BD-affected lamb, one produced a
lamb with severe neural and skeletal malformations (AP),
and three had normal lambs (Barlow et al.,1980a).
MATERIALS AND METHODS
Animals and experimental procedure. Eighteen mature ewes
without SN antibodies to BVDV-NADL and BDV-M were used.
Twelve ewes were separated from the other 6 and injected
subcutaneously with 2 ml of low passage BVDV-NADL virus
containing 4.0 l°g10 TCID50*
The ewes were oestrus-synchronised and 1 month after
infection a tup was added to each group. Seven weeks
later, between 49 and 51 days' gestation,the ewes were bled
and arranged into groups as summarised in Table 5.2. At
this time all animals except those in group 5 were injected
subcutaneously with 2 ml of low passage BDV-M virus
containing 6.4 log^QTCID^Q. At 75 or 85 days' gestation,
the ewes were bled and their uteri collected for
TABLE 5.2
Reciprocal serum neutralising antibody titres of the ewes
in a protection test between low passage pestiviruses
SN antibody SN antibody
Group Viruses Ewe Week 11 Week at death
No. received No. BVD BD-M Killed BVD BD-M
NADT. NADL
BVD-NADL V97 5 90 <4 14* 360 256
(Week 0) N632 90 6 14 >720 >720
1 BD-M N616 180 4 14 >720 720
(Week 11) X97 2 256 6 14 >720 720
T655 64 <4 14 >720 720
BVD-NADL V998 45 <4 16 + >720 360
(Week 0) 387A 128 6 16 180 90
2 BD-M 406A 256 6 16 360 256
(Week 11) 289B 128 <4 16 180 180
T656 180 <4 16 720 360
3 BVD-NADL 3 5 OA 360 8 14 45 4
(Week 0) V982 64 <4 14 256 <4
Z791 <4 <4 14 ND 256
4 BD-M X253 <4 <4 14 ND 180
(Week 11) X298 <4 <4 16 ND 360
T550 <4 <4 16 ND 128
5 NONE XI8 2 <4 <4 14 <4 <4
X262 <4 <4 16 <4 <4
* Week 14 represented 75 day's gestation.
+ Week 16 represented 85 day's gestation.
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virological and pathological studies of the placentae and
foetuses.
Serology. Serum samples from ewes and foetuses were tested
for the presence of SN antibodies to low passage BVDV-NADL
and BDV-M as described in Chapter 2.
Virology. For virus isolation the following samples were
collected. Cotyledon, blood clot from all foetuses,
cerebellum from second and third foetuses. Samples were
tested for the presence of viruses, using a minimum of 3
passages at weekly intervals in secondary FLK cells, as
described in Chapter 2.
Pathology. Foetuses and placentae were perfused with
Baker's calcium formol or Bouin's fixative. The methods
used for the examination of tissue sections, and the
criteria selected for the classification of the CNS
lesions, were as described previously (Barlow,1980; Barlow
et al.,1980a).
RESULTS
All the ewes injected with BVDV-NADL developed SN
antibody to the virus and 6 of the 12 developed low levels
of cross-neutralising antibody to BDV-M. Following
challenge with BDV-M, the 10 ewes in groups 1 and 2
developed high SN antibodies to both viruses. Animals in
the other 3 groups, which received one or other of the
viruses, produced good SN titres to the virus with which
they were infected (Table 5.2).
Injection with BVDV-NADL 4 weeks before pregnancy
protected the progeny of only one of the 10 ewes (X972 in
group 1) challenged at 50 days' gestation with low passage
BDV-M (Table 5.3).
TABLE 5.3
Viroloqical and pathological findings in placenta and
foetuses from ewes used in a protection test
with low passage pestiviruses
GROUP EWE VIRUS ISOLATION PATHOLOGY
No. No.
Plac- 1st foetus 2nd foetus Plac- Foetal
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Z7 91 NCP NCP CP NCP BD BD
4 X253 NCP CP NCP NCP BD BD
X298 CP CP BD BD
T550 NCP No foetus BD NS
5 X182 No foetus
X262 No foetus
* Three foetuses were tested from ewe no. N616.
Noncytopathic BDV was also isolated from the blood
and CNS of the third foetus.
, No virus isolated or no pathological evidence
of BD
NCP, Non-cytopathic BDV isolated
CP, Cytopathic BDV isolated NS, No sample
BD, Pathological evidence of BD
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There was no significant difference (X2= 0.1, p>
0.05) between the number of BD virus isolates from ewes
previously exposed to BVDV-NADL (Groups 1 and 2) and those
that were not (Group 4). Some qualitative differences in
virus isolations were, however, apparent between these
groups. Virus was recovered less readily from the placenta
of the ewes from groups 1 and 2 compared with group 4.
Cytopathic BDV-M was not recovered from ewes in group 1,
and was isolated from only the foetuses of 2 ewes in group
2. In group 4, however, cytopathic virus was recovered
from progeny of 3 of 4 ewes and from the placenta of one of
these animals.
Pathological lesions were consistent with a diagnosis
of BD. No evidence of AP was seen in any of the foetuses.
The effects of BDV-M on the uterine contents were obvious
grossly in 3 of the ewes in group 4. Both ewes killed at
75 days gestation had hydrops amnii; foetuses were alive
but deeply congested and one had anasarca. The foetus of
ewe T550 was dead and unfit for pathological examination.
Gross pathological lesions were not detected in ewes from
groups 1 and 2, but the presence of BD-associated lesions
in the placenta and foetal CNS correlated closely with the
results of virus isolation (Table 5.3).
No placental or foetal lesions were seen in the
control animals in groups 3 and 5, nor was any virus
detected in samples collected from these animals.
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CONCLUSIONS
The progeny of ewes injected with BVDV-NADL 1 month
before pregnancy were not protected from BDV-M virus when
the ewes were challenged at 50 days' gestation. There was
some evidence, however, that the prior exposure of ewes to
BVDV-NADL reduced the severity of the BD-specific placental
and foetal lesions.
SECTION 4. PATHOGENICITY TESTING OF LOW PASSAGE BDV-M
BY INFECTION OF EWES AT 54 DAYS' GESTATION.
Moredun IIB brain pool has consistently produced
lambs with classical BD pathology when injected into
pregnant ewes at 54 days' gestation (Gardiner, 1982).
When, however, tissue culture grown virus derived from this
pool was injected into ewes at titres of 5.0 and 6.8
]"og10TCID50 all but one of 39 sheep aborted (Vantsis et
al.,1976). The results from the previous section showed
that the inoculum used in that experiment was also very
(i athogenic for foetuses. Using tissue homogenates,
Richardson et al.,(1976) demonstrated that more live lambs
were born to ewes receiving a lower dose of BD virus. This
section describes the production of BD lambs using low
passage BDV-M, and their survival in the first seven months
of life.
MATERIALS AND METHODS
Inoculation of pregnant ewes. A group of Cheviot ewes from
a farm with no history of BD and and without SN antibody to
BDV-M or BVDV-NADL were oestrus-synchronised and mated to
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two Dorset Horn rams, which were also seronegative to both
viruses. On the 54th day of gestation 15 ewes were housed
and injected with 6 ml of tissue culture fluid containing
3.0 Log^pTCID^Q per ml of low passage BDV-M. Half the dose
was given subcutaneously and half intraperitoneally.
Monitoring and sampling of ewes and lambs. All ewes were
bled one month after injection with virus to assess their
SN antibody status to BDV-M. The ewes were examined daily;
animals that aborted, were found to be barren, or produced
dead lambs were removed from the group. Live lambs were
bled for virus isolation and SN antibody determination,
before being given colostrum from their dams. Lambs that
could stand were encouraged to feed from their dams, but
those that were too weak were hand reared on artificial
milk. Lambs were bled at regular intervals throughout life
for virological and serological studies. Lamb illnesses and
treatments were recorded.
RESULTS
Response of ewes to infection with low passage BDV-M. No
ewe showed any evidence of malaise after infection. All
ewes seroconverted to the virus, producing SN titres in the
range 180 to 2048. Five ewes aborted between 99 and 140
days gestation, three ewes produced stillborn lambs at
term, two were barren, one ewe produced one stillborn and
one live lamb, and the other four ewes each produced live
BD twins.
Of the 15 ewes, 5 were mated by one tup and 10 were
mated by the other. Only one of the 5 ewes mated by the
first tup produced live lambs (Twins - 1261 and 1262), the
other 7 live lambs being born to 4 ewes mated by the second
tup.
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Virology and serology of ewe's progeny. Virus isolation
was attempted from brain/spleen pools from the aborted
foetuses of three ewes; NCP BD virus was isolated from one
of twins from one ewe. The same type of virus was isolated
from two stillborn lambs, but a cytopathic BD virus was
recovered from a tissue pool of a third. None of the nine
live lambs had detectable SN titres to BDV-M at birth, but
NCP BD virus was recovered from blood clots of all of them.
Six weeks after birth 5 lambs had detectable SN
antibody to BDV-M, and this number had fallen to 4 two
weeks later. One week after this second bleeding, two
seronegative lambs were killed in-extremis(Twins - 1261 and
1262 (see below)). The remaining 7 lambs were seronegative
and viraemic 10 weeks after birth.
Disease among BD lambs. At birth, all lambs had
characteristic nervous signs of BD, but only 2 lambs
required artificial feeding (1250, 1254); two weeks after
birth these lambs were able to stand unaided.
One month after birth, one lamb (1251) was depressed,
mildly pyrexic (40.5°C) and hyperpnoeic; pneumonia was
diagnosed and daily treatment for 5 days with Trivetrin
injection (Wellcome Foundation Ltd.) effected recovery.
Six weeks after birth, two lambs (Twins - 1261 and
1262) were first seen to be depressed. Over the next 18
days Lamb number 1261 developed an intractable scour which
was not alleviated by treatment with Kaogel (Parke Davis &
Co.) and Ion-aid (Syntex Pharmaceuticals Ltd.). Lamb 1262
did not scour. Both lambs became very depressed, and
developed mucopurulent nasal and ocular discharges; lamb
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1262 showed bilateral corneal opacity (Figure 5.3), and
both lambs were killed on humanitarian grounds three weeks
after first becoming ill. Haematological examination
showed that these two lambs had lymphocytopaenia and
neutrophilia , 6 and 8 weeks after birth, compared with the
other lambs (Table 5.4). Cytopathic BD virus was recovered
from the buffy coats of both lambs collected just before
death.
At necropsy, both lambs had gross thickening of the
distal ileum, caecum and colon. This was the result of a
focal hyperplastic enteropathy, which was most apparent in
transverse gut sections or when the mucosal surface was
exposed (Figures 5.4 and 5.5). Small shallow mucosal ulcers
were present in lamb 1261 but not lamb 1262.
Histologically, however, both lambs showed ulcerative
hyperplasia of the mucosa with foci of massive penetration
of the muscularis, around which there was mononuclear cell
infiltration and necrosis. Generally, though, there was
relatively little lymphoid infiltration of the gut or other
organs. The thymus in both lambs was atrophic, and the
lymph nodes and spleens showed poor follicle development.
In the CNS, both lambs had residual lesions of BD.
Cytopathic BD virus was recovered from 15 of 16
organs cultured. No bacteria were cultured from the
spleens and only E.coli and Proteus species were isolated
from the large intestine.
The remaining 7 lambs all scoured due to coccidiosis
at 12 weeks of age, but remained bright and responded well
to treatment with Amprol-plus (Merck Sharp & Dohme Ltd.).
Figure 5.3 Lamb 1262, three weeks after first
becoming ill. Nasal and ocular
discharges, and excess salivation have
resulted in the matting of wool and scab
formation around the eye and muzzle.
The degree of corneal opacity is greatly
exaggerated in this photograph.
Comparison with Figure 1^5 is interesting.
Figure 5.4 Lamb 1262. Transverse section of colon
showing hyperplastic enteropathy with
pale tissue bulging from cut surface.
Figure 5.5 Lamb 1262. Mucosal surface of colon.




Haematoloqical values of border disease lambs
six and eight weeks after birth
Lamb Weeks Erythro¬ Haemo LEUCOCYTES
No. after cytes globi n Total Mono¬ Polymorpho¬
birth g/dl nuclear nuclear
1250 6 9.07* 9.7 6.69 + 3.68(55) 3.01(45)
8 10.35 10.5 8.61 5.34(62) 3.27(38)
1251 6 10.89 11.9 4.09 3.51(86) 0.57(14)
8 11.49 12. 4 7.56 6.58(87) 0.98(13)
1254 6 8. 91 9.0 7.22 3.03(42) 4.19(58)
8 8.44 7.9 3.70 2.30(62) 1.40(38)
1255 6 10.94 12.2 4.47 4.16(93) 0.31 (7)
8 11.87 12.8 10.70 9.63(90) 1.07(10)
1256 6 9.30 10.5 4.21 3.87(92) 0.34 (8)
8 11.09 11.5 7.06 5.72(81) 1.34(19)
1257 6 10. 87 11.2 6.16 5.61(91) 0.55 (9)
8 13.21 12.1 9.03 7.77(86) 1.26(14)
1259 6 9.42 10.8 5.79 5.16(89) 0.64(11)
8 11.23 12.7 4.71 4.28(91) 0.43 (9)
1261 6 10.47 10.4 10.40 7.59(73) 2.81(27)
8 12.25 14.1 11. 30 1.58(14) 9.72(86)
1262 6 10.59 12.3 4.37 2.01(46) 2.36(54)
8 11.60 11.9 5.74 1.89(33) 3.84(67)
* Erythrocyte counts are given x 1Cl12/l
+ Total leucocyte counts are given x 109/1
9Differential leucocyte counts are also given x 10 /I
and the % of the total count is shown in brackets
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One lamb died suddenly from acute pneumonia at five
months old. Pasteurella haemolytica type A2 and Mycoplasma
ovipneumoniae were cultured from the lungs. Non-cytopathic
BD virus was isolated from 7 of 8 organs cultured.
The remaining 6 lambs grew poorly, but suffered no
other major illnesses. At 7 months old they were used in
another experiment.
CONCLUSION. Low passage BDV-M was pathogenic for the
foetuses of ewes inoculated at 54 days' gestation. Only 9
live lambs were produced by 5 of 15 ewes. Two of the lambs
died at 9 weeks of age, with disease very similar to the
mucosal disease-like syndrome described in the
experimentally superinfected ewes (Chapter 4), and one lamb
died of pneumonia at 5 months old.
DISCUSSION
Work reported in this Chapter has confirmed the
pathogenicity of the low passage stocks of the two
pestivirus reference strains. The BVDV-NADL strain was
isolated originally from a fatal case of MD in a closed
herd (Gutekunst & Mai m qu i st ,1 963). It has been reported
frequently that BVDV isolates from fatal cases produce only
mild disease when injected into susceptible cattle (Baker
et al.,1954; Dow et al.,1956; Huck,1957 ; Thomson and
Savan,1963; Pritchard, 1963). The pyrexia, leucopaenia,
diarrhoea, and nasal discharges produced in the two calves,
used to prepare specific antisera, were wholly comparable
to the range of symptoms described by these earlier
authors.
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Little information is available on the pathogenicity
of BD virus for normal susceptible sheep, and so pregnant
animals were used. Infection of ewes in late gestation
resulted in the birth of lambs with low levels of SN
antibody, and with residual CNS lesions of periarteritis.
These confirmed the placenta-crossing ability of the virus
and agree with the pathological findings in lambs from
infections initiated between 90 days' gestation and early
post-natal life (Zakarian et al.,1975).
Infection of ewes at 54 days' gestation further
confirmed the pathogenicity of the BDV-M virus. Previous
exposure of the ewes to BVDV-NADL virus did not protect
their progeny, which showed lesions of hypomyelinogenesis
and interfascicular lipid consistent with a diagnosis of
BD. This contrasts with previous reports in which IIB pool
produced AP in a proportion of ewes infected previously
with BVDV-NADL, and also in a proportion of ewes injected
with IIB pool which had been incubated in-vitro with
antiserum against BVDV-NADL (Barlow et al.,1980a;
Gardiner,1982). The difference could have been due to the
large challenge dose of BDV-M used in the experiment
reported here.
Even a much reduced challenge dose was highly
pathogenic for the progeny of susceptible ewes. It has
been reported previously that the genotype of the dam can
influence the outcome of foetal infection (Barlow et
al.,1979; Barlow et al.,1980b; Barlow,1980). In this
experiment there was some evidence that the the genotype of
the sire could have influenced the outcome. Four of ten
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ewes sired by one ram produced live lambs, whereas only one
of 5 ewes sired by the second ram gave birth to live lambs.
This, in itself, is not significant, but it was interesting
that only the twins born to this ewe later succumbed to
BDV-related disease. The disease seen in these two lambs
bore a strong resemblance to the mucosal disease-like
syndrome described in Chapter 4, and provided further
evidence for the spontaneous occurrence of such cases as
reported previously (Barlow et al.,1983). The recovery of
cytopathic BDV from these two lambs was also consistent
with the finding in previous spontaneous and experimental
cases (Gardiner et al.,1983). At birth only NCP virus had
been recovered from the blood of both these lambs, and the
onset of disease coincided with loss of maternally-derived
antibody. This apparent reassertion of pathogenicity by
BDV, correlating with its ability to produce CPE in cell
cultures, was associated with profound haematological
changes in the twin lambs compared with their
contemporaries. It was also noteworthy that the disease
was not transmitted from the twins to their contemporaries
with which they were housed.
Cell culture-derived cytopathic BDV has previously
been shown to cross the placenta to infect foetuses (French
et al.,1974; Vantsis et al.,1976). In the first of these
reports an Australian agent was recovered readily from
lambs born to ewes infected at a range of gestation dates,
but the lambs were born apparently normal. In the second
report, however, BDV-M was highly pathogenic, and was
recovered from fresh aborted foetuses.
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The pathogenicity of the two low passage pestivirus
reference strains has been proven by the experiments
reported here. The low passage BDV-M, which was cultured
under conditions which minimised the chances of introducing
a contaminating pestivirus, could be considered for use in
a superinfection experiment. This experiment is described
in the next Chapter.
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CHAPTER 6
THE RESPONSE OF RECOVERED FIELD CASES OF BORDER DISEASE
TO EXPERIMENTAL INFECTION WITH BDV-M ~~
INTRODUCTION
The experiments reported in Chapter 4 showed that
sheep persistently infected with BD virus, following early
infection in-utero, responded dramatically when injected
with high passage BDV-M virus. This was a previously
unreported phenomenon in sheep. The enteric lesions,
however, were very similar to those present in calves dying
of mucosal disease. The pathogenesis of MD is still not
fully resolved, but in the light of the findings described
in Chapter 4 previous reports on the accidental induction
of MD were re-examined.
Peter et al. (1967) described a mucosal disease-like
syndrome which occurred in a small number of cattle in a
few herds, within 10 to 20 days of vaccination with a live
attenuated BVD virus vaccine. The pathogenesis of this
condition was not understood, and although the vaccine was
considered to be aetiologically involved, it was believed
that the condition was primarily caused by failure of the
immune mechanism in the affected animals. Nearly all the
animals which died were seronegative to BVD virus, a
regular finding in field cases of MD (see Chapter 1).
Liess et al.(1974) selected 4 seronegative animals
from herds in which more than 90% of the cattle were
seropositive. Following intra-nasal inoculation with
virulent BVD virus two developed an acute disease followed
by antibody formation, while two developed a persistent
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viraemia. There was, however, no mention of viraemia being
looked for before inoculation. One of the latter two
animals was killed and showed chronic pneumonia and
catarrhal enteritis, but the other died 52 days
post-inoculation with typical lesions of MD.
Steck et al.(1980), also examined a number of
seronegative cattle. In 56 herds in which 68.8% of animals
had neutralising antibodies to BVD virus there were 515
seronegative animals. Two hundred and nine of these were
vaccinated with a live attenuated BVD vaccine. Two animals
died shortly after vaccination but all the others developed
antibody to the vaccine strain. Four such animals later
died of MD apparently caused by a BVD virus antigenically
distinguishable from the vaccine virus. These results led
to the conclusion that BVD-vaccines should include a
broader spectrum of antigenic variants. The authors also
speculated that animals predisposed to MD or incubating MD
virus were among those succesfully vaccinated, and they
suggested that the parenteral inoculation of a large dose
of attenuated live virus would be able to overcome the
immune non-responsiveness and thereby confer protection.
In cattle, the evidence from these previous reports
was that MD could occur in a small number of animals, which
had some immune deficiency, following exposure to BVD
virus. The results in sheep reported in Chapter 4
suggested strongly that this immune deficiency, which was a
prerequisite for the development of MD, was associated with
early intra-uterine exposure to BVDV and the consequent
establishment of a persistent infection.
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Sheep and cattle persistently infected with
pestiviruses are efficient spreaders of virus and play a
key role in the epizootiology of BD and BVD (French et
al.,1974; Barlow et al.,1980b). An understanding of their
response to live pestivirus, both 'wild-type' and vaccine
virus, is therefore, crucial to any control policy. In
particular, it is vital to know if surviving animals
continue to excrete virus, and thus remain a source of
infection. In the following experiment two separate groups
of recovered field cases of BD and one group of normal
lambs were injected with low passage level BDV-M virus.
MATERIALS AND METHODS
Animals. Three groups of 5 lambs were used. Field cases
were obtained from 2 separate natural outbreaks of BD in
Wales. One group of Speckled Beulah lambs (Recovered hairy
shaker (RHS) 1) was brought to Moredun when approximately 6
months old. A second group of Suffolk x Speckled Beulah
lambs (RHS 2) had been separated from their dams and
brought to Moredun earlier when 3 to 4 weeks old. Both
groups were kept isolated from each other and from other
stock. The isolation of non-cytopathic BD virus from blood
and nasal secretions, confirmed that the lambs were
persistently infected.
Healthy Cheviot lambs, in whose blood neither BD
virus or antibody could be detected, were used as control
animals. They had been born and raised at pasture but were
housed under similar conditions to the Welsh lambs for 5~
weeks before receiving virus.
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At the time of challenge the Welsh lambs were
approximately 9 months old and the Cheviot lambs were 7-8
months old. Ten weeks after challenge each group was
rehoused and at this time two sentinel lambs without
t
neutralising antibody to BDV-M or BVDV-NADL, and without
detectable BD virus in their blood, were added to each
group. Six weeks later surviving RHS, and two Cheviot
lambs from the control group, were killed for pathological
and virological examination.
Virus inoculum. BDV-M was grown in secondary FLK cultures
from the third tissue culture pass. Each lamb received a 2
ml inoculation of clarified virus suspension containing
6.1 log^TCID^Q per ml given subcutaneously over the left
shoulder.
Clinical examination and sampling procedures. Rectal
temperatures were taken daily for 4 weeks after virus
inoculation and clinical observations were made daily
throughout the course of the experiment.
Lambs were bled before and regularly for 10 weeks
after infection. Seven ml of blood was collected into
evacuated glass tubes containing 70 iu of preservative-free
heparin. After thorough mixing 1 ml was removed for
haematology and the remainder was centrifuged at 2,000xg
for 15 minutes. Plasma was collected for antibody
determination and buffy coat cells used for virus
isolation, as described in Chapter 2.
After mixing with the sentinel lambs, animals were
bled at weekly intervals into preservative-free evacuated
glass tubes and the serum collected for antibody
measurement.
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Samples were also collected from any animal showing
marked clinical symptoms and these were examined for the
presence of microbial pathogens as described in Chapter 2.
Haematological examinations. Full haematological
examinations were carried out as described in Chapter 2.
To detect significant differences between the groups the
results from each bleeding were tested by analysis of
variance. The student's t test was used to compare group
mean values of each test after infection, with the group
mean of two samples taken before infection.
Pathological examinations. All animals dying or killed
were examined pathologically, and tissue samples collected
for virus isolation as described in Chapter 2.
RESULTS.
Clinical observations. Control lambs showed the least
evidence of disease. Two animals showed biphasic pyrexia
(>40°C) on days 8 and 11 and the group mean was highest on
these days (Fig.6.1). Between 14 and 24 days after
infection all animals in this group developed bilateral
serous nasal discharges and sporadic coughs; one animal had
a mild bilateral conjunctivitis between days 20 and 24.
Animals in the RHS 2 group of persistently infected
lambs showed evidence of disease similar to the controls.
All had mild pyrexia on some days between 9 and 12 days
after infection with the group mean being highest on day 9.
(Fig.6.1). Sporadic coughing and serous nasal discharge
were apparent in all animals between 18 and 24 days after
infection. In one animal (532) the nasal discharge became
progressively worse over the next ten weeks. There was a
108
gradual change from a serous to a mucopurulent discharge,
which became encrusted around the nares and over the muzzle
with excoriation of the underlying epithelium. The animal
was killed on humanitarian grounds 92 days after infection.
The most severe disease was seen in the RHS 1 group
of persistently infected lambs. In addition to respiratory
disease similar to that seen in the other groups, three
lambs showed depression, anorexia and diarrhoea at varying
times after infection. One animal (1247) had pyrexia
(40.0°C to 40.8°C) from day 6 to day 16 when it died, and
this increased the standard deviation of the group mean
(Fig. 6.1). This lamb was depressed from day 7 onwards
and started to scour on day 11. Faeces were loose and
mucoid, becoming very watery and foul-smelling by day 15.
A marked serous oculo-nasal discharge was apparent from day
13 to death. Rehydration therapy with Ion-Aid (Syntex
Pharmaceuticals Ltd.) on days 15 and 16 after infection did
not prevent death.
A second animal (1246) started to scour 28 days after
infection. The scour was intermittent during the next 12
days, but by day 40 it was watery and foul-smelling. The
lamb became weak, depressed and anorexic and was killed
in-extremis on day 44. This animal had mild pyrexia
(40.2°C to 40.4°C) on days 5,8,10,11, and 42 so that
pyrexia was not a major feature of this lamb's terminal
illness.
The third lamb to scour was first seen to do so 101
days after infection. At this time it had a serous nasal
discharge and a temperature of 39.5°C. The scour
5 6.1 Rectal temperatures of three groups of lambs
infected with BDV-M. Mean values ± SD.
DAYSAFTERIN ECTION
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worsened,and the lamb became weak and anorexic shortly
before dying 5 days later.
No disease was observed in the six sentinel lambs




Live animals. Virus recoveries from the blood of the three
groups of lambs are summarised in Figure 6.2. Virus was
isolated from all the animals in the control group 6 days
after infection. One lamb (402) also yielded virus on days
4, 8 and 11, and virus was recovered from one other lamb 11
days after infection. None of the isolates caused
cytopathic changes during two weekly passages in FLK cells.
Border disease virus was recovered consistently from
the blood of persistently infected lambs before, and
throughout the ten weeks after, they received cytopathic
BDV-M virus. The majority of isolates were non-cytopathic,
but cytopathic effects were seen after 2 weekly passages in
cultures exposed to blood from all animals in the RHS 1
group and from 3 of the lambs in the RHS 2 group.
Cytopathic virus was recovered only between days 4 and 18
with the majority of isolates being made 8 days after
inoculation. All cytopathic isolates, with the exception
of the single isolate on day 18, were passaged 6 times and
remained cytopathic at each pass.
All samples collected on days 8 and 11 were also
passaged 6 times. The classification of isolates as CP or
NCP remained the same after the further passages.
FIGURE 6.2 Isolations of BD virus from the blood of
three groups of lambs expressed as the % of
lambs in each group from which virus was
recovered.
| Non-cytopathic BD virus
H Cytopathic BD virus
Cytopathic virus was isolated from all 5
animals in the RHS1 group and 3 of the 5



















Dead animals. Virus recoveries from the four RHS lambs
that died or were killed before the end of the experiment
are summarised in Table 6.1. Border disease virus was
isolated from all samples tested. Cytopathic virus was
widespread in the 3 animals in the RHS 1 group, whereas
cytopathic virus was recovered only from the mesenteric
lymph node of lamb 532 in the RHS 2 group.
Virus recoveries from the lambs killed at the end of
the experiment are summarised in Table 6.2. No virus was
isolated from the 2 control lambs, but BD virus was
recovered from all the samples cultured from the RHS lambs.
Cytopathic virus was recovered only from 3 samples from one
of the two survivors in the RHS 1 group.
Other Microbiological Findings
Ocular swabs from the lamb in the control group with
conjunctivitis yielded Neisseria ovis and Mycoplasma
conjunctivae.
No pathogenic bacteria were grown from rectal swabs
taken from the 3 lambs that scoured.
Pasteurella haemolytica Type T4 and an untyped
Streptococcus were isolated from the retropharyngeal lymph
node of the lamb with nasal ulceration.
Haematology
There were differences in the haematological
responses of the 3 groups to infection with BDV-M. This was
most apparent with the total and differential leucocyte
counts. The control and RHS 1 groups, but not the RHS 2
group, showed evidence of reduced total leucocyte counts
(Figure 6.3). In the control group the reduction was
TABLE 6.1
Border disease virus recoveries from RHS lambs dying
or killed on humanitarian grounds


















Blood clot CP CP CP NCP
Faeces NT CP NCP NT
Spleen CP CP CP NCP
Mesenteric
lymph node
CP CP CP CP
Colon CP CP CP NCP
Ovary/Testis CP CP NCP NCP
Cerebellum CP NCP CP NCP
Kidney CP NCP CP NT
Lung CP CP NT NCP
Abomasum NT CP CP NT
Bone Marrow CP NT CP NCP





Virus recoveries from lambs sacrificed
at the end of the experiment.
Group/Lamb number
Control RHS 1 RHS 2
Samples
Tested
402 412 1245 1248 528 531 533 535
Buffy coat - - NCP CP NCP NCP NCP NCP




- - NCP CP NCP NCP NCP NCP
Bone Marrow - - NCP NCP NCP NCP NCP NCP
Testis/
ovary
NT NT NCP CP NCP NCP NCP NCP
Cerebellum - - NCP NCP NCP NCP NCP NCP
-, No virus isolated
NT, Not tested, lambs were castrates.
NCP, Non-cytopathic virus. CP, Cytopathic virus
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significant (p<0.05) on day 21; the RHS 1 group showed the
same degree of significant reduction on days 4 and 14. The
increase in the leucocyte count of the RHS 2 group was
significant (p<0.05) on days 18 and 35 after infection.
Significant differences between the responses of the groups
were detected by analysis of variance as shown on Fig. 6.3;
These were most marked 14,18,25 and 63 days after infection
and in all instances were due to low counts in the , RHS 1
group compared to the other two groups.
Differential leucocyte counts revealed evidence of
variable degrees of lymphocytopaenia and neutrophilia in
all groups. There were no obvious differences in monocyte,
eosinophil or basophil counts in any of the groups
following infection with BDV-M.
Lymphocytopaenia was most marked in the group (RHS 1)
with the worst disease (Figure 6.4). Of the two lambs
dying during the period of haematological examination, both
suffered severe lymphocytopaenia. Lamb number 1247 had
lymphocyte counts before infection of 6043(79%) and
3656(73.5%) xlO^/1. The counts obtained 4, 6, 8, 11, and
14 days after infection were 4143(80%), 2145(41.5%),
907(35%), 2069(36%) and 451(23%) respectively. At all
times after infection, the lamb killed 44 days after
infection (No. 1246) had reduced counts which went from
7013(89%) and 4807(84.5%) before infection to 2362(22.5%)
two days before death. Lymphocytopaenia in the control
group occurred most noticeably on days 4, 11, 14 and 21
after infection but these reductions were not
signiificantly different from the mean value of the group
r
FIGURE 6.3 Mean total leucocyte counts of the 3 groups
of lambs.
• •Controls A—A RHS1 ■ BRHS2
Levels of significance of differences between
the groups as revealed by analysis of




p< 0.05 > 0.01




FIGURE 6.4 Mean monuclear leucocyte cell counts of the 3
groups of lambs. A. Absolute values B.
Percentage of total leucocyte counts.
• ©Controls A—ARHS1 ■ ■RHS2
Levels of significance of differences between
the groups as revealed by analysis of




p< 0.05 > 0.01
p< 0.01 > 0.001
p< 0.001
x 10 /I
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D A v <; after infection
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days after infection
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before infection. Similarly, lymphocytopania in the RHS 2
group, was most apparent 11 days after infection but did
not differ significantly from the mean value before
infection.
Neutrophilia was seen in all 3 groups. Variable
responses between groups were significant 8,11, 42 and 49
days after infection and resulted from differences between
the control group and one or other of the RHS groups
(Figure 6.5).
The mean polymorphonuclear leucocyte counts of the
control group and the RHS 1 group were not significantly
higher than before infection on any day up until 35 days
after infection. On day 11 the mean of the RHS 2 group was
significantly higher (p<0.01) than before infection.
Haematological values relating to erythrocytes are
summarised in Figure 6.6. Before infection, the control
group had significantly higher haemoglobin and PCV values
than the two RHS groups. This continued after infection and
accounted for the significant differences between the
groups recorded for these values and the mean corpuscular
volume (MCV) and mean corpuscular haemoglobin concentration
(MCHC). Significant differences between the groups'
erythrocyte counts were not consistent. Twice the main
variation was between the RHS groups and on 2 other
occasions the difference was between the controls and the
RHS 2 group.
All groups showed reduced erythrocyte counts
following infection. In the control group this was
significant (p<0.05) from day 14 to day 28. In the RHS 1
FIGURE 6.5 Mean polymorphonuclear leucocyte cell counts
of the 3 groups of lambs. A. Absolute
values B. Percentage of total leucocyte
count.
•—# Controls ▲ ARHS1 ■—■ RHS2
Levels of significance of differences between
the groups as revealed by analysis of
variance are shown by the asterisks.
* p< 0.05 > 0.01


















C. Packed cell volume (PCV)
D. Mean corpuscular volume (MCV)
E. Mean corpuscular haemoglobin (MCH)
F. Mean corpuscular haemoglobin
concentration (MCHC)
+—# Controls ▲—▲ RHS1 ■—■ RHS2
Levels of significance of differences between
the groups as revealed by analysis of
variance are shown by the asterisks.
* p< 0.05 > 0.01
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group a similar reduction was only apparent on day 14. The
degree of reduction in the RHS 2 group was the same on days
14 and 21, but more significant on days 25 (p<0.01) and 28
and 35 (p<0.001). Haemoglobin levels declined
significantly only in the control group on days 8 and 14
and from day 21 to 28. The same was true for the PCV when
significant reductions were detected on days 6 to 11, 18 to
21 and 28 to 35.
Serology
Three groups following injection with BDV-M virus
Neutralising antibody to BDV-M was first detected in
the plasma of 3 animals 11 days after infection. On day 14
only 3 animals, all in RHS 2, had not seroconverted, and by
day 18 all lambs were seropositive. The lamb that died 16
days after infection (No.1247 from RHS 1 group) had a titre
of 11 two days before death.
The rate of development of neutralising antibodies by
the two groups of RHS was markedly different (Figure 6.7).
The group in which lambs scoured and died (RHS 1) developed
antibodies at the same rate as the controls. Only on day
42, shortly before the death of lamb 1246, which had the
lowest titre in the group was there a significant
difference(p<0.05) between the group mean and that of the
controls. From day 49 to the end of the experiment, the
mean titre of the survivors of the RHS 1 group was
consistently higher than that of the controls.
The RHS 2 group seroconverted very slowly to the
virus; the difference between the group mean and that of
the controls was highly significant (pCO.OOl) from day 21
FIGURE 6.7 The development of specific neutralising
antibody to BDV-M by the three groups of
lambs. The results are shown as geometric
means with the bar lines representing the














to day 49. During the next two weeks the group geometric
mean rose to 222 and stayed around this level for the
remainder of the experiment.
Only the control group produced cross-neutralising
antibody to BVDV-NADL virus. Three lambs had antibody 18
days after infection and all were seropositive by day 25.
There was considerable individual variation, but the group
mean rose slowly reaching a plateau 56 days after
infection. The mean neutralising antibody titres of all
three groups to BDV-M and BVDV-NADL ten weeks after
injection with BDV-M are shown in Table 6.3.
Sentinel lambs after mixing with the three groups
Sentinel lambs mixed with the RHS 1 and RHS 2 groups
seroconverted to BDV-M and BVDV-NADL viruses, whereas the
sentinel lambs mixed with the control group remained
seronegative to both viruses. The serum neutralising
antibody titres of the sentinel lambs 3 weeks and 6 weeks
after mixing with their respective groups are shown in
Table 6.4.
PATHOLOGY
Lambs dying or killed on humanitarian grounds. All four
lambs had residual CNS lesions consistent with an in-utero
infection with BD virus.
Of the three lambs from the RHS 1 group that
developed diarrhoea, the first to die 16 days after
infection had an atrophic thymus and obvious enteric
lesions. This lamb had gross thickening of the caecum,
colon and ileum, and the mesenteric lymph nodes were
enlarged. Histologically there was hyperplastic
TABLE 6.3
Geometric mean (range) neutralising antibody titre






















Neutralising antibody titres of sentinel lambs after
mixing with the 3 groups of lambs injected with BD-M
10 weeks previously
Sentinels mixed Days after Neutralising antibody to
with mixing BDV--M BVDV- NADL
CONTROLS 0 <4 + <4
21 <4 <4
42 <4 <4
RHS 1 0 <4 <4
21 45 , 20 * <4
42 202 , 101 16 , 4
RHS 2 0 <4 <4
21 80 , 6 <4
42 227 , 321 9 , 90
+ Both sentinel lambs <4.
* The values for each sentinel lamb are given.
115
enteropathy with glandular invasion of the submucosa,
without obvious inflammation. Gross enteric lesions were
not seen in the other two lambs, but the lamb killed 44
days after infection had histological evidence of mucosal
hyperplasia, again without obvious inflammation. Death of
the third lamb 106 days after infection was attributable to
pulmonary congestion and oedema with endobronchial
haemorrhage; the cause was obscure but could have been
associated with the administration of oral rehydration
therapy.
The lamb from the RHS 2 group killed 92 after
infection had foul necrotic ulceration around the nares and
lips. Histologically, the lip lesion showed non-specific
ulceration, haemorrhage with a mixed inflammatory
infiltrate and acanthosis. The retropharyngeal lymph nodes
were enlarged, but there was no evidence of disease
elsewhere in the respiratory tract.
Lambs killed 16 weeks after infection with BDV-M virus. No
gross or histological abnormalities were recognised in the
two control lambs. Compared with the RHS lambs in the
experiment, splenic follicles and Peyer1s patches appeared
better developed; in the thymus, the cortices were thicker
and better differentiated and the Hassal's corpuscles were
in a more advanced state of development.
The six surviving RHS lambs all had residual CNS
lesions of in-utero BD virus infection. The two lambs from
the RHS 1 group both had mild mucosal hyperplasia and
lymphoid infiltration of the lamina propria and submucosa
of the ileum and caecum. One lamb had a mild lymphoid
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infiltration of the renal pelvis, and the other had a
slight focal choroiditis.
No consistent lesions were present in the 4 survivors
of the RHS 2 group. Mild focal areas of non suppurative
meningitis, encephalitis, myocarditis, pancreatitis, and
nephritis were recorded in one or more of the lambs.
DISCUSSION
Each of the 3 groups of lambs responded differently
to infection with low passage BDV-M.
The normal control animals showed evidence of
transient pyrexia and mild disease 1 to 3 weeks after
infection. These findings, together with a short-lived
viraemia and rapid development of specific neutralising
antibody were consistent with the results of previous
experimental infections of normal sheep (Shaw et al.,1967;
Roeder et al.,1983; Terlecki &r d Boeder, 1983).
The differing responses of the 2 groups of RHS lambs
to BDV-M frustrate a single explanation of the
pathogenesis of such an infection. Nevertheless, the
finding that such animals remain effective excretors of
virus even though they have responded serologically to a
superinfecting pestivirus has serious practical
consequences for the control of pestivirus-induced disease
by vaccination. Recent analogous findings in cattle have
been reported. Liess et al. (1983) vaccinated 5
persistently viraemic cattle with a live attenuated,
cytopathic BVDV vaccine . They all seroconverted to the
vaccine virus strain and at least one other reference
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strain, but not to a cytopathic field isolate from the herd
of origin of one of the 5 cattle. Four of the 5 animals
developed a slowly progressing "runt-disease" like state,
and succumbed or had to be sacrificed 21 to 93 weeks after
vaccination. Persistent viraemia with non-cytopathic BVDV
was demonstrated regularly in the 4 animals until death.
Virus isolation was not attempted from dead animals, but
BVDV was demonstrated in a wide range of tissues by IFT.
Ernst and Butler (1983), without detailed virological
studies, have also provided good evidence that cattle can
die of BVDV-associated disease in spite of seroconverting
well to a live BVDV vaccine.
In this experiment further evidence was provided of
the specificity of the neutralising antibody response of
RHS to pestivirus infections. No cross-neutralising
antibody to BVDV-NADL was produced, in contrast to the
control group and the seroconverting sentinel lambs. The
difference in the rate of development of the serological
response to BDV-M by the two groups of RHS lambs was highly
significant. The rapid development of neutralising
antibodies in the group (RHS 1) that suffered fatalities
and the slow rise of such antibodies in the group (RHS 2)
that was comparatively disease-free suggest that humoral
immune mechanisms are not essential for the control of BD
virus replication in such animals.
The significant lymphocytopaenia in the RHS 1 group,
particularly the dying animals, suggest that lymphocyte
depletion or mobilisation to tissue sites is important in
the pathogenesis of disease in superinfected persistently
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infected animals. No other studies in comparable sheep
have yet been reported, but Roeder (1984) has recently
shown that lymphocytopaenia is a common sequel to
experimental infection of normal healthy lambs. Findings
in the control group in this experiment would support this.
Vantsis et al.,(1979), however, have demonstrated that
neutropaenia can also occur following the experimental
infection of normal sheep with BD virus (Vantsis et
al.,1979). Haematological data from BVDV infections in
cattle are also conflicting. Whilst leucopaenia has been
widely recorded this has been attributed variously to
decreases in the numbers of neutrophils, lymphocytes or
both; neutrophilia in animals dying of chronic disease has
also been reported. (Pritchard,1963). A recent study in
normal cattle infected with BVDV has recorded a decrease in
the absolute numbers of B and T lymphocytes and in the
percentage of T lymphocytes (Bolin et al,1985a).The same
group of workers has also shown that persistently infected
cattle superinfected with cytopathic BVDV suffer a
significant decrease of T lymphocytes (Bolin et al.,1985b).
The BDV-M used for infection was cytopathic in
tissue culture. Virus recovered from the blood of the
control lambs was non-cytopathic. It has been shown in
studies of the recovery of BVDV-NADL from experimentally
infected sheep that virus could be detected by IFT one
passage before cytopathic effects were seen, and that 3
passages were required before CPE was obvious
(Hassan,1979). In spite of up to 6 passages, virus from
the control lambs in this experiment remained
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non-cytopathic. The isolation of cytopathic virus from the
blood of the RHS groups occurred over a short time scale,
but apparent persistence of cytopathic virus in tissues of
the RHS 1 group was associated with disease in this group.
Recently reported findings in cattle, in which distinct
aetiological roles have been assigned to non-cytopathic and
cytopathic BVD viruses suggest that the balance of the two
populations is important for the precipitation of clinical
disease (Brownlie et al.,1984; Bolin et al., 1985b).
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CHAPTER 7
PLAQUE PURIFICATION AND CHARACTERISATION OF TWO
REFERENCE STRAINS AND THREE FIELD ISOLATES OF
CYTOPATHIC PESTIVIRUSES
INTRODUCTION
The results of the neutralisation tests described in
Chapter 5 confirmed the antigenic relationship between
BVDV-NADL and BDV-M established by previous workers
(Vantsis et al.,1976; Wrathall et al.,1978; Laude and
Gelfi,1979; Hassan,1979). The degree and nature of this
serological relationship between the two viruses remains
largely unexplored, as does their relationship with field
isolates of pestivirus. In this Chapter, results are
presented of some comparative aspects of the growth,
physical properties and pathogenicities of plaque purified
stocks of the two reference viruses and three cytopathic
BVDV field isolates.
MATERIALS AND METHODS
Cell cultures. Semi-continuous cell lines were prepared by
trypsin disaggregation of foetal lamb brains (FLB). They
were checked regularly for the presence of contaminating
NCP pestivirus by IF tests, and were used between passage
levels 5 and 50. Secondary FLK cells and BEK cells used
for virus isolation were prepared as described previously,
and all cells were grown in supplemented Eagle's MEM
(Chapter 2 ) .
Viruses. The low passage virus stock of BDV-M, derived
from the IIB brain pool, was passaged a further 4 times in
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secondary FLK cells, and a stock prepared at passage level
7, to match the passage level of the BVDV-NADL stock.
Three cytopathic BVD viruses isolated from cases of MD in
different regions of Scotland (Table 2.1) were available at
the 2nd passage level in BEK cells. Virus had been
isolated from different samples from each animal; a nasal
swab (BVDV-7446), a spleen/mesenteric lymph node
pool(BVDV-8085) and a retropharyngeal lymph
node(BVDV-B816).
All viruses were plaque purified 3 times in FLB
cells. Master stocks of each virus were grown, and working
stocks prepared from these as required. At every stage of
these procedures viruses were grown in the same batch of
cells, and uninfected cells were passaged along with the
viruses.
Plaque assay. The procedure was based on that described by
Laude and Gelfi (1979). Suspensions of FLB cells at a
C
concentration of 2 x 10 per ml were added to 55 mm
diameter plastic petri dishes(Sterilin Ltd.) or 12 well
Linbro plastic plates (Flow Laboratories Ltd.). The petri
dishes received 8 ml of suspension and each well of the
Linbro plates 1.5 ml of suspension. Cells were incubated
at 37°C in a humidified atmosphere containing 5 per cent
CC^, for 24 to 48 hours, until confluent monolayers
were formed. Growth medium was then removed and the cells
washed three times with Hanks' BSS.
Serial dilutions of virus, prepared in bijou bottles
were added in 0.2 ml volumes to duplicate cell monolayers,
and allowed to adsorb at 37°C for two hours. After this
time, petri dishes received 8 ml and Linbro plate wells
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received 2 ml of overlay medium. The overlay consisted of
'199' medium supplemented with BSA (0.5%), LAH (0.1%),
yeast extract (0.1%), and heat-inactivated horse serum
(3%), and contained 100 iu/ml penicillin, 100 yg/ml
streptomycin, 2 pg/ml amphotericin B deoxycholate and 0.6%
agarose (Sea-plaque, FMC Corporation, Rockland, USA).
Plates were left on the bench until the overlay
medium had solidified, and were then returned to the gassed
incubator. Four to five days later, cells were fixed with
10% formol saline and stained with 1% (w/v) crystal violet
in 20% (v/v) ethanol in distilled water.
Virus characterisation.
Immunofluorescence and neutralisation tests. Stocks of the
five viruses and the uninfected control cells were tested
for specific fluorescence by inoculation of 0.2 ml volumes
into each of four tubes containing coverslips. In two
tubes FLK cells were growing, while the other two contained
BEK cells. After 72 hours' incubation the coverslips were
fixed and stained in IIF tests as described in Chapter 2.
Ten-fold virus dilutions were tested against 1:20
dilutions of convalescent calf serum (385) and lamb serum
(D1479/14) in a microneutralisation assay.
Growth characteristics. The development of CPE caused by
the 5 viruses was studied by inoculating, at a m.o.i. of 1,
FLB cells grown on coverslips, which were fixed and stained
with May-Grunwald Giemsa firstly at six-hour and then at
12-hour intervals. Coverslips infected the same way were
also fixed and stained at the same time intervals in IIF
tests as described in Chapter 2.
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Growth curves of 3 of the viruses in FLB cells were
studied using confluent monolayers of cells grown in 15 cm
x 1.5 cm glass test tubes. At the start of the experiment
the cells in 3 tubes were trypsinised and counted. The mean
number of cells was used to adjust the concentration of
virus in the inocula so that each tube was infected at a
m.o.i. of 1. Growth medium was removed from the cells,
which were washed 3 times with Hanks' BSS. Each virus was
used to infect 16 tubes. After 2 hours' adsorption at 37°C
the inocula were removed, the cells washed twice with '199'
maintenance medium (m/m) supplemented with 3%
heat-inactivated horse serum, 1 ml of the same medium being
added finally to each tube.
At six hour intervals for the first 24 hours, and at
12 hour intervals for the next 144 hours, one tube for each
virus was removed from the incubator. Supernatant fluid
was aspirated into a vial, and 1 ml of m/m was added to the
tube. Vials and tubes were then frozen at -70°C awaiting
assay of extracellular and intracellular virus. All
samples were assayed in one test 7 weeks later.
Electron microscopy. Negative staining of infected and
uninfected disrupted cells, and thin sections of cell
pellets were both carried out as described in Chapter 2.
Ether and chloroform sensitivity. Virus suspensions were
treated with 50 per cent ether or 20 per cent chloroform at
room temperature for 30 minutes, the mixtures being kept
agitated constantly. The aqueous phases were removed for
virus assay and residual ether was blown off using sterile
air. A bovine enterovirus (G1984) was treated the same way
and assayed in tube cultures of secondary BEK cells.
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Filtration. Sterile 25 mm millipore filters in Swinnex
holders (Millipore (UK) Ltd.) were attached to disposable
plastic syringes and flushed with Hanks' BSS containing
0.5% BSA. A 10 ml stock of each virus was prepared by
filtration through a 200 nm average pore diameter (a.p.d.)
filter. Two ml volumes of these stocks were subsequently
passed through filters of 100 nm, 50 nm and 25nm a.p.d. All
suspensions were kept at 4°C and assayed for virus content
the same day.
Pathogenicity for sheep.
Infection of gnotobiotic lambs. Ten hysterectomy-derived,
colostrum-deprived gnotobiotic lambs, obtained according to
the method of Hart et al.(1971), were reared singly in
plastic isolators. In the first experiment, each of five
lambs were infected with one or other of the five viruses.
One-day-old lambs were infected intranasally with 3 x
4 410 to 12 x 10 pfu in a 5 ml dose divided equally between
each nostril. Nine days later, lambs received 10^ pfu of
virus given intravenously, and they were killed at three
weeks of age for the collection of convalescent sera.
The second experiment was similar to the first,
except that lambs were injected intravenously at 7 days
old, and intramuscularly at 21 days of age with 2 ml of a
four-fold concentrate of virus emulsified with an equal
volume of Marcol 52/Montanide 888 (Esso Ltd., London
/Seppic Ltd., Paris). These inocula were kindly prepared by
Miss I. Pow, Moredun Research Institute.
The lambs were exsanguinated under halothane
anaesthesia at 6 weeks old and the sera collected for
serological comparisons (Chapter 8).
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All lambs were bled before, and regularly after
infection, for virological and serological testing as
described in Chapter 2. Lamb temperatures were recorded
daily.
Infection of pregnant ewes. Nineteen oestrus-synchronised
ewes were divided into 6 groups. At 52 days' gestation,
groups of 3 ewes received one or other of the 5 viruses,
and a group of 4 received equivalent passage level tissue
culture fluid in a 2 ml dose given subcutaneously. Virus
titres were between 5.1 and 5.7 pfu per ml. At 82 days'
gestation, the ewes were killed and placenta and foetuses
collected for pathological, virological and serological
examinations as previously described (Chapter 5 Section 3).
RESULTS
Susceptibility of FLB cell cultures. Only four of twelve
cell cultures tested were susceptible to infection and
showed clear CPE following inoculation with the cytopathic
viruses. In the other cultures, plaques either did not
develop or were hazy and indistinct.
Plaque characteristics of viruses. No adaptation to FLB
cell cultures was required; all viruses produced plaques in
susceptible cells at the first passage. Plaques were
observable microscopically, 48 to 72 hours after infection,
as small foci of refractile, degenerating cells. The area
of affected cells increased with time so that easily
countable plaques were apparent 4 to 5 days after
infection. Within areas of degenerating cells, apparently
healthy cells were often seen (Figure 7.1).
FIGURE 7.1 Appearance of plaques formed by BDV-M in
foetal lamb brain (FLB) cells under agarose
overlay medium.
Figure 7.1a Uninfected FLB cells.
Magnification x 250
Figure 7.1b Early focus of CPE. Seventy-two hours
after infection.
Magnification x 120
Figure 7.1c More extensive CPE. Ninety-six hours
after infection. Apparently healthy





Plaque sizes of all the viruses varied from test to
test and showed a range of sizes, with the normal
distribution of single populations. One virus, BVDV-B816,
consistently produced small plaques (Table 7.1; Figure
7.2) .
The relationship between the plaque count and the
dilution of the inoculum was investigated with 3 of the
viruses. Using 6 wells per dilution for each virus, the
relationship was shown to be linear over nearly all of the
range of dilutions tested, with erratic results occurring
only at the end of the range (Table 7.2).
Growth characteristics of viruses. The first evidence of
CPE, detected in May-Grunwald Giemsa stained coverslips,
was seen 36 hours after infection in cells exposed to
BVDV-NADL and BVDV-7446 viruses. Twelve hours later,
BVDV-8085 was first seen to cause CPE, but the other two
viruses did not cause cell changes until 72 hours after
infection. The sequence of CPE development was the same for
all viruses.
The earliest changes seen, in a low number of cells,
were increased granularity and multiple vacuolation of the
cytoplasm. Over the next 4 days an increasing number of
cells became affected; many died and became detached from
the glass without showing these cytoplasmic changes, but at
the end of this time many of the remaining cells showed the
multiple cytoplasmic vacuolation very clearly (Figure 7.3).
The nuclear changes seen included pyknosis, karyorrhexis
and vacuolation; chromatin aggregation occurred in
degenerating cells, and when this was surrounded by a clear
TABLE 7.1
Virus titres, and mean diameters of 50 plaques, of
5 cytopathic pestiviruses before and after plaque
purification in foetal lamb brain fibroblasts(FLBF)
First assay in Assay after plaque
FLBF purification in FLBF
Virus
Virus Titre Plaque size Virus titre Plaque size
(pfu/0.2ml) mm + SD (pfu/0.2ml) mm + SD
BVDV-NADL 6.6



















FIGURE 7.2 Plaque characteristics of 5 cytopathic
pestiviruses in foetal lamb brain (FLB)
cells. Each 55 mm diameter petri dish was
inoculated with 0.2 ml of a 10 dilution of










THE RELATIONSHIP OF THE NUMBER OF PLAQUE FORMING
UNITS TO DILUTION OF THREE CYTOPATHIC PESTIVIRUSES
VIRUS
Virus BVDV-NADL BVDV-8085 BDV-M
Dilution MeaniSE Titre Mean+SE Titre MeaniSE Titre
lo9l0
3.4 20 . 5±1.3* 4.7 + 22.3+0.9 4.7 Uncountable
3.7 12.Oil.2 4.8 16.510.8 4.9 27.7+1.0 5.1
4.0 8.6 ±0.5 4.9 6.3+0.2 4.8 15.3+0.5 5.2
4.3 3.2±0.5 4.8 4.0+0.3 4.9 7.6+0.4 5.2
4.6 1.510.2 4.8 2.7+0.3 5.0 3.5+0.4 5.1
4.9 1.010.2 4.9 1.2+0.2 5.0 1.3+0.1 5.0
5.2 1.010.2 5.2 0.7+0.2 5.0 0.3+0.1 '4.7
5.5 0 . 2±0.1 4.8 0.0 — 0.2+0.1 4.8
* Mean of 6 wells ± SE
+ Calculated virus titre expressed as Log^ pfu/0.2 ml
FIGURE 7.3 The development of CPE caused by BDV-M




Figure 7.3a Uninfected FLB cells.
Magnification x 300
Figure 7.3b Infected FLB cells showing increased




Figure 7.3c Infected FLB cells showing cell
depletion. Remaining cells have





area, the impression was gained of an intranuclear
inclusion body. Such structures were only seen late in
infection in dying cells.
Specific immunofluorescence was detected only in the
cytoplasm of infected cells. The time course for each virus
followed that of the stained coverslips, but fluorescence
was always seen 24 hours before any CPE was observed. The
earliest appearance of fluorescence was in the perinuclear
region, usually around the whole perimeter of the nucleus.
Diffuse fluorescence spread slowly throughout the
cytoplasm, and the whole cytoplasm of degenerating cells
usually fluoresced brightly (Figure 7.4).
Growth curves of the 3 viruses tested are shown in
Figure 7.5. Despite the different timing of the onset of
CPE by the viruses, the growth curves were roughly
comparable, with the concentrations of intracellular and
extracellular virus being the same during the exponential
growth phase. Peak levels of intracellular virus were
detected just before the onset of CPE, and were higher
than the concentration of extracellular virus at this time.
Thereafter the concentration of extracellular virus
remained constant over several days, and was always higher
than that of the intracellular virus.
Immunofluorescence and neutralisation tests. Both FLK and
BEK cells infected with the 5 viruses showed bright
intracytoplasmic fluorescence when stained 72 hours after
infection. The CPE was advanced in FLK cells at this time,
and differed from that in FLB cells. There was more cell
clumping and webs of infected cells were seen (Figure 7.6)
FIGURE 7.4 Development of intracellular BDV-M antigen in
foetal lamb brain (FLB) cells detected by
indirect immunofluorescence.
Figure 7.4a Fluorescence first detected in the
perinuclear region of the cytoplasm of
individual cells. Eighteen hours after
infection.
Magnification x 300
Figure 7.4b Fluorescence has spread to involve more
of the cytoplasm and more cells show
evidence of viral antigen. Forty-eight
hours after infection.
Magnification x 300
Figure 7.4c Seventy-two hours after infection, cells
show fluorescence throughout the
cytoplasm. This is particularly marked
in degenerating cells (Top right).
Magnification x 300
 
FIGURE 7.5 Growth curves of 3 cytopathic pestiviruses in
foetal lamb brain (FLB) cells, infected at a
multiplicity of infection of 1.
The concentrations of intracellular (v v)
and extracellular (a a.) virus were assayed,
and the time at which virus-induced CPE first
became obvious was as shown.
0 20 4 0 6 0 80 100 120 140
TIME(hours)
FIGURE 7.6 Indirect immunofluorescence test on foetal
lamb kidney (FLK) cells infected with
cytopathic BDV-M (Top), and non-cytopathic BD





The CPE caused by the 5 viruses was readily
neutralised by antisera prepared against the unpurified
reference strains (Table 7.3).
Electron microscopy. Negative staining of virus infected
cells, in the presence or absence of dilutions of immune
sera, did not reveal the presence of any clearly
identifiable microorganisms.
Thin sections of FLB cells infected with the 5
viruses produced only meagre evidence of the presence of
pestiviruses. In comparison with changes detectable in BE
testis cells infected with the unpurified reference strains
(Figures 1.2, 1.3, 1.4) , there was less precocious
development of the rough endoplasmic reticulum, and only
occasional putative virus particles were seen.
Ether and chloroform sensitivity, and filtration studies.
The infectivity of all 5 viruses was destroyed by the
action of both lipid solvents; only BVDV-B816 showed slight
residual infectivity after exposure to ether. In contrast,
the infectivity of the bovine enterovirus was unaffected by
either chemical. All 5 viruses gave comparable results in
the filtration experiment. Only the membrane of 25 nm
a.p.d. retained more than 95% of infectious particles
(Table 7.4).
Pathogenicity for sheep.
Gnotobiotic lambs. None of the viruses showed any evidence
of pathogenicity for gnotobiotic lambs. No clinical
disease occurred. The body temperatures of all lambs
increased gradually during the first two weeks of life and
seven of the lambs reached a temperature plateau around
TABLE 7.3
Neutralisation of plaque purified viruses by
antisera against unpurified BVDV-NADL and BDV-M
Serum neutralisation index following
exposure to
Virus BVDV-NADL ANTISERUM BDV-M ANTISERUM
(From calf 385) (Lamb D1479/14)
BVDV-NADL 4.0 1.5





Infectivity titres (pfu/0.2 ml) of plaque purified
pestiviruses following exposure to lipid solvents
and after filtration through membranes of
different average pore diameters (a.p.d.)
Original After After After filtration
Virus titre ether chlor- through membranes of
form lOOnm 50nm 25nm
BVD-NADL 5.1 o•o A t-1 • O 4.8(50)+4.7(40) 3.6(3)
BVD-7446 5.1 0.0 <1.0 4.7(40) 4.1(10) 2.9(0.6 )
BVD-8085 4.3 0.0 <1.0 4.0(50) 3.4(13) 1.7(0.2)
BVD-B816 4.2 1.5 <1.0 4.1(79) 3.9(50) 2.2(1)




4.5* 4.5 4.5 ND ND ND
+ The percentage of virus remaining is shown in brackets.
* Log^gTCID^Q per 0.2 ml. ND - Not done
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40°C after this rise. Only one day of true pyrexia was
recorded: in the first experiment, the lamb infected with
BVDV-NADL had a temperature of 40.5°C 7 days after
intranasal infection, its temperature on days 6 and 8
being 38.7°C and 39.7°C respectively.
A total of 112 buffy coat samples was tested for the
presence of virus, but all samples proved negative. All
lambs seroconverted to the virus with which they were
infected. In the first experiment only low levels of SN
antibody were detectable when the lambs were killed 21 days
after infection. All Lambs killed at six weeks, however,
had high SN antibody levels at that time, and the rate of
antibody development was similar in all the lambs (Figure
7.7 ) .
Pregnant sheep. None of the sheep showed any evidence of
malaise following infection with the plaque purified
viruses. Examination of the uteri and foetuses 30 days
after infection revealed no gross evidence of disease
attributable to the pestiviruses. One of the control ewes
and one of the ewes infected with BVDV-NADL had recently
aborted, but there was no histopathological evidence from
the placentae that these abortions were pestivirus-induced.
Histopathological evidence of established pestivirus
infection was seen in the placentae of only 6 ewes: two
that received BVDV-NADL, two receiving BVDV-8085 and one
each of the ewes injected with BDV-M and BVDV-B816. Lesions
were small and focal, and were detected only in a low
number of the cotyledons examined from each ewe.
FIGURE 7.7 The development of serum neutralising
antibodies by gnotobiotic lambs each infected
with a different cytopathic pestivirus.
BVDV-NADL
^^ BVDV-74 4 6





Only two virus isolations were made. Cotyledons were
tested from all ewes except the control ewe that aborted,
and a cytopathic virus was isolated from one of the ewes
injected with BVDV-8085. No viruses were recovered from
the foetal blood clots or cerebellum tissue from 23
foetuses, but of 18 foetal spleen/gonad pools tested, one
yielded a non-cytopathic pestivirus; this virus-positive
pool was from one of two foetuses from a ewe injected with
BVDV-NADL.
Low pathogenicity of the plaque purified viruses was
also suggested by the low levels of SN antibody present in
the sera of the ewes 30 days after infection (Table 7.5).
No SN antibodies were detected in the sera of the control
ewes or in any of the foetal sera.
DISCUSSION
The use of semi-continuous lines of FLB cells to
study 5 cytopathic pestiviruses was hampered by the
insensitivity of 8 of 12 lines tested. Laude and Gelfi
(1979), working with foetal lamb muscle cells, and Rossi et
al.(1980) using foetal bovine lung cultures, have also
recorded the variable susceptibility of cell lines to
pestiviruses. Insensitivity has been attributed to
interference by non-cytopathic strains of pestivirus, but
failure to demonstrate such contamination in any of the 12
lines studied, suggests that other mechanisms of resistance
occur.
In susceptible cells all the viruses formed discrete
plaques under agarose-containing medium, enabling purified
TABLE 7.5
Serum neutralising antibody titres of ewes to plaque
purified cytopathic pestiviruses, 30 days after
infection with those viruses. The SN antibody titres
to low passage BVDV-NADL and BDV-M are shown also.
Ewe Injected SN ANTIBODY TITRES TO






X431 64 22 <4
Z839 BVDV-NADL 16 11 <4
Z828 <4 <4 <4
Z832 11 <4 <4
V889 BVDV-7446 22 8 <4
X432 45 <4 <4
Z820 22 <4 <4
Z826 BVDV-8085 22 <4 <4
Z830 45 11 <4
V860 16 <4 <4
V896 BVDV-B816 4 <4 <4
X471 <4 <4 <4
X469 22 <4 8
X505 BDV-M 128 4 16
Z824 22 <4 6
X587 Tissue <4* <4 <4
V862 culture <4 <4 <4
Z812 fluid <4 <4 <4
Z834 <4 <4 <4
* Tested against all 5 plaque purified viruses.
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stocks to be prepared. Partial characterisation of these
stocks showed them to have comparable growth properties in
FLB cells, although the rates of CPE development of one of
the BVD viruses (BVDV-B816) and of BDV-M were slower than
those of the other 3 viruses. Antigen detection by IIFT
showed that evidence of virus replication was restricted to
the cytoplasm. The perinuclear appearance of fluorescence
soon after infection suggests that nuclear contents or the
nuclear membrane fulfil a role in viral replication.The
filure to detect intranuclear fluorescence, however, makes
it unlikely that virus proteins are synthesised at this
site. The intranuclear inclusion-bodies were considered to
result from chromatin aggregating as the cells were dying.
Such inclusion have been described previously in both BVDV
and BDV-infected cells (Singh,1969b; Vantsis et al.,1976).
It has recently been suggested that they may represent
evidence of the presence of other agents replicating in
cells infected with non-cytopathic pestiviruses
(Terpstra,1985; Littlejohns and Walker,1985). Whilst this
possibility cannot be excluded completely, it would seem
unlikely since they were seen in cells infected with 5
viruses from very disparate sources.
The limited range of physico-chemical properties
tested revealed no significant differences between the 5
viruses, and the results were consistent with earlier
findings (Saurat et al.,1972; Harkness and Vantsis, 1982).
Immunofluorescence and neutralisation studies showed all
the viruses to be antigenically related to the unpurified
reference strains.
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The infection of gnotobiotic lambs and pregnant ewes
revealed that the plaque purified viruses were of low
pathogenicity for these animals. Difficulty in recovering
virus confirmed that only low levels of viraemia occurred.
Nevertheless, there was sufficient viral replication to
stimulate the formation of SN antibodies in nearly all the
animals. Lack of pathogenicity could have resulted from
attenuation following passage in FLB cells, or could have
been due to the use of plaque purified virus. There are
very few reports of the use of plaque purified pestiviruses
for pathogenicity studies. The available evidence,
however, suggests that such agents have reduced
pathogenicity. In cattle, Nuttall et al.,(1980) failed to
detect viraemia in calves infected with plaque purified
BVDV-NADL, whereas no such difficulty was encountered with
calves receiving unpurified NCP virus; the BVDV-NADL being
also much less pathogenic for the cattle than the NCP
virus. In sheep, the injection of ewes at 54 days
gestation with purified cytopathic BDV-M, resulted in the
birth of a much higher percentage of normal lambs, compared
to ewes given the same passage level of unpurified virus
(Vantsis et al.,1976).
There is thus an increasing weight of evidence that
purification of cytopathic pestiviruses away from the bulk




ANTIGENIC RELATIONSHIPS. COMPARISON OF BRITISH
ISOLATES OF BVD VIRUS AND BP VIRUS BY
CROSS-NEUTRALISATION, CROSS-IMMUNOFLUORESCENCE
AND WESTERN BLOTTING TESTS
INTRODUCTION
Antigenic relationships among BVD virus isolates have
been studied extensively by cross-immunity and
neutralisation tests, and both these procedures confirmed
relatedness between early reference strains of CP and NCP
isolates from cases of BVD and MD (Gillespie et al.,1960;
Gillespie et al., 1961). Neutralisation studies on
Italian, German, French and Belgium CP isolates showed
that, while all isolates were antigenically related,
antigenic differences were distinguishable (Castrucci et
al., 1968; Hafez and Liess, 1972; Corthier and Aynaud,
1973). Similar findings were reported by American workers
who proposed a classification of strains into 3 serotypes;
two represented by the CP virus strains, C24V and NADL, and
the third by NCP viruses (Fernelius et al.,1971). Further
work on the classification of BVDV strains has not been
reported, possibly because Castrucci et al.(1975)
demonstrated that serologically different CP strains of BVD
viruses were cross-protective in cattle.
Among BD viruses, the BDV-M and Weybridge BD-2
strains have been compared in cross-neutralisation tests,
and shown to be related to each other and to BVDV-NADL and
to 2 HCV strains. The 2 BD strains were more closely
related to each other than to BVD-NADL, and more closely
related to the BVD virus than to the HC viruses (Laude
and Gelfi,1979). Weybridge BD-2 has also been compared in
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cross-neutralisation tests with 3 strains of BVDV; the
reference strains NADL and C24V and a British isolate
(81422). The antigenic differences between BD-2 and the BVD
virus strains were reported to be no greater than the
differences between various other British BVD isolates
(Harkness and Vantsis,1982 ) .
In view of the results of the immunity test in sheep
using BVDV-NADL and BDV-M (Chapter 5 Section 3), it was
considered worthwhile to investigate further the antigenic
relationship between these viruses in cross-neutralisation
tests. For further comparison, three cytopathic British
isolates were also included in the study, and the
neutralisation of NCP pestivirus isolates by antisera
against the 2 cytopathic reference strains was
investigated. Cross-immunofluoresence studies were also
conducted since it has been shown that sera raised against
one BVD virus strain may fail to detect another strain
growing in culture (Heuschele,1976).
In the final section of this Chapter, attempts to
identify immunogenic proteins of the 5 CP pestiviruses by a
"Western Blotting" method are described.
MATERIALS AND METHODS
Cell cultures. Semi-continuous cultures of FLB cells free
of contaminating NCP pestiviruses, were used between
passage levels 5 and 50. They were grown in supplemented
Eagle's MEM (Chapter 2).
Viruses. Four cytopathic BVD viruses, and one cytopathic
BD virus were used: BVDV-NADL, BVDV-7446, BVDV-8085,
BVDV-B816 and BDV-M. Working stocks of the viruses were
grown after plaque purification over 3 passages.
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Three NCP isolates of BVDV were selected:
BVDV-D1787, from a pool of tissues from an aborted foetus,
BVDV-E3679, from the lung of a calf dying of pneumonia, and
BVDV-G982, from the blood of a persistently infected bull
with a sight defect. Three NCP isolates of BDV were chosen:
BDV-B1056, from the brain of an experimentally infected
lamb, BDV-G1305, from a pool of tissues from a lamb with
clinical BD, and BDV-G2048, from the blood of an apparently
normal persistently infected lamb. Working stocks of these
viruses were prepared following three terminal dilutions in
culture.
The details of the time and place of origin of the
three CP and six NCP field isolates are summarised in Table
2.1.
Production of antiserum. Antiserum against each of the 5
cytopathic isolates was prepared in a gnotobiotic lamb, as
described in Chapter 6. Basically, lambs received 5 ml of
virus intranasally the day after birth, 4 ml of virus
intravenously at 7 days old, and 2 ml intramuscularly of a
four-fold concentrate of virus emulsified with an equal
volume of Marcol 52/Montanide 888 at 3 weeks of age. Lambs
were exsanguinated under general anaesthesia when they were
6 weeks old, and sera were collected and stored at -20°C in
5 ml amounts. . The infectivity titres of the viruses
were 5.0, 5.0, 5.4, 4.5 and 5.1 log^pfu per 0.2 ml for
BVDV-NADL, BVDV-7446, BVDV-8085, BVDV-B816 and BDV-M
respectively.
A pool of sera from adult Scottish cattle was used as
a positive control serum in all neutralisation tests.
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Antiserum prepared against low passage BVDV-NADL
using autologous cell cultures from calf 368 (Chapter 5)
was also used in the Western blotting experiments.
Serological tests
Microneutralisation tests. The degree of
cross-neutralisation between the 5 cytopathic viruses was
measured using two-way constant-virus, varying-serum
microneutralisation tests. All the serum-virus combinations
being compared were tested at one time in the same batch of
cells. The results are expressed as the geometric mean
values from four tests.
The degree of antigenic relatedness between the
viruses was calculated by a slight modification of the
method of Archetti and Horsfall (1950) using the formula :-
R = V rl . r2 X 100
Where rl = Heterologous titre (Strain 2)
Homologous titre (Strain 1)
and r2 = Heterologous titre (Strain 1)
Homologous titre (Strain 2)
The closer the value of R is to 100 the more closely related
are the strains. A value of R < 5 signifies a more than
twenty-fold reciprocal difference between the homologous
and heterologous titres. Such a difference has been used to
define serotypes of rhinoviruses (Kapikian et al.,1967).
The degree of neutralisation of the NCP virus
isolates by gnotobiotic lamb antisera raised against
BVDV-NADL (Serum ref. No. 705) and BDV-M (No.704) was
measured in constant-serum, varying-virus neutralisation
tests. The antisera were diluted so as to contain 40 and 4
SN units, one SN unit being the highest reciprocal dilution
of serum which neutralised 100 TCID5() of homologous virus.
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The serum neutralisation index results are expressed as the
geometric mean of four results for the 40 SN unit tests and
three results for the 4 SN unit tests.
Cross-immunofluorescence tests. In each test, fixed
infected and uninfected cells grown on coverslips were
exposed to dilutions of all five test sera. The results are
expressed as the geometric mean of four tests.
The serological tests were performed as described
in Chapter 2.
Western blotting. The guidance of Dr. A.J. Herring and the
expert assistance of Mr.N.Inglis are gratefully
acknowledged.
Confluent monolayers of FLB cells grown in Sani/Glass
(S/G) bottles were washed and infected with virus at a
m.o.i. of 1 or with 10 ml of uninfected tissue culture
fluid. After 2 hours' adsorption at 37°C, inocula were
removed and 50 ml of supplemented maintenance medium added.
Forty-eight hours later, the maintenance medium was
removed, and cells contained therein sedimented by
centrifugation at 2000 x g for 20 minutes at 4°C.
Supernatant fluid was discarded and the cells resuspended
in 2 ml of PBS. Cells attached to the glass were scraped
off with a rubber 'policeman' into 10 ml of PBS, and pooled
with those derived from the maintenance medium. Cells were
sedimented by centrifugation at 2000 x g for 15 minutes,
and the supernatant discarded. The cell pellet was raised
in 1 ml of reticulocyte standard buffer (RSB)(10mM NaCl, 10
mM Tris-HCl, 1 mM MgCl2: pH 7.5) and kept at 4°C for 10
minutes, after which HOpl of RSB containing 5 per cent
NP40 (w/w) was added. Cells were disrupted by gentle
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homogenisation in a Griffith's tube, after which the fluid
was centrifuged at 2000 x g for 20 minutes at 4°C. The
supernatant was collected, and if not prepared for
electrophoresis the same day was stored at -20°C until use.
Sample preparation, electrophoresis and
electroblotting on to nitrocellulose paper were carried out
as described by Herring and Sharp (1984). Standard
proteins used to measure the molecular weights of the viral
proteins were B-galactosidase (130K), phosphorylase A
(94K), ovotransferrin (77K), albumin (66K), ovalbumin
(45K), chymotrypsinogen A (26K), myoglobin (17K) and
cytochrome C (12K).
Strips of nitrocellulose membrane were reacted with
50% (v/v) horse serum in washing buffer (WB), for 1 hour at
37°C, to "blank-out" non-specific binding sites. The strips
were then incubated with 1 in 30 dilutions of test sera in
10% (v/v) horse serum in WB for a further hour at room
temperature, after which they were washed thoroughly.
Strips were then incubated for 1 hour at room
temperature in detection serum diluted in 10% horse serum
in WB. The detection antibody was an affinity column
purified rabbit anti-sheep Fab2lgG iodinated to a
specific activity of 3 x 10 cpm/pg and used at a
dilution of around 4 x 10^cpm/ml. After incubation the
strips were washed thoroughly, vacuum dried and mounted on
filter paper for autoradiography. This was performed using
exposure to Kodak X omat 1S' film with a Dupont 'lightening
plus' intensifying screen.
The molecular weights of proteins detected by
autoradiography were calculated, from their mobility in the
gel, by extrapolation from a standard curve obtained by
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plotting mobilities of the marker proteins against their
known molecular weights on a semi-logarithmic scale (Weber
and Osborn, 1969).
RESULTS.
Antigenic relationships among 5 CP pestivirus isolates in
two-way cross-neutralisation tests. Homologous titres
ranged from 2042 to 180 and were higher than, or
equivalent, to those obtained with any of the heterologous
strains (Table 8.1). The BDV-M reference strain was
antigenically distinguishable from the 4 BVD viruses. With
R values <5 against the other viruses, BDV-M fulfilled the
criterion necessary for it to be considered as a separate
serotype. Further evidence that the BDV-M virus is
serologically distinct from the BVD viruses infecting
Scottish cattle was revealed by the lower titre of the
serum pool to this virus compared to the BVD viruses.
Two of the Scottish isolates, BVDV-7446 and BVD-8085,
appeared to be closely related to each other, less so to
BVD-B816, although none of the differences could be
considered significant. Likewise, there was no significant
difference between the 3 Scottish field isolates and the
BVDV-NADL reference strain. There was, however, a distinct
one-sided relationship between BVDV-NADL and sera raised
against the other BVD virus isolates.
Neutralisation of NCP BVD and BP virus isolates by antisera
raised against the two cytopathic reference strains. All
the NCP viruses were neutralised to some extent by both
antisera (Table 8.2). The bovine viruses were the same in
that they were strongly neutralised by the antiserum
TABLE 8.1
COMPARISON OF 5 CYTOPATHIC PESTIVIRUSES IN TWO-WAY
CROSS-NEUTRALISATION TESTS




VIRUS BVDV- BVDV- BVDV- BVDV- BDV-M escent
NADL 7446 8085 B816 Pool
BVDV-NADL 2042 19 69 11 0 331
BVDV-7446 1717 393 605 139 9 938
BVDV-8085 786 181 607 34 4 468
BVDV-B816 197 59 64 180 0 859
BDV-M 18 2 6 2 788 49
B. R Values *
LAMB ANTISERA
RAISED AGAINST
VIRUS BVDV- BVDV— BVDV- BVDV- BDV-M
NADL 7446 8085 B816
BVDV-NADL 100
BVDV-7446 15 100
BVDV-8085 21 68 100
BVDV-B816 7.5 34 14 100
BDV-M 0 1 1 0 100
* R = v rl . r2 X 100
Where rl = Heterologous titre (Strain 2)
Homologous titre (Strain 1)
and r2 = Heterologous titre (Strain 1)
Homologous titre (Strain 2)
TABLE 8.2
NEUTRALISATION OF NON-CYTOPATHIC BVD AND BP
VIRUSES BY TWO DILUTIONS OF ANTISERA RAISED
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+ Log^g serum neutralisation index.
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against BVDV-NADL, less so by the BDV-M antiserum; the
differences between the neutralisation indices were of the
order of 200 to 500 using 40 SN units of antisera, but
10-fold less than this with the more dilute sera.
The results with the NCP ovine viruses were not so
clear-cut. Two of the isolates (BDV-G1305 and BDV-G2048)
were neutralised more effectively by the BDV-M antiserum,
while the third (BDV-B1056) appeared to be more closely
related to BVDV-NADL.
Antigenic relationships among 5 CP pestivirus isolates in
two-way cross-immunofluoresecence tests. No significant
differences between the viruses were detected in these
tests. There was never more than a 3-fold difference
between the highest dilution at which any serum detected
fluorescence in cells infected with its homologous virus
compared to the heterologous viruses. Two sera, those
raised against BVDV-NADL and BVDV-B816, were able to detect
fluorescence at higher dilutions than the other 3 sera.
(Table 8.3).
Antigenic relationships among 5 CP pestiviruses by Western
blotting. When sera were reacted against preparations of
uninfected cells several bands were detected. Long exposure
of the autoradiograph increased the number and intensity of
these bands (Figure 8.1). The majority of these bands were
also present when sera were reacted with infected cell
extracts, but two additional bands could also be detected.
The specificity of these bands was confirmed by reducing
exposure times and by the incubation, before use, of test
sera with strips of membrane to which uninfected cell
proteins were bound (Figures 8.2 to 8.5).
TABLE 8.3














BVDV-NADL 722* 90 139 331 83
BVDV-7 4 4 6 1214 139 197 278 70
BVDV-8085 607 90 180 468 139
BVDV-B816 724 107 128 512 152
BDV-M 215 59 90 152 215
* Results are expressed as the reciprocal of the
highest dilution of antiserum that produced clear
specific immunofluorescence in an IIFT.
FIGURE 8.1 Uninfected FLB cell extracts on
nitrocellulose membrane strips were reacted
with preinfection (Odd numbers) and
convalescent (Even numbers) test sera :-
1,2 Calf anti BVDV-NADL
3,4 Lamb anti BVDV-NADL
5,6 Lamb anti BDV-M
00r- Lamb anti BVDV-7446
9,10 Lamb anti BVDV-8085
11,12 Lamb anti BVDV-B816
Sixty-four hour exposure of the
autoradiograph revealed several bands in the
even numbered strips, many of which were also
visible faintly in the strips exposed to
preinfection sera. This is most noticeable in
strips 1 and 2.
FIGURE 8.2 Extracts from FLB cells infected with
BVDV-NADL on nitrocellulose membrane strips
were reacted with preinfection (Odd numbers)
and convalescent (Even numbers) test sera:-
1,2 Calf anti BVDV-NADL
3,4 Lamb anti BDV-M
5,6 Lamb anti BVDV-NADL
7,8 Lamb anti BVDV-7446
9,10 Lamb anti BVDV-8085
11,12 Lamb anti BVDV-B816
Twenyty-four hour exposure. The 78K virus
band is detected by all convalescent sera,
but the 35K protein is only visible in strips
exposed to anti BVDV sera, being particularly
strong with the homologous serum in strip 6.
 
FIGURE 8.3 Extracts from FLB cells infected with
BVDV-7446 on nitrocellulose membrane strips
were reacted with preinfection (Odd numbers)
and convalescent (Even numbers) test sera :-
1,2 Calf anti BVDV-NADL
3,4 Lamb anti BVDV-NADL
5,6 Lamb anti BDV-M
00 Lamb anti BVDV-7446
9,10 Lamb anti BVDV-8085
11,12 Lamb anti BVDV-B816
The 78K virus band is visible with all
convalescent lamb sera, but the 35K virus
protein is only detected by one of the anti
BVDV sera.
Figure 8.4 Extracts from FLB cells infected with
BVDV-8085 on nitrocellulose membrane strips
were reacted with preinfection (Odd numbers)
and convalescent (Even numbers) test sera:-
1,2 Calf anti BVDV-NADL
3,4 Lamb anti BVDV-NADL
5,6 Lamb anti BDV-M
7,8 Lamb anti BVDV-7446
9,10 Lamb anti BVDV-8085
11,12 Lamb anti BVDV-B816
The 78K virus band is visible with all the
convalescent sera, but the 35K protein is
only visible in strips 4 and 10
1 2 3 4 5 6 7 8 9 10 11 12
1 2 3 4 5 6 7 8 9 10 11 12
7 8 K
3 5 K
FIGURE 8.5 Extracts from FLB cells infected with
BVDV-B816 on nitrocellulose membrane strips
were reacted with preinfection (Odd numbers)
and convalescent (Even numbers) test sera :-
1,2 Calf anti BVDV-NADL
3,4 Lamb anti BVDV-NADL
5,6 Lamb anti BDV-M
-o 00 Lamb anti BVDV-74 4 6
9,10 Lamb anti BVDV-8085
11,12 Lamb anti BVDV-B816
The 78K virus band is clear with all
convalescent sera. The 35K virus protein is
visible most clearly in strip 12, the
homologous antiserum.
Figure 8.6 Extracts from FLB cells infected with BDV-M
on nitrocellulose membrane strips were
reacted with preinfection (Odd numbers) and
convalescent (Even numbers) test sera:-
1,2 Calf anti BVDV-NADL
3,4 Lamb anti BVDV-NADL
5,6 Lamb anti BDV-M
00r- Lamb anti BVDV-7446
9,10 Lamb anti BVDV-8085
11,12 Lamb anti BVDV-B816
The 78K virus band is visible with all but
one of the convalescent sera, but there is no
evidence of a 35K virus protein.
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Two viral proteins were detected in preparations of
the 4 plaque purified BVD viruses by gnotobiotic lamb
antisera against these viruses and by calf serum against
low passage BVDV-NADL. The same two proteins were detected
when low passage BVDV-NADL, which had not been plaque
purified, was examined with the same sera. The mean
molecular weights of the two proteins were 78,000 and
35,000 (Table 8.4).
Antiserum against BDV-M, however, always detected
only the higher molecular weight protein in BVD Virus
preparations. When BDV-M was used as antigen, the high
molecular weight protein was detected by all the sera, but
no low molecular weight protein was detected even by the
BDV-M antiserum (Figure 8.6)
DISCUSSION
Results of the cross-neutralisation tests between the
CP viruses revealed that BDV-M was antigenically
distinguishable from the four BVD viruses. This extends the
finding of Vantsis et al. (1976), that BDV-M and BVDV-NADL
were serologically distinct. In that report, sera from
sheep injected with BDV-M which had been purified by
differential centrifugation and terminal dilution showed
the least cross-reactivity with BVDV-NADL. Similarly the
results reported here demonstrated that sera raised against
plaque purified viruses were even more discriminatory than
those raised against unpurified viruses.
Little is known of the epidemiology of BVD and BD
viruses. The preliminary evidence obtained from these
studies showed that, despite originating from different
disease syndromes from animals in different locations, the
TABLE 8.4
MOLECULAR WEIGHTS OF PROTEINS OF 5 CYTOPATHIC



























* Low passage virus, not plaque purified. All the
other viruses were plaque purified stocks.
ND, Not detected
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6 BVD viruses appeared to be closely related antigenically.
Two of the NCP ovine viruses were neutralised better by the
antiserum against BDV-M than that raised against BVDV-NADL,
suggesting that sheep pestiviruses may have evolved
separately from those in cattle. The third NCP ovine
virus, however, was more closely related to BVDV-NADL.
This isolate (BDV-B1056) was chosen deliberately as it had
originated from an outbreak of border disease in which the
ewes had had higher SN titres to BVDV-NADL than to BDV-M
(Vantsis et al.,1980 ). This virus may have originated
from cattle or the range of antigenicity among BD viruses
may be wider than that among BVD viruses.
The cross-immunofluorescence tests showed that all
the viruses shared a common antigen that was detected by
this method, and that this antigen was different from the
one determining the degree of cross-neutralisation between
the isolates. A possible explanation of this finding was
provided by the Western blotting studies which were
undertaken to examine the protein composition of the 5
cytopathic pestiviruses.
The difficulty of obtaining good yields of virus free
of contaminating host cell proteins is reflected in the
current confusion over the protein composition of
pestiviruses. There are five reports, in all of which
cytopathic viruses, usually BVDV-NADL, were studied. The
first report described 4 virus-specific proteins, two of
which migrated heterogenously, having molecular weights of
110,000 - 93,000: 110K - 93K, 70K, 59K -50K and 25K
(Pritchett and Zee,1975). A few years later, Matthaeus
(1979) described 3 viral polypeptides with molecular
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weights of 57K, 44K and 34K, the two larger proteins being
glycosylated. Coria et al„ (1983) using the Singer
strain, detected 4 proteins with molecular weights of 75K,
66K, 54K and 26K, of which the 75K and 54K proteins were
glycosylated. Close agreement existed between the other
two groups of workers who both described 5 proteins of
molecular weights 115K, 80K, 54K (55K), 45K and 35K (38K)
(Akkina, 1983; Purchio et al., 1984). The 115K and 80K
proteins were shown to be related and the 54K (55K) and 45K
proteins were shown to be glycosylated.
Considering the similar findings in the last 2
reports and their agreement with the work of Matthaeus
(1979), it would seem likely that there are 3 viral
structural proteins of molecular weights 57K to 54K (VP1),
45K or 44K (VP2) and 38K to 34K (VP3)., with the larger two
being glycosylated. There is also good evidence for a
larger viral protein 70K to 80K, but whether this is
structural is not yet clear.
The Western blotting procedure descibed in this
Chapter clearly failed to detect the 2 glycosylated
structural proteins, VP1 and VP2, Although they may have
been obscured by the presence of host cell protein, it is
more likely that they were not recognised by the 'early'
immune serum employed, possibly because of viral protein
denaturation during sample preparation. The 77K to 81K
viral protein detected in all our virus preparations almost
certainly corresponds to the larger BVD viral protein
described by other workers, and probably represents the
soluble antigen common to all members of the pestivirus
group (Matthaeus, 1980). This could also help to explain
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why antiserum against BVDV-7446 produced only a weak
reaction with this protein. It has been shown that the
quantity of soluble antigen produced may vary considerably
between BVD virus isolates (McClurkin and Coria, 1978).
In the experiments reported in this Chapter, the
small 35K protein, which was detected only in BVD virus
preparations by antisera against BVD viruses, represented
VP3. This protein has previously been suspected as being
type-specific, since VP3 from BVD virus was not
precipitated by HCV antibodies (Matthaeus,1981). A similar
situation would, therefore, appear to exist between the BVD
and BD viruses employed in our experiments, although this
will not be proved until the 35K protein has been detected
in BDV-M preparations by homologous antisera. Further
credibility has been given to the importance of the low
molecular weight protein by a recent report that a 37K
polypeptide is the major surface protein of BVD virus (Zee
and Chu,1984).
In conclusion, the tests described in this Chapter
did not detect major antigenic differences between the 7
BVD viruses examined. The cytopathic reference strain of
BD virus, however, was antigenically distinct from the
bovine viruses in the cross-neutralisation tests, and this
distinction could be the result of structural differences
in the 35K viral protein.
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CHAPTER 9
GENERAL DISCUSSION AND CONCLUSIONS
Aspects of the pathogenic and antigenic relationships
between BVD and BD viruses have been studied.
At the outset of this work it was well established
that both viruses shared the ability to cause congenital
infections following the infection of susceptible pregnant
cattle and sheep. In a comprehensive review of congenital
infections caused by pestiviruses and other non-arthropod
borne togaviruses, Van Oirschot (1983) emphasised the
ability of the pestiviruses to establish lifelong
persistent infections in cattle, sheep and pigs which had
survived an early intrauterine infection. These animals
shed virus continuously and were likened by Van Oirschot to
"the 'Trojan Horse' that surreptitiously introduces an army
of pestiviruses into animal populations".
The existence of such animals has serious
implications for strategies to control pestivirus-induced
diseases.
Among cattle the occurrence of persistently infected
animals has often been demonstrated, with or without signs
of unthriftiness (Malmquist,1968; Coria and McClurkin,
1978b; Done et al.,1980; Straver et al., 1983). What the
prevalence is of such animals is difficult to ascertain. A
survey of apparently healthy slaughterhouse cattle in
Denmark detected 12 viraemic animals in 1332 animals
tested, but in herds with recent outbreaks of BVDV-related
disease 38 of 363 apparently healthy cattle were viraemic
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(Meyling,1984). In this present work, indirect evidence of
the prevalence of persistently infected cattle in Scotland
was gained from the results of testing secondary BEK cells
derived from abattoir foetuses for the presence of BVD
virus. The contamination rate of 13.3% indicated a high
incidence of intrauterine exposure of calves to the virus,
a proportion of which would have been born persistently
infected (Chapter 3).
Among sheep, persistently infected lambs frequently
have signs of clinical BD but this is not true of animals
infected with some virus strains (Westbury et al.,1979;
Terpstra, 1981). There is little evidence on which to base
an estimate of the number of persistently infected sheep in
any population. A serological survey has shown the
prevalence of antibodies to pestiviruses among sheep in
England and Wales to vary from region to region (Harkness
et al.,1978). In Scotland only 4% of sheep have antibodies
to BDV-M (Vantsis et al.,1979). In spite of this apparent
low prevalence of infection, it is of interest that the
results in Chapter 3 show that no fewer than 1.9% of the
FLK cells prepared from local abattoir foetuses were
contaminated with a non-cytopathic pestivirus. Thus the
risk of transmission of infection to susceptible animals is
present in many flocks.
Of the 3 types of viral persistence identified by
Mims (1982), pestiviruses clearly fit into the type
offering "the ultimate insult to the host immune defences
by replicating and being continuously shed to the outside
world". Pestiviruses can thus provoke and maintain a state
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of persistence which has far-reaching consequences for the
infected individual, and for the population as a whole.
Although the mechanisms responsible for inducing and
maintaining persistent pestivirus infections are not fully
understood, they represent a fascinating biological
phenomenon. It is reasonable to suggest that some degree of
immune tolerance by the host must exist and, in order to
test the specificity of this tolerance, the experiments
described in Chapter 4 were undertaken. These showed not
only that lambs persistently infected with BDV-M were very
susceptible to superinfection with a tissue culture stock
of the same virus but that seven of eight RHS lambs
suffered severe disease which, in some repects, resembled
natural cases of bovine MD. Two important findings were
that animals dying from the infection failed to mount an
effective humoral immune response to the virus, and that
cytopathic BDV-M was readily recoverable from their
tissues. The mechanisms involved were obscure but a
justifiable practical conclusion was that the mucosal
disease-like syndrome could be precipitated only in
persistently infected lambs since the same virus given to
normal lambs produced no clinical disease (Chapter 4;
Barlow et al., 1983; Gardiner et al., 1983).
Similar findings have recently been reported in
cattle (Roeder and Drew, 1984; Brownlie et al.,1984;
Nagele,1984; Bolin et al.,1985b). Thus the prediction of
Malmquist (1968), that many cases of MD could result from
immunological tolerance has been substantiated, and the
early proposal of Liess et al. (1974), that MD is not an
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acute viral infection, has also been largely vindicated.
Moreover, the enigma of why only a small number of cattle
in a group ever succumb to MD and why the disease can
rarely be reproduced is also partially explained.
Now that it is clear that persistent pestiviraemia in
cattle and sheep arising from early intrauterine exposure
is an essential prerequisite for the development of MD, or
the equivalent disease in sheep, further attention ought to
be focused on the factors that can trigger clinical
illness.
The available evidence is limited, but under
experimental conditions at least, the disease can be
precipitated by superinfection with some other
pestiviruses. This was seen clearly in the experiments
reported in Chapters 4 and 6. No other comparable studies
with sheep have yet been documented, although Terpstra
(1985) failed to induce disease in persistently infected
sheep superinfected with homologous or heterologous Dutch
isolates of BDV. The results reported in Chapters 4 and 6
also indicate that the outcome of experimental
superinfections depends on the nature of the inoculum and
the status of the persistently infected sheep. Because
high passage virus and experimentally produced RHS were
used in the first experiments (Chapter 4) while low passage
virus and recovered field cases were used in the second
experiment (Chapter 6) no direct comparisons are valid.
The results of the experiments reported in Chapter 4
showed that sheep, persistently infected with virus
contained in the IIB brain pool, developed disease when
149
superinfected with a high tissue culture pass of BDV-M
derived from that pool, but not when superinfected with a
high tissue culture pass of BVDV-NADL. This result could
have been due to differences in the pathogenicity of the
two viruses, although it is considered more likely that the
antigenic disparity accounted for the differing responses.
One conclusion could, therefore, be that, in order to
precipitate disease, the superinfecting virus must be
antigenically closely related to the virus causing the
persistent infection.
Antigenic diversity between the persisting and
superinfecting virus may have contributed to the different
responses of the two groups of field cases of RHS lambs
reported in Chapter 6. What became clear from that
experiment, however, was that the outcome of
superinfection experiments could differ between groups of
animals,and even amongst animals from the same outbreak.
Also, it became clear that persistently infected animals
injected with live pestivirus could seroconvert to that
virus but remain a source of infection.
One further point arising from the sheep experiments
that merits discussion relates to the development of a
spontaneous mucosal disease-like syndrome in the
persistently infected twins, 1261 and 1262 (Chapter 5
section 4). The clinical symptoms, and pathological and
virological results were wholly comparable to those seen in
the superinfected sheep in Chapter 4, and yet there had
been no opportunity for superinfection to occur. The
disease appeared in the twins as the levels of
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maternally-derived antibody became undetectable, but other
persistently infected lambs in the same pen were not
affected. The major difference between the lambs showing
clinical signs of disease and their pen-mates was that they
had been sired by a different tup. Because host genetic
factors have an important influence on other aspects of BD
virus infections (Barlow et al.,1979) it is not
unreasonable to suppose that they also play a part in the
fate of persistently infected lambs.
The deliberate reproduction of MD in experimental
cattle has been reported recently. During field
investigations of cases of MD, Brownlie et al. (1984)
isolated NCP BVD virus from the blood of apparently healthy
persistently infected cattle, and a mixture of NCP and CP
viruses from animals dying of MD. Cytopathic virus was
found at high levels in gut tissue and could be separated
from the NCP virus by plaque purification. Also when two
persistently infected cattle were infected intranasally
with the CP virus they both died of acute MD within 2 to 3
weeks, whereas normal cattle receiving the same inoculum,
remained healthy. These findings led the authors to
propose that "clinical mucosal disease in cattle requires a
persistent infection with NCP BVDV and a subsequent
infection with CP virus". This hypothesis is helpful, and
is consistent with their findings, but is unlikely to
embrace every situation in which BVDV infection results in
MD.
In another recent report, Bolin et al.(1985b)
described the production of severe MD in persistently
infected cattle, following the intravenous injection of CP
virus.
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These findings in cattle imply that the distinction
between NCP and CP pestiviruses is critical. Regrettably,
the CP characteristic is insufficiently defined and is not
necessarily an intrinsic viral property. While some strains
maintain their cytopathogenicity in a wide range of host
tissues, the cytopathogenicity of others changes during
passage in the same or in different host systems (Fernelius
et al., 1969a). This feature of pestivirus behaviour was
demonstrated clearly by the results in Chapter 3 which
showed that BDV-M was highly cytopathic for ovine cells but
markedly less so for bovine cells. Nevertheless, high
titres of BDV-M were produced by BE testis cells, although
it could be detected only by its CPE in sensitive FLK
cells. On the other hand, both BDV-M and BVDV-NADL failed
to induce CPE in porcine cells, although infectious virus
was produced.
A further implication of the recent work in cattle is
that every laboratory isolate of cytopathic BVDV has to be
a heterogeneous mixture of NCP and CP virus, a supposition
recently endorsed by the demonstration of both types of
virus in 28 of 38 bovine spleens from diseased animals
(McCLurkin et al.,1985). Passage of these two populations
in tissue culture can only lead to variable proportions of
each virus at every pass level since NCP virus interferes
with CP virus (Gillespie et al.,1962) and CP virus grows
faster than NCP virus (Nuttall,1980 ) .
The idea of at least two classes of virus within any
given pestivirus population would help to explain the
capricious growth of some CP isolates and the reports of
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NCP viruses causing a CPE under certain conditions
(Straver,1971; Laude and Gelfi,1979). In one such account
the fact that BVDV and BDV isolates, which were NCP in
conventional fluid overlay cultures, produced plaques at
high dilutions when titrated under agar overlay, strongly
suggested that an interference phenomenon was involved
(Evermann et al.,1981).
Failure to titrate CP and NCP viruses within our
experimentally infected sheep detracts from the findings
reported in this thesis, but nevertheless a summary of the
results allows some conclusions to be reached. From the
tissues of lambs dying after superinfection with 28th
passage BDV-M, virtually all isolates were cytopathic. The
infection of ewes at 52 days gestation with low passage
BDV-M resulted in the recovery of both CP and NCP viruses
from foetuses, but only NCP virus was recovered from the
precolostral blood of live lambs. Two of these lambs
suffered from an MD-like disease nine weeks later and when
they were killed in extremis CP virus was isolated from
virtually all their tissues. From normal lambs injected
with low pass virus, transient viraemias were detected but
only NCP virus was recovered. The same virus given to RHS
lambs produced transient viraemias of CP virus against the
background of consistently recoverable NCP virus. CP virus
was recovered from many tissues of the animals in one of
the groups of RHS lambs, but not from any of the other
group. When BDV-M and the 4 BVD viruses were plaque
purified and used to infect gnotobiotic lambs and pregnant
ewes, there was an almosl total failure to recover virus
from blood or placental and foetal tissues.
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If the existence of both CP and NCP virus wihin any
given pestivirus population is accepted, the results
summarised above could be explained as follows. The 28th
passage virus contained a high proportion of CP virus
following prolonged cultivation in vitro making it a potent
inducer of the MD-like syndrome in persistently infected
lambs. The low passage BD virus contained only a slightly
higher proportion of CP to NCP virus. The combination was
highly pathogenic for foetuses, which were infected
predominantly with NCP virus. In normal lambs replication
of the CP virus was restricted so that only NCP virus was
detectable in the blood. In the RHS lambs CP virus caused
a transient viraemia in both groups, one of which
eliminated the virus before it became established at tissue
sites. When the CP virus was plaque purified it appeared to
be defective in vivo. Limited replication must have
occurred since SN antibody was produced and minor
pathological lesions were present in the placenta of some
ewes. Virus levels, however, remained below detectable
limits, apart from two isolations.
The idea that the CP component of a pestivirus
population could be defective in vivo is not new. The
possibility was discussed when normal lambs were born to
ewes infected with purifed BDV-M during early gestation
(Vantsis et al,1976). These authors likened their findings
to the defectiveness of Rous sarcoma virus, and the analogy
is worth pursuing. In that system, Rous associated virus
(RAV) is an avian leukosis virus isolated from stocks of
Rous sarcoma virus (RSV). The two viruses are
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indistinguishable in size and structure; they have the same
sensitivity to thermal inactivation, and have the same
buoyant density in rubidium chloride. They are
indistinguishable in neutralisation tests and have parallel
growth curves (Hanafusa et al., 1964). The viruses do,
however, differ markedly in biological effect, since only
RSV but not RAV produces foci of transformed cells in
tissue culture and sarcomas in chickens. It has been
concluded that RSV is a defective virus, and cannot produce
infectious progeny in the absence of RAV or of some other
avian leukosis virus (Hanafusa et al., 1963). Although not
entirely identical the situation with pestiviruses could be
parallel with the CP component being defective. This would
mean that the CP virus could not be grown in the absence of
NCP virus, although procedures aimed at purifying CP virus
could be expected to change the proportions of the two
populations.
One other possible explanation for the distinction
between CP and NCP pestiviruses is that CPE can be produced
in cells infected with NCP virus in the presence of a
satellite agent, either virus or nucleic acid. The case
for this possibility has been argued cogently (Littlejohns
and Walker,1985), but fails to be as attractive as the case
for defective and helper viruses within a pestivirus
population.
Clearly the reason for the existence of NCP and CP
pestiviruses, and their distribution within any virus stock
is of vital importance to an understanding of the
pathogenesis of MD and the equivalent disease in sheep, and
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this is an important area for future work. Inconsistency
among reports on the structure of pestiviruses implies that
they are difficult viruses to study, but more information
at the molecular level is urgently required to help to
distinguish isolates with different biological properties.
Western blotting procedures, as reported here, still need
further development, although they may have helped to
identify two important immunogenic determinants.
Radioimmunoprecipitation tests with both conventional and
monoclonal antibodies will provide more information as the
reagents are developed.
As well as differences in the pathogenicity of virus
preparations from separate sources antigenic relationships
between isolates are also important. The work reported in
this thesis has consistently shown that BVD viruses,
particularly BVDV-NADL, are antigenically distinguishable
from BDV-M in neutralisation tests using early immune sera.
This, together with the results of the protection test in
ewes, has re-emphasised the likely need to include more
than one antigenic type in any pestivirus vaccine
especially if this is to be considered for use in both
cattle and sheep.
The need for such a vaccine is now well recognised
(Nagele,1984;Roeder,1984; Barber et al.,1985). The aims of
this thesis were to explore pathogenic and antigenic
relationships between pestiviruses to provide information
to assist with the formulation of disease control
strategies. Work described here plus that reported recently
elsewhere has shown that persistently infected animals hold
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the key to the spread of virus within animal populations.
Such animals may succumb to the effects of the virus with
which they are persistently infected and may die following
superinfection with some other pestiviruses, but as long as
they survive they continue to be a source of infection.
The major thrust of any control programme must, therefore,
be the recognition of such animals and their separation
from pregnant stock. An effective inactivated vaccine must
be sought for use on animals before they reach breeding
age.
Finally, the mechanisms involved in the maintenance
of persistent pestivirus infections are an area of obvious
fascination. Work reported in this thesis has demonstrated
the similarites between pestivirus infections of cattle and
sheep. Detailed virological and immunological assesssent of
such animals should contribute further to an understanding
of persistent viral infections.
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THE PATHOLOGY OF A SPONTANEOUS AND
EXPERIMENTAL MUCOSAL DISEASE-LIKE SYNDROME
IN SHEEP RECOVERED FROM CLINICAL
BORDER DISEASE
By
R. M. Barlow, A. C. Gardiner and P. F. Nettleton
Moredun Research Institute, 408 Gilmerton Road, Edinburgh EH17 7JH, Scotland
introduction
Border disease (BD) of lambs is caused by prenatal infection with a placenta-
crossing pestivirus closely related to bovine virus diarrhoea-mucosal disease
virus (BVD-MD). Three distinct forms of neuropathological change have been
described, together with the conditions under which they may occur. These are,
congenital hypomyelinogenesis (Markson, Terlecki, Shand, Sellers and Woods,
1959; Barlow and Gardiner, 1969), nodular periarteritis (Zakarian, Barlow
and Rennie, 1975; Gardiner, Zakarian and Barlow, 1980) and necrosis and in¬
flammation of the germinal layers of the CNS resulting in gross malformations
such as hydranencephaly and cerebellar dysplasia (Clarke and Osburn, 1978;
Barlow, 1980). These forms of neuropathology may be associated with ab¬
normalities of conformation (Terlecki, Hebert and Done, 1973).
Border disease-affected lambs,* commonly described as "hairy-shakers", per¬
sistently excrete virus but only rarely produce specific serum neutralizing
antibody. The clinical signs resolve with time, but infected lambs are difficult
to rear and the effect of weaning is drastic; many which survive to this event die
when separated from their mothers. The cause of death is uncertain (Hughes,
Kershaw and Shaw, 1959) but pneumonia and gastrointestinal parasitism have
been implicated.
In the present report attention is drawn to characteristic pathological
changes in the CNS and viscera of sheep apparently recovered from naturally-
occurring and from experimental BD. Several developed intractable diarrhoea
or respiratory distress with nasal discharge and died or were killed in extremis.
The clinical signs and pathological changes observed were similar to those seen
in calves with mucosal disease. The syndrome has been reproduced experi¬
mentally and has led to an hypothesis by means of which the pathogenic
mechanisms involved can be partially explained (Gardiner, Nettleton and
Barlow, 1983).
MATERIALS AND METHODS
As summarized in Table 1, 26 animals of various breeds and crosses were involved.
Although the groupings are not the same as in the accompanying paper (Gardiner et
al., 1983) the individual animal numbers correspond. Group I consisted of 5 animals,
3 of which were recovered "hairy shakers" (RHS) from experimentally produced BD
0021-9975/83/030451 + 11 $03.00/0 © 1983 Academic Press Inc. (London) Limited
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and 2 were from a field outbreak of the disease though they were not known to have
themselves shown overt clinical signs. All 5, however, were fatally affected by a
spontaneous clinical syndrome characterized by depression, persistent diarrhoea and/
or nasal discharge. Groups II to IV were made up of experimentally produced RHS
sheep and in each group there was a similar range of age and breed type. Group II
was injected with the cytopathic virus grown from the Moredun IIB pool (Vantsis,
Barlow, Fraser, Rennie and Mould, 1976), constituting a homologous challenge
(since all the laboratory produced RHS sheep were the result of maternal inoculation
of IIB pool). Group III was injected with the NADL strain of bovine virus diarrhoea
(BVD) virus, constituting a heterologous challenge, whilst Group IV was left un-
inoculated. Group V consisted of the progeny of BD immune ewes which had been
challenged on the 54th day of pregnancy with IIB pool. The lambs were born and
raised in pen-contact with the RHS sheep but had never shown any clinical illness.
Group VI were 2 normal sheep initially free of BD neutralizing antibody and were
used to test the immunogenicity of the BD virus inoculum.
Preparation of Inocula, Dose and Route of Administration
Clarified BD virus suspensions containing 105 to 10s TCID60 per ml were prepared
from the 28th passage virus as previously described (Vantsis, Rennie, Gardiner,
Wells, Barlow and Martin, 1980). BVD virus (NADL strain) of unknown passage
number was grown in secondary bovine embryonic kidney cells by a similar
method to the above and a clarified virus suspension containing 103,5 TCID50 per ml
was used. The suspensions were injected in 2 ml amounts subcutaneously over the
shoulder.
Pathology
Animals either died or were killed by exsanguination under deep sodium
pentobarbitone anaesthesia. At necropsy, the entire CNS and representative
samples of other organs and tissues were fixed by immersion in Baker's calcium
formol; blocks were taken, processed to paraffin, sectioned and examined by
light microscopy. Stains used included HE, Luxol Fast Blue, Alcian Blue-PAS,
methyl green-pyronin and Feulgen.
RESULTS
Eight of the sheep (Table 1) developed a persistent debilitating diarrhoea, all
of Group I spontaneously and 3 of Group II (nos 6, 7 and 9) 2 to 3 weeks after
injection of homologous virus. The diarrhoea was watery and foetid, but exam¬
ination of faeces revealed neither gastro-intestinal parasites nor pathogenic
bacteria. Another 4 Group II sheep (nos 8, 10, 11 and 13) became severely
depressed and one of them (no. 8) developed respiratory distress and a nasal
discharge; sheep no. 13, however, subsequently recovered. The remaining
Group II sheep (no. 12) and all of Groups III to VI showed no clinical malaise.
All sheep, except no. 13, died or were killed within 1 month of injection for
pathological examination and virus isolation. Necropsy of sheep 13 was delayed
for 10 months during which time it remained clinically normal.
At necropsy, animals in Groups V and VI were in good condition and no
macroscopic abnormalities were found. In contrast, RHS sheep showed varying
degrees of ill-thrift and several had enlarged spleens and lymph nodes. All the
diarrhoeic sheep had lesions involving caecum and colon and extending in one
TABLE1





















































































































































































































































































































































454 r. m. barlow et al.
or two cases for up to 10 cm into the terminal ileum. These lesions varied in
intensity from slight thickening of the bowel wall to gross swelling of the muscle
coats, subserous and submucous oedema, diffuse and polypoid hyperplasia of the
mucous membrane, mucosal hyperaemia, ulceration and haemorrhage. Sheep nos
2, 10 and 11 had grey hepatization in the apical and cardiac lobes of the lungs.
The distribution of microscopic lesions is given in Table 1, except for sheep
nos 4 and 5 which were field cases from a BD outbreak from which only brain
tissue was submitted. The lesions in those RHS sheep with clinical disease
were not only more widespread (Table 1) but also more severe than those in any
of the other groups.
In all the affected organs (Table 1) the lesions were essentially lymphoid and
proliferative. In the CNS, lymphoid infiltrations containing a variable propor¬
tion of plasma cells and macrophages were prominent in the choroid plexuses
(Fig. 1). The choroidal epithelial cells were often rounded and vacuolated and
some had sloughed to form cellular aggregates with lymphocytes elsewhere
within the ventricular system. The periventricular brain substance showed
focal and diffuse glial proliferations and perivenous lymphoid cuffings (Fig. 2).
The intestinal lesions were most marked in diarrhoeic sheep. The epithelium
was hypertrophied and grossly elongated glands not infrequently breached the
muscularis mucosae (Fig. 3). In sheep nos 1, 2 and 3 the epithelium of some of
these ectopic glands appeared metaplastic and degenerate glandular elements
were observed in submucous lymphatics (Fig. 4). The lamina propria was
diffusely infiltrated with lymphoid cells and some eosinophils, causing disten¬
tion of villi. Some glands were plugged with cellular detritus (Fig. 5). Focal
mucosal sloughing with haemorrhage and ulceration was also encountered.
The submucosa and subserosa were usually oedematous and infiltrated with
lymphocytes. Muscle coats were often hypertrophied and oedematous and
Meissner's plexus was unusually prominent.
Slight mucosal hypertrophy and focal submucosal and subserosal lymphoid
infiltrations were present in 3 sheep (Nos 14 and 15 from Group III and No.
19 from Group IV) in which diarrhoea had not been observed.
Lesions of the liver were less common and consisted of prominent lymphoid
infiltrations of the portal tracts.
The kidney lesions consisted of dense focal accumulations of lymphoid cells
in the subcapsular cortex, around the vessels of the cortico-medullary junction
and in the subepithelial connective tissue of the calyces (Figs 6 and 7). In the
heart the lesions consisted of small foci of non-suppurative myocarditis with
lymphocyte infiltration and degeneration of muscle fibres (Fig. 8).
Thyroid lesions were infrequent but severe. They consisted of heavy in¬
filtrations of lymphoid cells associated with degeneration and obliteration of
acini (Fig. 9).
In the lung the most frequently observed changes were peribronchial lym¬
phoid infiltrations and hyperplasia of smooth muscle and bronchial and bron-
chiolar epithelium (Fig. 10). In sheep nos 2, 10 and 11 there were, in addition,
areas of pneumonic consolidation due to macrophage infiltration or collapse of
alveoli. The presence of pneumonia did not correlate with clinically evident
respiratory distress, viz. sheep no. 8.
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Fig. 1. Choroid plexus of 4th ventricle showing heavy infiltration by lymphoid cells. There is peri¬
vascular cuffing and diffuse proliferation of glial cells in the adjacent medulla. HEX 19.
Fig. 2. Periventricular encephalitis with perivenous lymphoid cuffs and diffuse glial proliferation.
HE X 75.
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Fig. 6. Kidney showing dense focal lymphoid infiltrations in the cortex. A small artery is evident at the
centre of some of the lymphoid foci. HE x 19. Inset, X 180.
Fig. 7. Kidney showing massive periarterial infiltrations of lymphocytes in the connective tissue of the
calyces. HE x 19.
Fig. 3. Caecum showing hypertrophy of the mucosa with penetration of the muscularis mucosa by
glandular elements and severe submucous oedema. Alcian Blue-PAS X 19.
Fig. 4. Hyperplastic typhlo-colitis. The mucosa and the oedematous submucosa are infiltrated by
lymphoid cells. Degenerate glandular elements are present in a submucous lymphatic which has
a lymphoid cuff (lower right centre). HE X 75.
Fig. 5. Typhlo-colitis. The mucosa is hyperplastic with a diphtheritic membrane. Many mucosal glands
are plugged with epithelial cell detritus and inflammatory cells. HE x 75.
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The white pulp of the spleen and lymph nodes was hyperplastic in animals
with clinical disease but focal necrosis of lymphoid nodules was not observed.
The virological and serological results are presented in Gardiner et ill. (1983).
Suffice it to say here that virus was detected terminally in all RHS animals from
which isolation was attempted but only sheep no. 13 developed a significant
titre of BD neutralizing antibody. In contrast, control sheep (Groups V and VI)
with one exception (no. 22) had terminal neutralizing antibody titres^ 1 in 160.
DISCUSSION
As can be seen from Table 1, RHS sheep in this study had lymphoid proli¬
ferations in several organs. These proliferations were most severe and widespread
in those sheep which developed enteric or respiratory disease either spon¬
taneously or following injection of homologous virus. Minor lesions of the same
type were irregularly encountered in uninoculated RHS sheep, those receiving
heterologous (BVD) virus and one of 2 normal susceptible adult sheep killed 4
weeks after injection with the cytopathic Moredun strain BD virus. Such
lesions were not found in any of 5 normal sheep from immune mothers which
had been born and raised in pen contact with the "hairy-shaker" animals.
These findings strongly suggest that the lymphoid proliferations were BD-virus
related, though the possibility that the RHS sheep were in some way uniquely
susceptible to some other unknown infection cannot be completely excluded.
The original purpose of the injections was to determine whether apparently
tolerant animals might be induced to mount an immune response and the
lympho-proliferations which occurred could be interpreted in this way. How¬
ever, only one RHS sheep (no. 13) clearly seroconverted, though both normal
control animals did so when given the same inoculum.
Disseminated lymphoid infiltrations of the type seen here occur in some
neoplastic disorders and in conditions such as malignant catarrhal fever (MCF).
The heavy lymphoid infiltrations observed in kidneys and thyroids of some
animals were similar to those found in MCF, though the focal necrosis of lymph
nodes and the fibrinoid necrosis of the media of arteries, which are features of
the latter, appeared to be absent.
Non-suppurative periventricular encephalitis in sheep with heavy lymphoid
infiltrations of the choroid plexuses is a characteristic feature of infection with
maedi/visna virus (Palsson, 1976) and it seemed prudent to have the sera from
these animals tested for antibody by the agar gel immunodiffusion test. None
was positive. CNS lesions of this type have been encountered in neuropatho-
logical diagnostic material (unpublished observations) and their presence here
in sheep from a farm experiencing BD, as well as in laboratory-produced RHS
sheep, suggests that periventricular encephalitis may be an indication of
previously undiagnosed BD infection.
Fig. 8. Heart muscle with a focus of non-suppurative myocarditis; lymphoid infiltration and necrosis
of muscle fibres. HE X75.
Fig. 9. Thyroid with interstitial lymphoid infiltration and degeneration and obliteration of acini.
HE X 75.
Fig. 10. Lung showing mild interstitial pneumonia and prominent peribronchial and perivascular
lymphoid infiltrations. HE X 75.
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The pulmonary changes observed—peribronchial lymphoid infiltrations, and
hyperplasia of bronchial epithelium and smooth muscle—are also features of
maedi/visna and ofovine atypical or proliferative exudative pneumonia (Stamp
and Nisbet, 1963; Gilmour, Jones and Rae, 1979). The latter is a common dis¬
order of sheep in these age groups and the possibility that the pulmonary
changes represent intercurrent infection cannot be excluded.
The enteric lesions are more specific. Though the hyperplastic epithelium
and the glandular penetration of the submucosa with extension into lymphatics
are tumour-like properties, reminiscent of the porcine adenomatosis complex
(Rowland, Lawson and Maxwell, 1973), this typhlo-colitis can be distinguished
histologically from most other forms of ovine enteritis. The ulcerative, haemor-
rhagic changes in a hyperplastic, heavily infiltrated mucosa with crypt ab¬
scesses closely resemble the changes seen in calves with mucosal disease. Whilst
the possibility exists that the lesions seen here are due to some unsuspected
intercurrent infection, it seems probable that the lympho-proliferative disorder
described represents a further, newly recognized component of the pathology
of BD infection. As such it links the disease even more closely to BVD.
In conclusion, we suggest that the lympho-proliferative disease in these RHS
sheep was triggered by a disturbance in the virus-host relationship in apparently
tolerant, persistently infected animals. Though the mechanisms are unclear it is
possible that the lesion represented a florid, immune-type cellular response
which was usually ineffective, though one sheep did seroconvert and recover.
SUMMARY
The pathological changes which accompanied a severe clinical syndrome
characterized by intractable diarrhoea and/or respiratory distress in sheep
recovered from clinical Border disease consisted of inflammatory lympho-
proliferative lesions in several organs, notably the CNS and intestinal tract. The
syndrome has been reproduced experimentally by "super-infection" with
homologous Border disease virus. The differential diagnosis is discussed and
attention drawn to the similarity between the enteric lesions and those of
bovine mucosal disease.
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VIROLOGY AND IMMUNOLOGY OF A SPONTANEOUS
AND EXPERIMENTAL MUCOSAL DISEASE-LIKE
SYNDROME IN SHEEP RECOVERED FROM CLINICAL
BORDER DISEASE
By
A. C. Gardiner, P. F. Nettleton and R. M. Barlow
Moredun Research Institute, 408 Gilmerton Road, Edinburgh EH17 7JH, Scotland
introduction
A new virus-related phenomenon has been described in young sheep clinically
recovered from Border disease (BD) (Barlow, Gardiner and Nettleton, 1983).
In this paper the virological and serological findings are presented and their
significance discussed in relation to mucosal disease (MD) of cattle, a fatal
form of bovine virus diarrhoea (BVD) virus infection.
Border disease-affected lambs ("hairy shakers") result from transplacental
infection occurring during, approximately, the first half of gestation. They re¬
main persistent excretors of virus for several years but rarely develop neutraliz¬
ing antibodies (Plant, Gard and Acland, 1977; Vantsis, Linklater, Rennie and
Barlow, 1979). Such animals may be immuno-tolerant to the virus.
To test the stability and specificity of this putative immune tolerance,
groups of recovered hairy shaker (RHS) sheep were challenged with live
homologous (BD) or heterologous (NADL strain BVD) virus. The results of
homologous challenge were dramatic and paralleled spontaneous but pre¬
viously unexplained disease observed in RHS sheep.
materials and methods
Animals
As summarized in Table 1, 17 RHS and 4 susceptible normal sheep were examined.
Although the groupings are not the same as in the previous paper (Barlow et al.,
1983) individual animal numbers correspond. All the RHS had been produced by
inoculating their dams at 54 days gestation with IIB BD brain pool (Barlow, 1972).
Group 1 comprised 3 RHS sheep in which a clinical syndrome characterized by
depression, with persistent diarrhoea or nasal discharge, had occurred spontaneously
(Barlow et al., 1983). Groups 2 and 3 were inoculated respectively with (a) the
cytopathic Moredun strain BD tissue culture virus grown from the IIB pool (Vantsis,
Barlow, Fraser, Rennie and Mould, 1976) and (b) the NADL strain of BVD virus,
which is also cytopathic, representing homologous and heterologous challenges, re¬
spectively. Group IV consisted of untreated RHS sheep while Groups V and VI
were normal sheep initially free of BD and BVD neutralizing antibodies used to test
the immunogenicity of the 2 virus inocula.
Preparation of Inocula, Dose and Route of Administration
BD virus for animal inoculation was grown on primary foetal lamb kidney (FLK)
0021-9975/83/030463 + 07 $03.00/0 © 1983 Academic Press Inc. (London) Limited
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cells from the 28th passage virus as previously described (Vantsis, Rennie, Gardiner,
Wells, Barlow and Martin, 1980). Clarified virus suspensions containing 105 to 10°
TCID30 per ml were used as inocula. BVD virus (NADL strain) of unknown passage
number was grown in secondary bovine embryonic kidney cells by a similar method
to the above and a clarified virus suspension containing 105'5 TCID60 per ml was
used for experimental infection.
Animals received a 2 ml inoculation of live virus subcutaneously over the left
shoulder.
Virus Isolation
Samples of between 4 and 11 tissues from each animal were collected aseptically
into virus transport medium and subsequently inoculated into duplicate tubes of
secondary FLK cells previously screened and shown to be free of contaminating
pestiviruses (Nettleton, Herring and Corrigall, 1980). The cells were incubated at
37°G and examined regularly for virus cytopathic effect (CPE). After 7 days cultures
were frozen and thawed and passaged into further tubes of FLK cells. All specimens
received a minimum of 3 such weekly passages and viruses which had caused com¬
plete destruction of the cell sheet after this time were classified as cytopathic. Non-
cytopathic pestiviruses were detected by an indirect immunofluorescent test with a
convalescent sheep serum with a high titre against BD virus (Gardiner, 1980) and
the identity of all the isolates was confirmed by this method.
Serology
Heat inactivated serum samples were tested for the presence of antibodies in a
micro-neutralization test against both BD and BVD viruses with approximately 100
TCID50 of virus per well. Serum dilutions and virus were incubated for 1 h at 37°C
before the addition of cells from a semi-continuous fibroblastic cell line grown from
foetal lamb brain. Cultures were examined for the presence of CPE after 5 days and
the result expressed as the reciprocal of the serum dilution corresponding to the 50
per cent end-point of neutralization as calculated by the Spearman-Karber method
(Lennette and Schmidt, 1969). The results quoted are the means of at least 3 separate
tests against each of the viruses.
RESULTS
Serological and virological results are summarized in Table 1 together with
the occurrence of clinical disease. Detailed pathological findings are to be found
in the previous paper (Barlow et al., 1983).
Clinical
Six sheep developed an intractable debilitating scour, nos 1, 2 and 3 spon¬
taneously and 6, 7 and 9, 2 to 3 weeks after the injection of homologous live
virus. Examination of the faeces revealed no evidence of gastro-intestinal
parasites or pathogenic bacteria. Four of the sheep injected with live homolo¬
gous virus (nos 8, 10, 11 and 13) became severely depressed, no. 8 developing
mucous nasal discharge and mild respiratory distress. No sheep in any of the
other injected groups displayed any clinical malaise. All the sheep except no.
13 died or were killed within a month of injection. As no. 13 showed signs of
recovery, necropsy was delayed for 10 months during which period it remained
clinically normal.
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Serology
In normal sheep, both challenge viruses stimulated the production of serum
neutralizing (SN) antibodies with a degree of cross-reactivity by 3 weeks after
inoculation but BD virus appeared to be more immunogenic. However, the
antibody produced by RHS sheep after challenge did not cross-react; groups 1
and 2 produced only anti-BD antibodies and group 3 only anti-BVD antibodies.
Sheep no. 13 was negative at 3 weeks but subsequently seroconverted speci¬
fically, having anti-BD titres of 47, 110 and 73 at 2, 4 and 8 months after
inoculation, respectively, whilst anti-BVD antibodies remained undetectable
over this period.
Virology
No virus was detected in any of the 12 tissues examined from the 2 normal
sheep 3 weeks after inoculation with live BD virus but virus was isolated from
all the RHS sheep. In those groups in which clinical disease occurred (Table 1)
virus was predominantly cytopathic and was isolated from a larger range of
tissues.
DISCUSSION
Clinical disease associated with widespread and severe lympho-proliferative
changes occurred either spontaneously or after "superinfection" with the
homologous BD virus but not with the heterologous BVD virus. Although these
changes suggest an immunological response, they were associated with little or
no neutralizing antibody and virus was not eliminated, and it is possible that
the immune system was specifically compromised by exposure to the same virus
during foetal life. Most affected lambs and RHS persistently excrete virus and
the distribution of BD viral antigen is comparatively stable over long periods
(Gardiner, 1980). Thus a type of dynamic equilibrium exists between virus
and host.
The virological results in groups 3 and 4 confirm our experience that BD
virus isolated from RHS lambs and sheep is almost always non-cytopathic in
tissue culture, even when the original infecting virus was cytopathic. However,
in the groups of animals with clinical signs of disease, isolates of virus were
predominantly cytopathic. In the experimental cases re-isolation of the cyto¬
pathic super-infecting virus may have occurred but a more generally valid
explanation would be that changes, reflected as regained cytopathogenicity in
culture, occurred in the persisting virus. The state of equilibrium in the ap¬
parently healthy RHS lamb may therefore reflect some form of virus attenua¬
tion within host cells, disease arising from an upset of this virus/host equilibrium,
with reassertion of viral pathogenicity.
The disease syndrome observed in these sheep bears a strong resemblance to
aspects of BVD infection in cattle, notably the fatal form known as mucosal
disease (Malmquist 1968; Steck, Lazary, Fey, Wandeler, Huggler, Oppliger,
Baumberger, Kaderli and Martig, 1980). Antigenic cross-reactivity occurs be¬
tween BD, BVD and swine fever/hog cholera viruses (Acland, Gard and Plant,
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1972; Hamilton and Timoney, 1972; Plant, Littlejohns, Gardiner, Vantsis and
Huck, 1973) and similar teratogenic consequences of infecting sheep with
BVD virus and cattle with BD virus have been recorded (Barlow, Rennie,
Gardiner and Vantsis, 1980; Gibbons, Winkler, Shaw, Terlecki, Richardson
and Done, 1974). In BVD, changes in cytopathogenicity have also been re¬
ported (Malmquist, 1968; Done, Terlecki, Richardson, Harkness, Sands,
Patterson, Sweasey, Shaw, Winkler and Duffell, 1980). Thus it is clear that BD
and BVD have much in common, differences being more of degree than of a
fundamental nature.
Persistence of virus and lack of antibodies following foetal infection are indi¬
cators of immune tolerance or suppression. Malmquist (1968) and Steck et al.
(1980) have associated MD or chronic BVD with prenatal infection and poss¬
ible immune tolerance. Johnson and Muscoplat (1973) and Muscoplat,
Johnson and Teuscher (1973) have presented evidence for immunosuppression
and upsets in lymphocyte function in young cattle brought in from the field
suffering from chronic BVD infection. Immunosuppression associated with
acute BVD infections and suppressive effects of the virus on lymphocyte cultures
have also been described (Muscoplat, Johnson and Stevens, 1973; Pospisil,
Machatkova, Mensik, Rodak and Muller, 1975; Roth, Kaeberle and Griffith,
1981; Reggiardo and Kaebcrle, 1981).
A hypothetical concept of immune tolerance in relation to the present work
is illustrated in Fig. 1. If an animal were completely tolerant to virus SA,
reactivity to all the shared antigens enclosed by the broken line would be
absent. Subsequent immune response to viruses SB, SC and SD would be
directed against B or C or D antigens only, i.e. tolerance confers specificity on
a partially cross-reacting system.
! 1 ; 0 1 0
Fig. 1. A hypothetical series of viruses with shared (S) and unshared (A, B, C, D) antigens. Tolerance
to virus SA confers non-reactivity to the shared antigenic components of the other viruses enclosed
within the broken line.
The experiments reported here support this theory. Lambs were specifically
susceptible to superinfection with the strain of virus they were excreting and to
which, up to the time of challenge, they had no SN antibodies. Following
challenge there was an apparent breakdown in tolerance in 4 out of 8 animals
but antibodies cross-reacting with BVD virus were not detected. The antibody
produced by RHS sheep challenged with BVD virus did not cross-react with BD
virus. Had the animals lived longer, cross-reacting antibodies might have ap¬
peared, but in the one animal (no. 13) that survived for 10 months this did
not happen.
These results are relevant to poorly explained aspects of mucosal disease viz.
the occurrence of spontaneous illness and death in persistent virus excretors in
the presence or absence of SN antibody. A recent report on the vaccination of
209 seronegative cattle with a live Oregon strain BVD virus vaccine (Steck et
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al., 1980) is typical. Four animals persistently excreted a field strain of BVD
virus to which they produced no SN antibody either before or after vaccination.
Although they responded specifically and well to the vaccine, they subsequently
died of MD. Two further animals did not respond to the vaccine and died 8 and
16 days later, MD being diagnosed in one. Such results have serious implica¬
tions for vaccination. Non-reactors, or those producing non-cross-reacting
antibody, may be immunotolerant persistent excretors of virus and may die
from mucosal disease subsequently.
In view of the foregoing we conclude that sheep and cattle persistently ex¬
creting BD or BVD viruses are likely to be specifically immunotolerant to a
particular strain of virus as a result of transplacental infection with that strain
in early pregnancy. In such animals the virus appears to exist in equilibrium
with the host in some attenuated form. Pathogenicity may be reasserted follow¬
ing specific homologous re-infection or following some unknown event, the
consequence being mucosal disease in cattle and a similar syndrome in sheep.
SUMMARY
A disease similar to mucosal disease (MD) of cattle has occurred spontane¬
ously in sheep clinically recovered from Border disease (BD). Evidence is
presented to suggest that, in such animals, a specific and dynamic equilibrium
exists between an attenuated form of the virus and the immunotolerant host.
Upset of this equilibrium either by injection of BD virus of the same strain or by
some unknown spontaneous event appears to lead to the reassertion of viral
pathogenicity with fatal consequences.
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